[{"source":"bitly bitlink","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/lxsIdWInwa","expanded_url":"http://bit.ly/1jhnSKI","display_url":"bit.ly/1jhnSKI"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"425229600256696320","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T11:33:31.000Z","conversation_id":"425229600256696320","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Last year we recommended 81 human #medicines for marketing authorisation, including 38 with new active substances: http://t.co/lxsIdWInwa","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/mJUxIbzXuR","expanded_url":"http://bit.ly/1bd7LWw","display_url":"bit.ly/1bd7LWw"}],"hashtags":[{"start":36,"end":47,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"425229056020582400","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T11:31:21.000Z","conversation_id":"425229056020582400","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last year we saw a record number of #veterinary applications for marketing authorisations: http://t.co/mJUxIbzXuR","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"id":"425222654686031872","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T11:05:55.000Z","conversation_id":"425222654686031872","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/M…","referenced_tweets":[{"type":"retweeted","id":"425221856178995200"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/C81pfU1ARS","expanded_url":"http://bit.ly/1aDjTD9","display_url":"bit.ly/1aDjTD9"}],"hashtags":[{"start":18,"end":23,"tag":"Gene"},{"start":34,"end":44,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"id":"425222617197334528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T11:05:46.000Z","conversation_id":"425222617197334528","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: #Gene therapy 4 #Parkinson's disease: A step closer? http://t.co/C81pfU1ARS","referenced_tweets":[{"type":"retweeted","id":"425221313800577026"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"425222521487507456","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T11:05:24.000Z","conversation_id":"425222521487507456","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Safety warnings and messages for medicines: Information sent to healthcare professionals in December about the... http:/…","referenced_tweets":[{"type":"retweeted","id":"425220893078343680"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/lIorRrHXAG","expanded_url":"http://goo.gl/Gr5roQ","display_url":"goo.gl/Gr5roQ"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"425217250111414272","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:44:27.000Z","conversation_id":"425217250111414272","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 http://t.co/lIorRrHXAG (20 January 2014)","referenced_tweets":[{"type":"retweeted","id":"425216299984113665"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/mizDsr1f9j","expanded_url":"http://bit.ly/1jb1oLd","display_url":"bit.ly/1jb1oLd"}],"hashtags":[{"start":53,"end":64,"tag":"veterinary"},{"start":93,"end":98,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"425217103579197440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:43:52.000Z","conversation_id":"425217103579197440","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"On Friday we published the highlights of our January #veterinary medicines committee meeting #CVMP: http://t.co/mizDsr1f9j","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/IlCnshcCry","expanded_url":"http://bit.ly/LpS9t2","display_url":"bit.ly/LpS9t2"}],"hashtags":[{"start":31,"end":42,"tag":"Sisymbrium"}],"mentions":{},"annotations":{}},"id":"425216705904652288","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:42:17.000Z","conversation_id":"425216705904652288","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our draft herbal monograph for #Sisymbrium (hedge mustard) is out for public consultation until 15 April: http://t.co/IlCnshcCry","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/2fvxdotDNS","expanded_url":"http://bit.ly/1e222X6","display_url":"bit.ly/1e222X6"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"id":"425214335476969472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:32:52.000Z","conversation_id":"425214335476969472","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Legemiddelinfo: Does the long-term use of paracetamol during pregnancy affect neurological development? http://t.co/2fvxdotDNS","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/YWwBmX6qq2","expanded_url":"http://bit.ly/1eYB6bO","display_url":"bit.ly/1eYB6bO"}],"hashtags":[{"start":90,"end":101,"tag":"alzheimers"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":24,"end":32,"probability":0.5317,"type":"Other","normalized_text":"Alzheimer"}]},"id":"425213711440019457","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:30:23.000Z","conversation_id":"425213711440019457","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Mechanism in Alzheimer's-related memory loss identified http://t.co/YWwBmX6qq2 #alzheimers","referenced_tweets":[{"type":"retweeted","id":"425207974550716416"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":23,"end":28,"tag":"H7N9"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"425213604166524928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:29:57.000Z","conversation_id":"425213604166524928","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: The source of #H7N9 infection is still under investigation. So far, there is no evidence of sustained human-to-human transmission","referenced_tweets":[{"type":"retweeted","id":"425207036662386688"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/RXoEoq86Mt","expanded_url":"http://bit.ly/1dn3H5R","display_url":"bit.ly/1dn3H5R"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":69,"end":84,"username":"VaccinesEurope","id":"1262320285"}],"annotations":{}},"id":"425213288176435200","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:28:42.000Z","conversation_id":"425213288176435200","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: HPV Vaccine Shows Dramatic Success http://t.co/RXoEoq86Mt @VaccinesEurope","referenced_tweets":[{"type":"retweeted","id":"425191878485491712"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":8,"username":"FLKamal","id":"1562191868"}],"annotations":{}},"id":"425210810772639744","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-20T10:18:51.000Z","conversation_id":"424279206894501889","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"@FLKamal We're aiming to publish the agenda today.","referenced_tweets":[{"type":"replied_to","id":"424279206894501889"}],"in_reply_to_user_id":"1562191868","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/lliHsdUaYI","expanded_url":"https://ec.europa.eu/digital-agenda/en/eu-policy-ehealth","display_url":"ec.europa.eu/digital-agenda…"}],"hashtags":[{"start":34,"end":42,"tag":"eHealth"},{"start":75,"end":78,"tag":"EU"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"annotations":{}},"id":"424224925176455168","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T17:01:18.000Z","conversation_id":"424224925176455168","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Check out our new #eHealth webpages incl studies, experts, #EU activities &amp; projects, ...\nhttps://t.co/lliHsdUaYI @DigitalA…","referenced_tweets":[{"type":"retweeted","id":"424213134594023424"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/oClmIjuQ2n","expanded_url":"http://bit.ly/1mb5ikm","display_url":"bit.ly/1mb5ikm"}],"hashtags":[{"start":66,"end":70,"tag":"flu"},{"start":78,"end":83,"tag":"H7N9"},{"start":85,"end":97,"tag":"chikungunya"},{"start":99,"end":104,"tag":"zika"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"424224439002075137","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T16:59:22.000Z","conversation_id":"424224439002075137","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Our weekly threats report is out and covers seasonal #flu, avian #H7N9, #chikungunya, #zika and more: http://t.co/oClmIjuQ2n","referenced_tweets":[{"type":"retweeted","id":"424218676615581696"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/0HWbA6hvSa","expanded_url":"http://bit.ly/LpS9t2","display_url":"bit.ly/LpS9t2"}],"hashtags":[{"start":47,"end":58,"tag":"Sisymbrium"}],"mentions":{},"annotations":{}},"id":"424204271752851456","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:39:14.000Z","conversation_id":"424204271752851456","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the draft herbal monograph for #Sisymbrium (hedge mustard) for public consultation:  http://t.co/0HWbA6hvSa","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"424200890182942720","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:25:48.000Z","conversation_id":"424111658752278528","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk Line extensions are not in highlights, but see agenda next week + minutes next month. To send a query: http://t.co/PXIKAo9uV4","referenced_tweets":[{"type":"replied_to","id":"424116312953323521"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ee3XNmieSU","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"hashtags":[{"start":85,"end":96,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"424196424251629568","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:08:03.000Z","conversation_id":"424196424251629568","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our concept paper on harmonising withdrawal periods for #veterinary medicines: http://t.co/ee3XNmieSU","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/l1OLxmq096","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"hashtags":[{"start":107,"end":111,"tag":"ALS"}],"mentions":{},"annotations":{}},"id":"424196332673196032","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:07:41.000Z","conversation_id":"424196332673196032","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks to comment on guideline on clinical investigation of medicines for amyotrophic lateral sclerosis #ALS: http://t.co/l1OLxmq096","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/v5dygHNGA4","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"hashtags":[{"start":96,"end":109,"tag":"hypertension"}],"mentions":{},"annotations":{}},"id":"424196166893334528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:07:02.000Z","conversation_id":"424196166893334528","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on update of our guideline on clinical investigation of medicines for #hypertension: http://t.co/v5dygHNGA4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/t5vBbsrYl9","expanded_url":"http://bit.ly/1dAXr0q","display_url":"bit.ly/1dAXr0q"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"424195458760577026","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:04:13.000Z","conversation_id":"424195458760577026","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our human medicines committee, #CHMP, holds its first 2014 meeting next week. Highlights out next Friday: http://t.co/t5vBbsrYl9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/VPkkgdJItD","expanded_url":"http://bit.ly/1jb1oLd","display_url":"bit.ly/1jb1oLd"}],"hashtags":[{"start":38,"end":49,"tag":"veterinary"},{"start":88,"end":93,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"424194998457081856","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T15:02:23.000Z","conversation_id":"424194998457081856","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights of our #veterinary medicines committee meeting this week #CVMP: http://t.co/VPkkgdJItD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":15,"end":25,"tag":"Medicines"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":114,"end":125,"username":"bmj_latest","id":"16949344"}],"annotations":[{"start":43,"end":44,"probability":0.4852,"type":"Organization","normalized_text":"EU"}]},"id":"424181247766581248","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T14:07:45.000Z","conversation_id":"424181247766581248","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: #Medicines withdrawn in the EU for safety reasons and evidence used to support the decision making @bmj_latest http://t.co/s…","referenced_tweets":[{"type":"retweeted","id":"424118166684332032"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/WHvpHgcZsE","expanded_url":"http://bit.ly/1dfVOSZ","display_url":"bit.ly/1dfVOSZ"}],"hashtags":[{"start":91,"end":97,"tag":"lipid"}],"mentions":{},"annotations":{}},"id":"424142682881916928","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T11:34:30.000Z","conversation_id":"424142682881916928","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published a guideline on the clinical investigation of medicines in the treatment of #lipid disorders: http://t.co/WHvpHgcZsE","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/sfstXoyBqs","expanded_url":"http://bit.ly/1dANpe9","display_url":"bit.ly/1dANpe9"}],"hashtags":[{"start":85,"end":96,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"424142133193633793","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T11:32:19.000Z","conversation_id":"424142133193633793","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our concept paper on harmonising withdrawal periods for #veterinary medicines: http://t.co/sfstXoyBqs","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/eVLX7dS45P","expanded_url":"http://bit.ly/Lo9Xoe","display_url":"bit.ly/Lo9Xoe"}],"hashtags":[{"start":112,"end":116,"tag":"ALS"}],"mentions":{},"annotations":{}},"id":"424114892749438976","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T09:44:04.000Z","conversation_id":"424114892749438976","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to comment on guideline on clinical investigation of medicines for amyotrophic lateral sclerosis #ALS: http://t.co/eVLX7dS45P","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/GUXusFvTI9","expanded_url":"http://bit.ly/KmWGe9","display_url":"bit.ly/KmWGe9"}],"hashtags":[{"start":103,"end":116,"tag":"hypertension"}],"mentions":{},"annotations":{}},"id":"424112949096349696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T09:36:21.000Z","conversation_id":"424112949096349696","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on latest update of our guideline on clinical investigation of medicines for #hypertension: http://t.co/GUXusFvTI9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WKYQ9BIxPn","expanded_url":"http://bit.ly/1dAXr0q","display_url":"bit.ly/1dAXr0q"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"424111658752278528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-17T09:31:13.000Z","conversation_id":"424111658752278528","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Our human medicines committee, #CHMP, is meeting next week. Highlights out next Friday: http://t.co/WKYQ9BIxPn","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"tomayates","id":"261643662"},{"start":93,"end":107,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"id":"423865361906143232","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T17:12:31.000Z","conversation_id":"420439570862206976","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"@tomayates We will publish full details about the authorisation and its conditions after the @EU_Commission grants marketing authorisation.","referenced_tweets":[{"type":"replied_to","id":"420439570862206976"}],"in_reply_to_user_id":"261643662","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/TmCQqhUZA9","expanded_url":"http://bit.ly/1asvc14","display_url":"bit.ly/1asvc14"}],"hashtags":[{"start":17,"end":28,"tag":"Riboflavin"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"id":"423862056400326657","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T16:59:23.000Z","conversation_id":"423862056400326657","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: #Riboflavin for all animal species http://t.co/TmCQqhUZA9","referenced_tweets":[{"type":"retweeted","id":"423860524137197568"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/CFAcDRYHLH","expanded_url":"http://bit.ly/1kEgOcN","display_url":"bit.ly/1kEgOcN"}],"hashtags":[{"start":17,"end":25,"tag":"Vitamin"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"id":"423862043834212352","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T16:59:20.000Z","conversation_id":"423862043834212352","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: #Vitamin K3 for all animal species http://t.co/CFAcDRYHLH","referenced_tweets":[{"type":"retweeted","id":"423860505988435968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/4X779HM8oC","expanded_url":"http://bit.ly/LasfJ5","display_url":"bit.ly/LasfJ5"}],"hashtags":[{"start":20,"end":30,"tag":"plantarum"},{"start":38,"end":47,"tag":"buchneri"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"annotations":{}},"id":"423862031712677888","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T16:59:18.000Z","conversation_id":"423862031712677888","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSAJournal: L. #plantarum and L. #buchneri for cattle and sheep http://t.co/4X779HM8oC","referenced_tweets":[{"type":"retweeted","id":"423860484324851712"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/JFr3uA2nLV","expanded_url":"http://www.fiercepharmamanufacturing.com/story/fda-assigns-agent-europol-fight-against-fakes/2014-01-16?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.UtgKwZV40V1.twitter","display_url":"fiercepharmamanufacturing.com/story/fda-assi…"}],"hashtags":[{"start":20,"end":24,"tag":"FDA"}],"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"},{"start":82,"end":95,"username":"FiercePharma","id":"18294275"}],"annotations":{}},"id":"423858491791396864","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T16:45:14.000Z","conversation_id":"423858491791396864","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @USPharmacopeia: #FDA assigns an agent to Europol in its fight against fakes - @FiercePharma: http://t.co/JFr3uA2nLV","referenced_tweets":[{"type":"retweeted","id":"423856782725763072"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/cSh5dBUDav","expanded_url":"http://bit.ly/1dfVOSZ","display_url":"bit.ly/1dfVOSZ"}],"hashtags":[{"start":100,"end":106,"tag":"lipid"}],"mentions":{},"annotations":{}},"id":"423854294388199426","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T16:28:33.000Z","conversation_id":"423854294388199426","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published a guideline on the clinical investigation of medicinal products in the treatment of #lipid disorders: http://t.co/cSh5dBUDav","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/8zUQYR04q8","expanded_url":"http://goo.gl/X2Hzdb","display_url":"goo.gl/X2Hzdb"}],"hashtags":[{"start":45,"end":50,"tag":"H7N9"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":54,"end":58,"probability":0.9881,"type":"Place","normalized_text":"China"}]},"id":"423839280750804992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:28:53.000Z","conversation_id":"423839280750804992","public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Latest WHO Disease Outbreak News on #H7N9 in China http://t.co/8zUQYR04q8 (16 January 2014)","referenced_tweets":[{"type":"retweeted","id":"423839203558842368"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/P1DOFIxhMl","expanded_url":"http://bit.ly/1dyDXcO","display_url":"bit.ly/1dyDXcO"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"id":"423838386336456704","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:25:20.000Z","conversation_id":"423838386336456704","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Publication of the monthly bulletin from the Spanish medicines agency for December 2013 http://t.co/P1DOFIxhMl","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/Tnu4QvVKyw","expanded_url":"http://bit.ly/1b5ZjYT","display_url":"bit.ly/1b5ZjYT"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"id":"423837488860246016","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:21:46.000Z","conversation_id":"423837488860246016","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Recall of the product Epistabol http://t.co/Tnu4QvVKyw","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Q2MrQmopwo","expanded_url":"http://bit.ly/1aZeKCi","display_url":"bit.ly/1aZeKCi"}],"hashtags":[{"start":13,"end":24,"tag":"Brintellix"},{"start":26,"end":39,"tag":"vortioxetine"},{"start":88,"end":99,"tag":"depression"}],"mentions":{},"annotations":{}},"id":"423837136668741632","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:20:22.000Z","conversation_id":"423837136668741632","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"The EPAR for #Brintellix (#vortioxetine), a recently authorised medicine to treat major #depression, is available: http://t.co/Q2MrQmopwo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"id":"423836599260946433","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:18:14.000Z","conversation_id":"423836599260946433","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: MHRA Stakeholder Engagement Meeting - 25 October 2013: The minutes of the Medicines &amp; Healthcare products Regu... http://t.c…","referenced_tweets":[{"type":"retweeted","id":"423835588244938752"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/1W5yvUeX7r","expanded_url":"http://bit.ly/1aQa4Cm","display_url":"bit.ly/1aQa4Cm"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"id":"423836558140006402","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:18:04.000Z","conversation_id":"423836558140006402","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: MHRA Stakeholder Engagement Meeting - 25 October 2013 http://t.co/1W5yvUeX7r","referenced_tweets":[{"type":"retweeted","id":"423835585854193664"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/m4xwtkJDnp","expanded_url":"http://ow.ly/so3hX","display_url":"ow.ly/so3hX"}],"hashtags":[{"start":23,"end":38,"tag":"WorldCancerDay"},{"start":120,"end":138,"tag":"debunkcancermyths"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"id":"423834633516490752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T15:10:25.000Z","conversation_id":"423834633516490752","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @uicc: Download the #WorldCancerDay 2014 campaign materials here http://t.co/m4xwtkJDnp and disseminate them to help #debunkcancermyths","referenced_tweets":[{"type":"retweeted","id":"423802712007131136"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":45,"end":60,"tag":"WorldCancerDay"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"id":"423814974822051840","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:52:18.000Z","conversation_id":"423814974822051840","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @uicc: You have something planned to mark #WorldCancerDay 2014? No matter how big or small, share it on our Map of Events: http://t.co/Z…","referenced_tweets":[{"type":"retweeted","id":"423772269522202625"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/RRbNr1eBba","expanded_url":"http://bit.ly/1dSXIGM","display_url":"bit.ly/1dSXIGM"}],"hashtags":[{"start":31,"end":39,"tag":"Tobacco"},{"start":41,"end":56,"tag":"Clinicaltrials"},{"start":71,"end":77,"tag":"waste"},{"start":79,"end":88,"tag":"aviation"},{"start":95,"end":101,"tag":"EUETS"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"}],"annotations":{}},"id":"423814417537441792","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:50:05.000Z","conversation_id":"423814417537441792","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EP_Environment: Next week: #Tobacco, #Clinicaltrials, shipments of #waste, #aviation &amp; #EUETS. agenda http://t.co/RRbNr1eBba docs http:…","referenced_tweets":[{"type":"retweeted","id":"423766188062035968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/7rAP7xmNlg","expanded_url":"http://bit.ly/1aNDwsw","display_url":"bit.ly/1aNDwsw"}],"hashtags":[{"start":106,"end":119,"tag":"AnimalHealth"},{"start":120,"end":131,"tag":"Regulation"}],"mentions":{},"annotations":[{"start":40,"end":45,"probability":0.7077,"type":"Place","normalized_text":"Europe"},{"start":75,"end":80,"probability":0.8935,"type":"Place","normalized_text":"London"}]},"id":"423814380585623552","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:49:57.000Z","conversation_id":"423814380585623552","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: Save the date! EMA/IFAH-Europe Info-day, 13-14 March 2014, London: http://t.co/7rAP7xmNlg #AnimalHealth #Regulation","referenced_tweets":[{"type":"retweeted","id":"423765981719048192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":18,"end":25,"tag":"EUReMS"},{"start":42,"end":60,"tag":"MultipleSclerosis"}],"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"annotations":[{"start":78,"end":83,"probability":0.9795,"type":"Place","normalized_text":"Europe"}]},"id":"423814270992662528","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:49:30.000Z","conversation_id":"423814270992662528","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eumsplatform: #EUReMS started pooling #MultipleSclerosis data from across Europe and will soon produce landmark studies http://t.co/TgJ…","referenced_tweets":[{"type":"retweeted","id":"423763213528739842"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/fxA8DgkjxQ","expanded_url":"http://bit.ly/1eUHEWU","display_url":"bit.ly/1eUHEWU"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"423814100238356480","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:48:50.000Z","conversation_id":"423814100238356480","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: AIFA encourages transparency as a tool against corruption http://t.co/fxA8DgkjxQ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/gE9w6qkYT0","expanded_url":"http://link.springer.com/content/pdf/10.1007%2Fs00125-013-3098-3.pdf","display_url":"link.springer.com/content/pdf/10…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"annotations":{}},"id":"423813412007596032","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-16T13:46:06.000Z","conversation_id":"423813412007596032","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EASDnews: Are we overestimating the loss of beta cells in type 2 diabetes?  http://t.co/gE9w6qkYT0","referenced_tweets":[{"type":"retweeted","id":"423757861026410496"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":20,"tag":"HINARI"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"423511449223172096","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-15T17:46:12.000Z","conversation_id":"423511449223172096","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: WHO #HINARI Access to Research in Health programme provides access to one of world’s largest collections of biomedical, health lit…","referenced_tweets":[{"type":"retweeted","id":"423490233162678272"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/LKmvlfpHmT","expanded_url":"http://www.rare-diseases.eu/registration/","display_url":"rare-diseases.eu/registration/"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":95,"end":100,"probability":0.5514,"type":"Place","normalized_text":"Berlin"}]},"id":"423491766306631681","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-15T16:27:59.000Z","conversation_id":"423491766306631681","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Only one month left to benefit from \"early-bird\" registration fees for ECRD 2014 Berlin. Register http://t.co/LKmvlfpHmT #Rar…","referenced_tweets":[{"type":"retweeted","id":"423462902994321408"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":51,"end":65,"tag":"Communication"},{"start":102,"end":110,"tag":"vacancy"},{"start":111,"end":123,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"423386082575536129","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-15T09:28:02.000Z","conversation_id":"423386082575536129","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our vacancy as Head of #Communication Department: http://t.co/q7szO133Tt  #vacancy #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/9Y7Mh3K1Yp","expanded_url":"http://bit.ly/1a4eTd2","display_url":"bit.ly/1a4eTd2"}],"hashtags":[{"start":108,"end":116,"tag":"BigData"},{"start":117,"end":126,"tag":"Diseases"},{"start":127,"end":137,"tag":"Analytics"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":[{"start":45,"end":51,"probability":0.4806,"type":"Product","normalized_text":"Twitter"}]},"id":"423124474628554752","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-14T16:08:30.000Z","conversation_id":"423124474628554752","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: WATCH - How Big Data Analytics on Twitter Can Help Predict Disease Spread http://t.co/9Y7Mh3K1Yp #BigData #Diseases #Analytics","referenced_tweets":[{"type":"retweeted","id":"423124373399011329"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/VBIWZYRMLr","expanded_url":"http://bit.ly/1aZeKCi","display_url":"bit.ly/1aZeKCi"}],"hashtags":[{"start":100,"end":111,"tag":"depression"}],"mentions":{},"annotations":[{"start":42,"end":51,"probability":0.3385,"type":"Organization","normalized_text":"Brintellix"}]},"id":"423058005186600960","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-14T11:44:23.000Z","conversation_id":"423058005186600960","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for Brintellix, a recently authorised medicine to treat major #depression: http://t.co/VBIWZYRMLr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/vJml4d0YpT","expanded_url":"http://bit.ly/1cZdDpo","display_url":"bit.ly/1cZdDpo"}],"hashtags":[{"start":107,"end":111,"tag":"IBS"}],"mentions":{},"annotations":{}},"id":"423021883223965696","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-14T09:20:50.000Z","conversation_id":"423021883223965696","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on draft guideline on evaluation of medicines for treating irritable bowel syndrome #IBS: http://t.co/vJml4d0YpT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/rtYY5P6xVg","expanded_url":"http://bit.ly/1dmai4Q","display_url":"bit.ly/1dmai4Q"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"423021111795007488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-14T09:17:47.000Z","conversation_id":"423021111795007488","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on guideline on developing medicines to prevent stroke in patients with atrial fibrillation:  http://t.co/rtYY5P6xVg","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"Yenenga","id":"14648460"}],"annotations":{}},"id":"422778045607313408","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T17:11:55.000Z","conversation_id":"422690550219677696","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@Yenenga It is currently being finalised and publication expected in Q1 2014. You can send us a detailed question at http://t.co/PXIKAo9uV4","referenced_tweets":[{"type":"replied_to","id":"422690550219677696"}],"in_reply_to_user_id":"14648460","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"annotations":{}},"id":"422740376370171904","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T14:42:14.000Z","conversation_id":"422740376370171904","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IAPOtweets: Putting patients first: Five global healthcare organizations sign Consensus Framework for Ethical Collaboration http://t.co…","referenced_tweets":[{"type":"retweeted","id":"422725665591287808"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/l3w2Nuiam5","expanded_url":"http://euapm.eu/","display_url":"euapm.eu"}],"hashtags":[{"start":35,"end":56,"tag":"personalisedmedicine"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"422739989797928960","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T14:40:42.000Z","conversation_id":"422739989797928960","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: What’s your opinion on #personalisedmedicine? The EAPM wants to know! Survey at http://t.co/l3w2Nuiam5","referenced_tweets":[{"type":"retweeted","id":"422731587487162369"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/IbYnIy6JU7","expanded_url":"http://bit.ly/1djS0Tm","display_url":"bit.ly/1djS0Tm"}],"hashtags":[{"start":90,"end":99,"tag":"Protelos"},{"start":102,"end":109,"tag":"Osseor"}],"mentions":{},"annotations":{}},"id":"422676888788541440","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T10:29:57.000Z","conversation_id":"422676888788541440","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We published the PRAC meeting highlights last Friday - PRAC recommended suspending use of #Protelos / #Osseor : http://t.co/IbYnIy6JU7","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/otZtO7cuUF","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"hashtags":{},"mentions":{},"annotations":[{"start":35,"end":37,"probability":0.3458,"type":"Organization","normalized_text":"EMA"}]},"id":"422660360550612992","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T09:24:17.000Z","conversation_id":"422660360550612992","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Interested in a traineeship at the EMA? Application details for 2014 now available: http://t.co/otZtO7cuUF","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/FNGVbdh30M","expanded_url":"http://bit.ly/1ipYgsd","display_url":"bit.ly/1ipYgsd"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":41,"end":46,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"422659287786065921","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-13T09:20:01.000Z","conversation_id":"422659287786065921","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #veterinary medicines committee, the #CVMP, meets this week. Highlights out this Friday: http://t.co/FNGVbdh30M","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/hEODiqQZxd","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"421648886475005953","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-10T14:25:03.000Z","conversation_id":"421648886475005953","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":3,"quote_count":0},"lang":"en","text":"Apply for our 2014 traineeship programme. Details and application form on our website: http://t.co/hEODiqQZxd","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/BeTo1SuNnt","expanded_url":"http://bit.ly/1ipYgsd","display_url":"bit.ly/1ipYgsd"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":41,"end":46,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"421630347999449088","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-10T13:11:23.000Z","conversation_id":"421630347999449088","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #veterinary medicines committee, the #CVMP, meets next week. Highlights published next Friday: http://t.co/BeTo1SuNnt","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/tqoymrlVH2","expanded_url":"http://bit.ly/1djS0Tm","display_url":"bit.ly/1djS0Tm"}],"hashtags":[{"start":85,"end":94,"tag":"Protelos"},{"start":97,"end":104,"tag":"Osseor"}],"mentions":{},"annotations":{}},"id":"421616057481449472","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-10T12:14:36.000Z","conversation_id":"421616057481449472","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've just published the PRAC meeting highlights - PRAC recommends suspending use of #Protelos / #Osseor : http://t.co/tqoymrlVH2","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"421583022530367488","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-10T10:03:19.000Z","conversation_id":"421573200145707008","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk It is CHMP that recommends approval or not. Next mtg 20-23 Jan. For more info please send us a query at http://t.co/PXIKAo9uV4","referenced_tweets":[{"type":"replied_to","id":"421573200145707008"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/KCg3HaeDrW","expanded_url":"http://bit.ly/1a7vlU9","display_url":"bit.ly/1a7vlU9"}],"hashtags":[{"start":106,"end":112,"tag":"EPIET"},{"start":113,"end":120,"tag":"EUPHEM"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":16,"end":24,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"421279526543323136","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-09T13:57:20.000Z","conversation_id":"421279526543323136","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_TB: MT @ECDC_EU: Apply for epidemiology &amp; public health microbiology training by 2 Feb 2014, #EPIET #EUPHEM http://t.co/KCg3HaeDrW","referenced_tweets":[{"type":"retweeted","id":"421216604303544321"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/LkrE5fvECr","expanded_url":"http://ow.ly/snm8x","display_url":"ow.ly/snm8x"}],"hashtags":[{"start":50,"end":62,"tag":"cancerfacts"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"id":"421272965284499458","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-09T13:31:16.000Z","conversation_id":"421272965284499458","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @uicc: Want to see the evidence behind the key #cancerfacts? Download the Evidence Sheets available here: http://t.co/LkrE5fvECr #WorldC…","referenced_tweets":[{"type":"retweeted","id":"421265565588942848"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/cToPC79JIR","expanded_url":"http://ow.ly/snho4","display_url":"ow.ly/snho4"}],"hashtags":[{"start":23,"end":38,"tag":"WorldCancerDay"},{"start":120,"end":138,"tag":"debunkcancermyths"}],"mentions":[{"start":3,"end":8,"username":"uicc","id":"53023973"}],"annotations":{}},"id":"420932749487120384","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-08T14:59:22.000Z","conversation_id":"420932749487120384","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @uicc: Download the #WorldCancerDay 2014 campaign materials here http://t.co/cToPC79JIR and disseminate them to help #debunkcancermyths","referenced_tweets":[{"type":"retweeted","id":"420903705941397504"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"420854238613221376","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-08T09:47:24.000Z","conversation_id":"420850346680782848","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk CHMP is the committee to recommend approval or not. When 20-23 Jan CHMP agenda published you can check if going for opinion.","referenced_tweets":[{"type":"replied_to","id":"420850346680782848"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/LFOsRFFLno","expanded_url":"http://bit.ly/17vmF90","display_url":"bit.ly/17vmF90"}],"hashtags":[{"start":73,"end":80,"tag":"stroke"}],"mentions":{},"annotations":{}},"id":"420848855341490176","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-08T09:26:00.000Z","conversation_id":"420848855341490176","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment on draft guidance on developing medicines to prevent #stroke in atrial fibrillation patients: http://t.co/LFOsRFFLno","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"measles"},{"start":28,"end":36,"tag":"rubella"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":60,"end":65,"probability":0.9899,"type":"Place","normalized_text":"Europe"}]},"id":"420592210766086144","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-07T16:26:11.000Z","conversation_id":"420592210766086144","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #measles &amp; #rubella cases unacceptably high in Europe to meet elimination target in 2015, see latest annual data: http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"420591180062015488"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Bg628FXr4V","expanded_url":"http://bit.ly/1bKgEpO","display_url":"bit.ly/1bKgEpO"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"id":"420143226566098944","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-06T10:42:05.000Z","conversation_id":"419170307492954112","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@RK_PassingCloud Please discuss in detail with the treating doctor who may refer you to a suitable trial: http://t.co/Bg628FXr4V","referenced_tweets":[{"type":"replied_to","id":"420135742090657793"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"Rayafadil","id":"355424757"}],"annotations":{}},"id":"420132836918566912","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-06T10:00:48.000Z","conversation_id":"419578559041380352","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@Rayafadil Not standard but may concern good pharmacovigilance practice or public health programmes. For more info please provide reference.","referenced_tweets":[{"type":"replied_to","id":"419578559041380352"}],"in_reply_to_user_id":"355424757","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/c21zUA82wL","expanded_url":"http://bit.ly/1g6iA01","display_url":"bit.ly/1g6iA01"},{"start":113,"end":135,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"id":"420125593150042112","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-06T09:32:01.000Z","conversation_id":"419170307492954112","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@RK_PassingCloud Please contact the sponsor for information. Check our site re. our role: http://t.co/c21zUA82wL http://t.co/Z7GrvbXFM6","referenced_tweets":[{"type":"replied_to","id":"419170307492954112"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/naN4gMT8Hp","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"420125008971567106","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-06T09:29:42.000Z","conversation_id":"420125008971567106","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're consulting on draft guidance on prescribing information for plasma-derived fibrin sealant/haemostatic products: http://t.co/naN4gMT8Hp","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/KFfwjtY4sa","expanded_url":"http://bit.ly/JO7XUv","display_url":"bit.ly/JO7XUv"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"419151177025331200","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T17:00:02.000Z","conversation_id":"419151177025331200","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've issued a draft guideline on the prescribing information for plasma-derived fibrin sealant/haemostatic products: http://t.co/KFfwjtY4sa","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/jTITVjREts","expanded_url":"http://bit.ly/1cqbAue","display_url":"bit.ly/1cqbAue"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"419147642677903361","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T16:46:00.000Z","conversation_id":"419147642677903361","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee is meeting next week. We'll publish the highlights next Friday: http://t.co/jTITVjREts","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/U5qzbMGdlo","expanded_url":"http://bit.ly/Kn8LRw","display_url":"bit.ly/Kn8LRw"}],"hashtags":[{"start":20,"end":24,"tag":"flu"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{}},"id":"419146707499118592","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T16:42:17.000Z","conversation_id":"419146707499118592","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: #flu vaccination of elderly is recommended, but coverage is uneven across the Euro Region: http://t.co/U5qzbMGdlo http:…","referenced_tweets":[{"type":"retweeted","id":"419135648646197248"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":101,"end":111,"tag":"IMIcall11"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"419076678552260610","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T12:04:01.000Z","conversation_id":"419076678552260610","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Healthcare-associated infections due to Gram-negative pathogens is one of the topics of  #IMIcall11. Join the webinar http://t.…","referenced_tweets":[{"type":"retweeted","id":"419068475706200064"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/wa1e8pA7Fy","expanded_url":"http://bit.ly/1bVPD2n","display_url":"bit.ly/1bVPD2n"}],"hashtags":[{"start":10,"end":17,"tag":"herbal"},{"start":42,"end":47,"tag":"Rosa"},{"start":49,"end":54,"tag":"rose"}],"mentions":{},"annotations":{}},"id":"419060704033792000","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T11:00:32.000Z","conversation_id":"419060704033792000","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The draft #herbal Community monograph for #Rosa (#rose flower) is out for public consultation: http://t.co/wa1e8pA7Fy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/flC2OAjlYB","expanded_url":"http://bit.ly/1jpyZCo","display_url":"bit.ly/1jpyZCo"}],"hashtags":[{"start":35,"end":43,"tag":"Kadcyla"},{"start":45,"end":57,"tag":"trastuzumab"},{"start":85,"end":98,"tag":"breastcancer"}],"mentions":{},"annotations":{}},"id":"419059999118090241","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T10:57:44.000Z","conversation_id":"419059999118090241","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We recently published the EPAR for #Kadcyla (#trastuzumab emtansine), a medicine for #breastcancer: http://t.co/flC2OAjlYB","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/He8HLnVYAe","expanded_url":"http://bit.ly/1cqbAue","display_url":"bit.ly/1cqbAue"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"419058332247543808","author_id":"116716199","possibly_sensitive":false,"created_at":"2014-01-03T10:51:06.000Z","conversation_id":"419058332247543808","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee holds its first 2014 meeting next week. Highlights out next Friday: http://t.co/He8HLnVYAe","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/80aX2nZxSO","expanded_url":"http://www.basg.gv.at/news-center/news/sicherheitsinformationen-details/article/zulassung-von-linoladiol-soll-unter-gewissen-einschraenkungen-beibehalten-werden/","display_url":"basg.gv.at/news-center/ne…"}],"hashtags":[{"start":44,"end":55,"tag":"Linoladiol"},{"start":56,"end":66,"tag":"estradiol"}],"mentions":[{"start":1,"end":10,"username":"agesnews","id":"223456379"}],"annotations":{}},"id":"414084524864450560","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T17:26:58.000Z","conversation_id":"414082788649107456","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"“@agesnews: Medicine safety information on \n#Linoladiol #estradiol: Authorisation is maintained under restrictions http://t.co/80aX2nZxSO”","referenced_tweets":[{"type":"replied_to","id":"414082788649107456"}],"in_reply_to_user_id":"223456379","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":27,"end":31,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":44,"end":49,"probability":0.9953,"type":"Place","normalized_text":"Europe"}]},"id":"414069485729878017","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T16:27:13.000Z","conversation_id":"414069485729878017","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: No sustained #flu activity in Europe, but % of positive samples has risen from 3 to 8% in a week. Report of week 50: http://t…","referenced_tweets":[{"type":"retweeted","id":"414069052160491520"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/lOn11xjYgn","expanded_url":"http://bit.ly/1cWx7eV","display_url":"bit.ly/1cWx7eV"}],"hashtags":[{"start":39,"end":51,"tag":"antibiotics"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":105,"end":109,"probability":0.9898,"type":"Place","normalized_text":"Italy"}]},"id":"414065616140509184","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T16:11:50.000Z","conversation_id":"414065616140509184","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Appropriate use of #antibiotics is the only weapon against resistance, high level in Italy http://t.co/lOn11xjYgn","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/dQA5eH36Vc","expanded_url":"http://bit.ly/1drlOtj","display_url":"bit.ly/1drlOtj"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"414065278662615040","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T16:10:30.000Z","conversation_id":"414065278662615040","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Antibiotics: prudent and appropriate use is the only weapon against the resistance. http://t.co/dQA5eH36Vc","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/oqUlG6kw55","expanded_url":"http://bit.ly/IMInews","display_url":"bit.ly/IMInews"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"414064067871903746","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T16:05:41.000Z","conversation_id":"414064067871903746","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Read the last IMI newsletter of 2013 - 11th Call launch &amp; webinars, news from the projects, and more http://t.co/oqUlG6kw55","referenced_tweets":[{"type":"retweeted","id":"414064026339901440"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/kyRsm1HZT6","expanded_url":"http://bit.ly/1drjdiY","display_url":"bit.ly/1drjdiY"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"id":"414060714224263168","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:52:21.000Z","conversation_id":"414060714224263168","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"es","text":"RT @AEMPSGOB: Alert: quality defect in veterinary medicines nos. 34V/2013 DOG VAC Rabia registration no. 10283 NAL.\n http://t.co/kyRsm1HZT6","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/lQG5icsva4","expanded_url":"http://bit.ly/1cWtWDV","display_url":"bit.ly/1cWtWDV"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"id":"414059368150085633","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:47:00.000Z","conversation_id":"414059368150085633","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Withdrawal of the product Epistane 18 http://t.co/lQG5icsva4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":43,"end":52,"tag":"clinical"},{"start":79,"end":94,"tag":"clinicaltrials"},{"start":107,"end":118,"tag":"innovative"},{"start":120,"end":132,"tag":"competitive"},{"start":133,"end":136,"tag":"EU"}],"mentions":{},"annotations":{}},"id":"414058412238831616","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:43:12.000Z","conversation_id":"414058412238831616","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU2013LTpress: MS endorse agreement on #clinical trials. Will lead to more #clinicaltrials in the EU.  #innovative  #competitive #EU ht…","referenced_tweets":[{"type":"retweeted","id":"414058323927781377"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/TpLgnque1a","expanded_url":"http://bit.ly/1bVPD2n","display_url":"bit.ly/1bVPD2n"}],"hashtags":[{"start":23,"end":30,"tag":"herbal"},{"start":55,"end":60,"tag":"Rosa"},{"start":62,"end":67,"tag":"rose"}],"mentions":{},"annotations":{}},"id":"414056686937473024","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:36:21.000Z","conversation_id":"414056686937473024","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've released a draft #herbal Community monograph for #Rosa (#rose flower) for public consultation: http://t.co/TpLgnque1a","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/eQKvCsvRtV","expanded_url":"http://bit.ly/1jpyZCo","display_url":"bit.ly/1jpyZCo"}],"hashtags":[{"start":42,"end":50,"tag":"Kadcyla"},{"start":52,"end":64,"tag":"trastuzumab"},{"start":80,"end":93,"tag":"breastcancer"}],"mentions":{},"annotations":{}},"id":"414055830460583936","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:32:57.000Z","conversation_id":"414055830460583936","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Kadcyla (#trastuzumab emtansine) for #breastcancer: http://t.co/eQKvCsvRtV","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/A8yWmEfcha","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/12/news_detail_002002.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":41,"end":50,"probability":0.8276,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"414049244119449600","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:06:47.000Z","conversation_id":"414049244119449600","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Looking back at 2013 - from Guido Rasi, Executive Director of EMA http://t.co/A8yWmEfcha","referenced_tweets":[{"type":"retweeted","id":"414048055487262720"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":[{"start":48,"end":67,"probability":0.6315,"type":"Organization","normalized_text":"Scientific Committee"}]},"id":"414047832350285824","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T15:01:10.000Z","conversation_id":"414047832350285824","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EMCDDA: Delighted to announce today our new Scientific Committee for 2014-2016. Warm thanks also to the outgoing members: http://t.co/b…","referenced_tweets":[{"type":"retweeted","id":"414047753421860864"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/zGwHn1nkSD","expanded_url":"http://bit.ly/1dWj9s1","display_url":"bit.ly/1dWj9s1"}],"hashtags":{},"mentions":{},"annotations":[{"start":24,"end":33,"probability":0.982,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"414046597686001664","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:56:16.000Z","conversation_id":"414046597686001664","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our Executive Director, Guido Rasi, looks back at 2013: http://t.co/zGwHn1nkSD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/hOd8OSPURG","expanded_url":"http://bit.ly/1cFtLcE","display_url":"bit.ly/1cFtLcE"}],"hashtags":[{"start":55,"end":61,"tag":"avian"},{"start":62,"end":66,"tag":"flu"},{"start":67,"end":72,"tag":"H7N9"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":90,"end":98,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"414041208130785280","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:34:51.000Z","conversation_id":"414041208130785280","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Age and gender distribution of confirmed #avian #flu #H7N9 cases in 2013 in @ECDC_EU update: http://t.co/hOd8OSPURG http://t.…","referenced_tweets":[{"type":"retweeted","id":"414040941503471616"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/XMDeS6JRyk","expanded_url":"http://bit.ly/1fLiYld","display_url":"bit.ly/1fLiYld"}],"hashtags":[{"start":18,"end":28,"tag":"estradiol"}],"mentions":{},"annotations":{}},"id":"414040373468876800","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:31:32.000Z","conversation_id":"414040373468876800","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We recommend that #estradiol-containing creams Linoladiol N and Linoladiol HN remain available: http://t.co/XMDeS6JRyk","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/hOd8OSPURG","expanded_url":"http://bit.ly/1cFtLcE","display_url":"bit.ly/1cFtLcE"}],"hashtags":[{"start":14,"end":19,"tag":"H7N9"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"id":"414036410404855808","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:15:47.000Z","conversation_id":"414036410404855808","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: #H7N9 remains a threat with pandemic potential. Cases in 2013 by week in ECDC update of 19 Dec http://t.co/hOd8OSPURG http://…","referenced_tweets":[{"type":"retweeted","id":"414036244528914433"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/LKOhev48P6","expanded_url":"http://bit.ly/1hqWmac","display_url":"bit.ly/1hqWmac"}],"hashtags":[{"start":51,"end":61,"tag":"aspartame"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":13,"end":21,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"id":"414033999950913536","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:06:12.000Z","conversation_id":"414033999950913536","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EPHA_EU: @EFSA_EU completes risk assessment on #aspartame &amp;concludes it's safe at current levels of exposure:http://t.co/LKOhev48P6 #Sw…","referenced_tweets":[{"type":"retweeted","id":"414033482755489793"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/hOd8OSPURG","expanded_url":"http://bit.ly/1cFtLcE","display_url":"bit.ly/1cFtLcE"}],"hashtags":[{"start":31,"end":37,"tag":"avian"},{"start":38,"end":42,"tag":"flu"},{"start":43,"end":48,"tag":"H7N9"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"id":"414033764088438784","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:05:16.000Z","conversation_id":"414033764088438784","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Latest update on #avian #flu #H7N9 reports on the 147 lab-confirmed cases so far: http://t.co/hOd8OSPURG http://t.co/s0rzEqcc…","referenced_tweets":[{"type":"retweeted","id":"414030013529616384"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":50,"end":62,"tag":"chikungunya"},{"start":63,"end":69,"tag":"fever"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":73,"end":84,"probability":0.6268,"type":"Person","normalized_text":"Saint Martin"}]},"id":"414033565232275456","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T14:04:28.000Z","conversation_id":"414033565232275456","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: The latest on autochthonous cases of #chikungunya #fever on Saint Martin in the new ECDC epidemiological update:  http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"414028734174216192"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/e0jm2BOQDg","expanded_url":"http://ow.ly/rWOia","display_url":"ow.ly/rWOia"}],"hashtags":[{"start":86,"end":89,"tag":"EU"},{"start":99,"end":114,"tag":"ClinicalTrials"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":39,"end":47,"username":"borgton","id":"1605512862"}],"annotations":{}},"id":"414016229037207552","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:55:35.000Z","conversation_id":"414016229037207552","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: Health Commissioner @Borgton welcomes agreement on the revision of #EU rules on #ClinicalTrials http://t.co/e0jm2BOQDg","referenced_tweets":[{"type":"retweeted","id":"414016112498868224"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":45,"end":60,"tag":"clinicaltrials"},{"start":90,"end":97,"tag":"health"},{"start":102,"end":105,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"},{"start":19,"end":28,"username":"EU2013LT","id":"2484749870"}],"annotations":{}},"id":"414012044535267330","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:38:58.000Z","conversation_id":"414012044535267330","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @borgton: thank @EU2013LT for the work on #clinicaltrials. Very important for people's #health and #EU competitiveness http://t.co/GaJ40…","referenced_tweets":[{"type":"retweeted","id":"414011686350503936"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/GaJ40KL8qt","expanded_url":"http://europa.eu/!Qt39uw","display_url":"europa.eu/!Qt39uw"}],"hashtags":[{"start":17,"end":32,"tag":"clinicaltrials"},{"start":96,"end":99,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"borgton","id":"1605512862"}],"annotations":{}},"id":"414011977359306752","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:38:42.000Z","conversation_id":"414011977359306752","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @borgton: New #clinicaltrials regulation means stronger rules directly applicable throughout #EU  http://t.co/GaJ40KL8qt","referenced_tweets":[{"type":"retweeted","id":"414011539575029760"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/jO7nN6UPQo","expanded_url":"http://bit.ly/18WCsOF","display_url":"bit.ly/18WCsOF"}],"hashtags":[{"start":37,"end":46,"tag":"Acipimox"}],"mentions":{},"annotations":{}},"id":"414011526711095296","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:36:54.000Z","conversation_id":"414011526711095296","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"CMDh endorses PRAC recommendation on #Acipimox: http://t.co/jO7nN6UPQo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/4o82UrLNFA","expanded_url":"http://bit.ly/JOPY1l","display_url":"bit.ly/JOPY1l"}],"hashtags":[{"start":38,"end":47,"tag":"Kogenate"}],"mentions":{},"annotations":[{"start":54,"end":68,"probability":0.5019,"type":"Organization","normalized_text":"Helixate NexGen"}]},"id":"414011099533836288","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:35:12.000Z","conversation_id":"414011099533836288","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"CHMP confirms PRAC recommendations on #Kogenate Bayer/Helixate NexGen: http://t.co/4o82UrLNFA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/Z7lT0fdTOY","expanded_url":"http://bit.ly/1cW5zX1","display_url":"bit.ly/1cW5zX1"}],"hashtags":[{"start":25,"end":33,"tag":"Sirturo"},{"start":58,"end":71,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"id":"414010288749699072","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:31:59.000Z","conversation_id":"414010288749699072","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We recommend approval of #Sirturo for multidrug-resistant #tuberculosis: http://t.co/Z7lT0fdTOY","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/qLSiMKjFaL","expanded_url":"http://bit.ly/1fL3oWH","display_url":"bit.ly/1fL3oWH"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"414009260432166912","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:27:54.000Z","conversation_id":"414009260432166912","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've just published the CHMP meeting highlights: 2013 http://t.co/qLSiMKjFaL","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/6tuvcIdO9w","expanded_url":"http://bit.ly/1bUIjYb","display_url":"bit.ly/1bUIjYb"}],"hashtags":[{"start":56,"end":60,"tag":"IMI"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":92,"end":99,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"414008071770210304","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:23:10.000Z","conversation_id":"414008071770210304","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: What is the Innovative Medicines Initiative? #IMI WATCH : http://t.co/6tuvcIdO9w @IMI_JU","referenced_tweets":[{"type":"retweeted","id":"414007672954822656"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/XBYkUDahSt","expanded_url":"http://bit.ly/J9Njhm","display_url":"bit.ly/J9Njhm"}],"hashtags":[{"start":58,"end":65,"tag":"stroke"},{"start":72,"end":81,"tag":"embolism"},{"start":99,"end":106,"tag":"atrial"},{"start":107,"end":120,"tag":"fibrillation"}],"mentions":{},"annotations":{}},"id":"414004481018187776","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:08:54.000Z","conversation_id":"414004481018187776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few weeks left to comment on guideline on prevention of #stroke &amp; #embolism in patients with #atrial #fibrillation: http://t.co/XBYkUDahSt","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/llL8pEi40A","expanded_url":"http://bit.ly/15I7Miy","display_url":"bit.ly/15I7Miy"}],"hashtags":[{"start":91,"end":108,"tag":"gastrointestinal"}],"mentions":{},"annotations":{}},"id":"414004333215100928","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:08:19.000Z","conversation_id":"414004333215100928","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few days left to comment on concept paper on therapeutic equivalence for products in the #gastrointestinal tract: http://t.co/llL8pEi40A","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5lXkR8yTgH","expanded_url":"http://bit.ly/18Wdi2W","display_url":"bit.ly/18Wdi2W"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"414004005950353408","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:07:01.000Z","conversation_id":"414004005950353408","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"A few days left to comment on our draft concept paper on revising guidance on manufacture of finished dosage form: http://t.co/5lXkR8yTgH","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/p9E7v00eR4","expanded_url":"http://bit.ly/1dVfRW4","display_url":"bit.ly/1dVfRW4"}],"hashtags":[{"start":101,"end":108,"tag":"asthma"}],"mentions":{},"annotations":{}},"id":"414003814304206848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:06:15.000Z","conversation_id":"414003814304206848","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few days left to comment on our draft note for guidance on clinical investigation of medicines for #asthma: http://t.co/p9E7v00eR4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/YBjpg0nnVy","expanded_url":"http://bit.ly/1bUptjS","display_url":"bit.ly/1bUptjS"}],"hashtags":[{"start":111,"end":115,"tag":"IBS"}],"mentions":{},"annotations":{}},"id":"414003242037547008","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:03:59.000Z","conversation_id":"414003242037547008","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few weeks left to comment on our draft guideline on medicines for the treatment of irritable bowel syndrome (#IBS): http://t.co/YBjpg0nnVy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/hbjNrMivks","expanded_url":"http://bit.ly/1dVeZAK","display_url":"bit.ly/1dVeZAK"}],"hashtags":[{"start":77,"end":88,"tag":"covariates"}],"mentions":{},"annotations":{}},"id":"414003067650973696","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T12:03:17.000Z","conversation_id":"414003067650973696","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few days left to comment on our draft guideline on adjustment for baseline #covariates: http://t.co/hbjNrMivks","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"JorgeSegon","id":"3919565956"}],"annotations":{}},"id":"413999874963550208","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:50:36.000Z","conversation_id":"413997970531831808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@JorgeSegon Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","referenced_tweets":[{"type":"replied_to","id":"413997970531831808"}],"in_reply_to_user_id":"125443078","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/zDsNsJYaju","expanded_url":"http://bit.ly/1bVhS16","display_url":"bit.ly/1bVhS16"}],"hashtags":[{"start":36,"end":51,"tag":"clinicaltrials"},{"start":127,"end":131,"tag":"MEP"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"}],"annotations":{}},"id":"413999467340103680","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:48:59.000Z","conversation_id":"413999467340103680","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EP_Environment: Press release - #clinicaltrials: clearer rules, better protection for patients http://t.co/zDsNsJYaju lead #MEP @Glenis…","referenced_tweets":[{"type":"retweeted","id":"413997901723885568"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":12,"end":22,"tag":"IMIcall11"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"413995329118154753","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:32:32.000Z","conversation_id":"413995329118154753","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: #IMIcall11 topic on ‘EcoRisk prediction’: a webinar with the topic coordinator will take place on 07/01 at 11 am CET http://t.c…","referenced_tweets":[{"type":"retweeted","id":"413995080987721728"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/D6wpaeYm0C","expanded_url":"http://bit.ly/191PiP3","display_url":"bit.ly/191PiP3"}],"hashtags":[{"start":37,"end":46,"tag":"mosquito"},{"start":53,"end":58,"tag":"tick"},{"start":88,"end":95,"tag":"vector"},{"start":96,"end":101,"tag":"maps"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":67,"end":72,"probability":0.9901,"type":"Place","normalized_text":"Europe"}]},"id":"413995143566331904","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:31:48.000Z","conversation_id":"413995143566331904","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: New data about areas w/ #mosquito &amp; #tick presence in Europe. See ECDC #vector #maps http://t.co/D6wpaeYm0C http://t.co/lR48Ar…","referenced_tweets":[{"type":"retweeted","id":"413994482648879105"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/L50bEO5CAZ","expanded_url":"http://bit.ly/19UZaqH","display_url":"bit.ly/19UZaqH"}],"hashtags":[{"start":17,"end":32,"tag":"Clinicaltrials"},{"start":70,"end":83,"tag":"pressrelease"},{"start":89,"end":93,"tag":"WMA"}],"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"},{"start":117,"end":128,"username":"CEDentists","id":"434841732"}],"annotations":{}},"id":"413993641686740992","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:25:50.000Z","conversation_id":"413993641686740992","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @CPME_EUROPA: #Clinicaltrials:'Not enough safeguards for EU Citiz' #pressrelease with #WMA http://t.co/L50bEO5CAZ @CEDentists @emsa_euro…","referenced_tweets":[{"type":"retweeted","id":"413962246406955009"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/si7Ehagjhx","expanded_url":"http://www.eu2013.lt/en/news/pressreleases/agreement-on-clinical-trials-major-step-towards-innovative-and-competitive-europe#.UrQg2Mp18aU.twitter","display_url":"eu2013.lt/en/news/pressr…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":[{"start":92,"end":97,"probability":0.9075,"type":"Place","normalized_text":"Europe"}]},"id":"413993591560613888","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:25:38.000Z","conversation_id":"413993591560613888","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Agreement on clinical trials - major step towards innovative and competitive Europe  http://t.co/si7Ehagjhx”","referenced_tweets":[{"type":"retweeted","id":"413993453836832768"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":81,"end":96,"tag":"clinicaltrials"},{"start":125,"end":128,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"413992230391537664","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:20:13.000Z","conversation_id":"413992230391537664","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Agreement means more transparency on the conduct &amp; results of #clinicaltrials; compulsory registration on #EU portal http://…","referenced_tweets":[{"type":"retweeted","id":"413992178294075392"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"413991840560340992","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:18:41.000Z","conversation_id":"413991840560340992","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Press release IMI/NEWMEDS Nature study on impact in healthy carriers of genetic variants linked w schizophrenia http://t.co/XHJ…","referenced_tweets":[{"type":"retweeted","id":"413991700546060288"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/9pVm16DJuy","expanded_url":"http://europa.eu/!Qt39uw","display_url":"europa.eu/!Qt39uw"}],"hashtags":[{"start":70,"end":73,"tag":"EU"},{"start":102,"end":117,"tag":"clinicaltrials"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"413988869365714944","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:06:52.000Z","conversation_id":"413988869365714944","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Streamlined application and new single entry point via #EU portal and database for all #clinicaltrials http://t.co/9pVm16DJuy","referenced_tweets":[{"type":"retweeted","id":"413988793201348608"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/9pVm16DJuy","expanded_url":"http://europa.eu/!Qt39uw","display_url":"europa.eu/!Qt39uw"}],"hashtags":[{"start":16,"end":31,"tag":"Clinicaltrials"},{"start":79,"end":89,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":102,"end":110,"username":"borgton","id":"1605512862"}],"annotations":{}},"id":"413988580910829568","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:05:43.000Z","conversation_id":"413988580910829568","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: \"#Clinicaltrials are indispensable for developing and improving #medicines\" says Cssr. @Borgton http://t.co/9pVm16DJuy","referenced_tweets":[{"type":"retweeted","id":"413988512669519872"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":45,"end":53,"username":"borgton","id":"1605512862"}],"annotations":[{"start":34,"end":43,"probability":0.8375,"type":"Person","normalized_text":"Tonio Borg"},{"start":94,"end":95,"probability":0.4638,"type":"Organization","normalized_text":"EU"}]},"id":"413987688740446208","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T11:02:11.000Z","conversation_id":"413987688740446208","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Health Commissioner, Tonio Borg @borgton , welcomes agreement on the revision of EU rules on Clinical Trials http://t.co/kNTsP…","referenced_tweets":[{"type":"retweeted","id":"413985996309405696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/Ox2SaOuR7V","expanded_url":"http://bit.ly/18Tgg8a","display_url":"bit.ly/18Tgg8a"},{"start":110,"end":132,"url":"http://t.co/BE9wH7GztV","expanded_url":"https://twitter.com/EFPIA/status/413606034146471936/photo/1","display_url":"pic.twitter.com/BE9wH7GztV"}],"hashtags":[{"start":76,"end":84,"tag":"Storify"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"413985516543959041","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:53:33.000Z","conversation_id":"413985516543959041","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: 2013 EFPIA Wrap Up! A Story of our major events and publications #Storify http://t.co/Ox2SaOuR7V   http://t.co/BE9wH7GztV","referenced_tweets":[{"type":"retweeted","id":"413985397840936960"}],"attachments":{"media_keys":["3_413606034154860544"]}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/t1ljrOMa28","expanded_url":"http://www.eu2013.lt/en/news/pressreleases/agreement-on-clinical-trials-major-step-towards-innovative-and-competitive-europe#.UrQg2Mp18aU.twitter","display_url":"eu2013.lt/en/news/pressr…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":90,"end":95,"probability":0.9365,"type":"Place","normalized_text":"Europe"}]},"id":"413984897309491200","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:51:05.000Z","conversation_id":"413984897309491200","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: Agreement on clinical trials - major step towards innovative and competitive Europe  http://t.co/t1ljrOMa28","referenced_tweets":[{"type":"retweeted","id":"413984781387300864"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"413984802182660096","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:50:42.000Z","conversation_id":"413984802182660096","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA Welcomes Agreement on EU Clinical Trials Regulation as a Step towards Reigniting European Competitiveness http://t.co/OeHf…","referenced_tweets":[{"type":"retweeted","id":"413984557491171328"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Z9z9sfUzdG","expanded_url":"http://www.eu2013.lt/en/news/pressreleases/agreement-on-clinical-trials-major-step-towards-innovative-and-competitive-europe","display_url":"eu2013.lt/en/news/pressr…"}],"hashtags":[{"start":93,"end":100,"tag":"Europe"},{"start":101,"end":110,"tag":"EU2013LT"}],"mentions":[{"start":3,"end":12,"username":"EU2013LT","id":"2484749870"}],"annotations":{}},"id":"413980251840987136","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:32:38.000Z","conversation_id":"413980251840987136","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU2013LT: Agreement on clinical trials - major step towards innovative &amp; competitive #Europe #EU2013LT\nhttp://t.co/Z9z9sfUzdG","referenced_tweets":[{"type":"retweeted","id":"413979831244963840"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":19,"end":34,"tag":"Clinicaltrials"},{"start":109,"end":118,"tag":"EU2013LT"}],"mentions":{},"annotations":{}},"id":"413980208220209152","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:32:27.000Z","conversation_id":"413980208220209152","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU2013LTpress: #Clinicaltrials dossier agreed with EP &amp; approved by Member States today in CRP! Read #EU2013LT statement http://t.co/vq…","referenced_tweets":[{"type":"retweeted","id":"413979823993024512"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":23,"end":38,"tag":"clinicaltrials"},{"start":93,"end":102,"tag":"patients"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"413976584404467713","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:18:03.000Z","conversation_id":"413976584404467713","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: New #EU #clinicaltrials rules include strengthened rules on the protection of #patients and informed consent http://t.co/9pV…","referenced_tweets":[{"type":"retweeted","id":"413976462673186817"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/JD2xxoLcqz","expanded_url":"http://bit.ly/1bV7qH7","display_url":"bit.ly/1bV7qH7"}],"hashtags":[{"start":15,"end":29,"tag":"clinicaltrial"},{"start":79,"end":88,"tag":"research"},{"start":92,"end":95,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"413976354825056256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:17:08.000Z","conversation_id":"413976354825056256","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @EU_Health: #clinicaltrial agreement reached. New rules will boost clinical #research in #EU http://t.co/JD2xxoLcqz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/w0O4alLZdx","expanded_url":"http://bit.ly/1bScpvz","display_url":"bit.ly/1bScpvz"}],"hashtags":[{"start":31,"end":38,"tag":"orphan"}],"mentions":{},"annotations":[{"start":68,"end":69,"probability":0.7485,"type":"Place","normalized_text":"US"}]},"id":"413976168715411456","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:16:24.000Z","conversation_id":"413976168715411456","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We're organising a workshop on #orphan medicines in March 2014 with US and Japanese regulators. Register now: http://t.co/w0O4alLZdx","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/KtrbmVHsHj","expanded_url":"http://bit.ly/J9Njhm","display_url":"bit.ly/J9Njhm"}],"hashtags":[{"start":56,"end":63,"tag":"stroke"},{"start":70,"end":79,"tag":"embolism"},{"start":97,"end":104,"tag":"atrial"},{"start":105,"end":118,"tag":"fibrillation"}],"mentions":{},"annotations":{}},"id":"413975420032548864","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:13:26.000Z","conversation_id":"413975420032548864","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few weeks to comment on guideline on prevention of #stroke &amp; #embolism in patients with #atrial #fibrillation: http://t.co/KtrbmVHsHj","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/ysOtErqTdy","expanded_url":"http://bit.ly/15I7Miy","display_url":"bit.ly/15I7Miy"}],"hashtags":[{"start":89,"end":106,"tag":"gastrointestinal"}],"mentions":{},"annotations":{}},"id":"413974137456328704","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:08:20.000Z","conversation_id":"413974137456328704","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on concept paper on therapeutic equivalence for products in the #gastrointestinal tract: http://t.co/ysOtErqTdy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/Osb6x8Xexs","expanded_url":"http://bit.ly/18Wdi2W","display_url":"bit.ly/18Wdi2W"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413973746677207040","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:06:47.000Z","conversation_id":"413973746677207040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft concept paper on revising guidance on manufacture of the finished dosage form: http://t.co/Osb6x8Xexs","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/BLrCdLFlza","expanded_url":"http://www.dementiablog.org/new-alzheimers-treatments/","display_url":"dementiablog.org/new-alzheimers…"}],"hashtags":[{"start":38,"end":48,"tag":"Alzheimer"}],"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"},{"start":100,"end":109,"username":"ARUKnews","id":"1131917797867610114"}],"annotations":[{"start":76,"end":98,"probability":0.582,"type":"Organization","normalized_text":"Alzheimer's Research UK"}]},"id":"413972678014279680","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:02:32.000Z","conversation_id":"413972678014279680","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AlzDisInt: When will there be new #Alzheimer's treatments? Article from Alzheimer's Research UK @ARUKnews http://t.co/BLrCdLFlza","referenced_tweets":[{"type":"retweeted","id":"413968897499353088"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/DL9Uiy1X0J","expanded_url":"http://bit.ly/1cgiLra","display_url":"bit.ly/1cgiLra"}],"hashtags":[{"start":78,"end":86,"tag":"storify"},{"start":87,"end":91,"tag":"imi"},{"start":92,"end":102,"tag":"Obamacare"},{"start":103,"end":116,"tag":"clinicaldata"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"413972599035531264","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T10:02:13.000Z","conversation_id":"413972599035531264","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Last 2013 EFPIA Newsletter - Don't miss it! http://t.co/DL9Uiy1X0J #storify #imi #Obamacare #clinicaldata","referenced_tweets":[{"type":"retweeted","id":"413967777272037376"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/84m5GYvccz","expanded_url":"http://bit.ly/1dVfRW4","display_url":"bit.ly/1dVfRW4"}],"hashtags":[{"start":99,"end":106,"tag":"asthma"}],"mentions":{},"annotations":[{"start":46,"end":46,"probability":0.5012,"type":"Organization","normalized_text":""}]},"id":"413962484467650560","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T09:22:02.000Z","conversation_id":"413962484467650560","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft note for\nguidance on clinical investigation of medicines for #asthma: http://t.co/84m5GYvccz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/unJKFNDcME","expanded_url":"http://bit.ly/1bUptjS","display_url":"bit.ly/1bUptjS"}],"hashtags":[{"start":109,"end":113,"tag":"IBS"}],"mentions":{},"annotations":{}},"id":"413961847252209664","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T09:19:30.000Z","conversation_id":"413961847252209664","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few weeks to comment on our draft guideline on medicines for the treatment of irritable bowel syndrome (#IBS): http://t.co/unJKFNDcME","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/KiuC3mFbBz","expanded_url":"http://bit.ly/1dVeZAK","display_url":"bit.ly/1dVeZAK"}],"hashtags":[{"start":75,"end":86,"tag":"covariates"}],"mentions":{},"annotations":{}},"id":"413961189459513344","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-20T09:16:53.000Z","conversation_id":"413961189459513344","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft guideline on adjustment for baseline #covariates: http://t.co/KiuC3mFbBz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/wQGvoupB0A","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":67,"end":82,"tag":"HumanResources"}],"mentions":{},"annotations":{}},"id":"413724623474147328","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T17:36:51.000Z","conversation_id":"413724623474147328","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Tomorrow is the final deadline to apply to our vacancy for Head of #HumanResources: http://t.co/wQGvoupB0A","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/z63t2E7hrW","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":67,"end":70,"tag":"IT"}],"mentions":{},"annotations":{}},"id":"413724453076361216","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T17:36:10.000Z","conversation_id":"413724453076361216","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Tomorrow is the final deadline to apply to our vacancy for Head of #IT Operations: http://t.co/z63t2E7hrW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/huQNPCX7LU","expanded_url":"http://bit.ly/1cT5HXd","display_url":"bit.ly/1cT5HXd"}],"hashtags":{},"mentions":{},"annotations":[{"start":28,"end":36,"probability":0.9851,"type":"Other","normalized_text":"Christmas"}]},"id":"413697030012157952","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T15:47:12.000Z","conversation_id":"413697030012157952","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our offices are closed over Christmas from Mon 23 Dec 2013 to Thu 2 Jan 2014. We'll be open on Fri 3 Jan: http://t.co/huQNPCX7LU","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"annotations":{}},"id":"413673011997204481","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T14:11:46.000Z","conversation_id":"413673011997204481","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eupatientsforum: Our newsletter's special issue with our 2013 Annual Review is out and available on our website - enjoy the reading! ht…","referenced_tweets":[{"type":"retweeted","id":"413672946545086464"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/XMFBwdZhlm","expanded_url":"http://bit.ly/1bScpvz","display_url":"bit.ly/1bScpvz"}],"hashtags":[{"start":103,"end":116,"tag":"rarediseases"}],"mentions":{},"annotations":[{"start":75,"end":76,"probability":0.8597,"type":"Place","normalized_text":"US"}]},"id":"413644748206141440","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T12:19:27.000Z","conversation_id":"413644748206141440","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Register for the orphan medicines workshop in March 2014 co-organised with US and Japanese regulators  #rarediseases: http://t.co/XMFBwdZhlm","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/CvEvBknHPf","expanded_url":"http://bit.ly/webinars11","display_url":"bit.ly/webinars11"}],"hashtags":[{"start":64,"end":74,"tag":"IMICall11"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"413642438595469312","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T12:10:17.000Z","conversation_id":"413642438595469312","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Planning to submit a proposal for IMI funding under #IMICall11? Attend our webinars http://t.co/CvEvBknHPf for info on the topi…","referenced_tweets":[{"type":"retweeted","id":"413608902442639360"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/dbZaxm220P","expanded_url":"http://bit.ly/19cEIqS","display_url":"bit.ly/19cEIqS"}],"hashtags":{},"mentions":[{"start":76,"end":83,"username":"US_FDA","id":"208120290"}],"annotations":{}},"id":"413625897808179200","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T11:04:33.000Z","conversation_id":"413625897808179200","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"We launched a generic medicines application inspections initiative with the @US_FDA: http://t.co/dbZaxm220P","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/beN5nP1PwD","expanded_url":"http://bit.ly/1cT5HXd","display_url":"bit.ly/1cT5HXd"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413623266281275393","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T10:54:06.000Z","conversation_id":"413623266281275393","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A quick reminder that we are closed next week, we re-open on Fri 3 Jan 2014: http://t.co/beN5nP1PwD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/I8fsBJuhzO","expanded_url":"http://bit.ly/1fmIjB1","display_url":"bit.ly/1fmIjB1"}],"hashtags":[{"start":77,"end":81,"tag":"GMP"},{"start":97,"end":107,"tag":"EudraGMDP"}],"mentions":{},"annotations":{}},"id":"413608334088880129","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T09:54:45.000Z","conversation_id":"413608334088880129","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"You can now find non-compliance statements with good manufacturing practice (#GMP) in the public #EudraGMDP database: http://t.co/I8fsBJuhzO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/yc9Ba29XxB","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":48,"end":51,"tag":"IT"}],"mentions":{},"annotations":{}},"id":"413607145100541952","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T09:50:02.000Z","conversation_id":"413607145100541952","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to apply to our vacancy for Head of #IT Operations: http://t.co/yc9Ba29XxB","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/cl7tW1hx6o","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":48,"end":63,"tag":"HumanResources"}],"mentions":{},"annotations":{}},"id":"413606908067864576","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T09:49:05.000Z","conversation_id":"413606908067864576","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to apply to our vacancy for Head of #HumanResources: http://t.co/cl7tW1hx6o","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"UNLibrary","id":"109720244"},{"start":110,"end":118,"username":"FAOnews","id":"994571434382053376"}],"annotations":{}},"id":"413605194040352768","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-19T09:42:17.000Z","conversation_id":"413605194040352768","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @UNLibrary: 70% of the new diseases that have emerged in humans over recent decades are\nof animal origin - @FAOnews report: http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"413603438657019904"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/3iFRjtk92a","expanded_url":"http://www.pharmafile.com/print/181821","display_url":"pharmafile.com/print/181821"}],"hashtags":{},"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":[{"start":18,"end":23,"probability":0.9886,"type":"Place","normalized_text":"Europe"}]},"id":"413360903984136192","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T17:31:34.000Z","conversation_id":"413360903984136192","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Europe to vote on greater trial transparency http://t.co/3iFRjtk92a","referenced_tweets":[{"type":"retweeted","id":"413360451234185216"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/MXENwF2yng","expanded_url":"http://erc.europa.eu/erc-stories/hiv-how-modern-science-fighting-back?utm_medium=email&utm_campaign=ERC+News+Alert&utm_source=Newsletter_June_2012&utm_term=HIV%3A+How+modern+science+is+fig","display_url":"erc.europa.eu/erc-stories/hi…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"annotations":[{"start":81,"end":83,"probability":0.5833,"type":"Other","normalized_text":"HIV"}]},"id":"413357366508154881","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T17:17:30.000Z","conversation_id":"413357366508154881","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ScienceChief: Find out how ERC researchers are understanding and fighting HIV http://t.co/MXENwF2yng...","referenced_tweets":[{"type":"retweeted","id":"413356949955022848"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/ADDFKcqEor","expanded_url":"http://bit.ly/19cEIqS","display_url":"bit.ly/19cEIqS"}],"hashtags":{},"mentions":[{"start":79,"end":86,"username":"US_FDA","id":"208120290"}],"annotations":{}},"id":"413342576570552321","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T16:18:44.000Z","conversation_id":"413342576570552321","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"We've launched a generic medicines application inspections initiative with the @US_FDA: http://t.co/ADDFKcqEor","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":30,"end":42,"tag":"EUCOPDBrx13"},{"start":99,"end":104,"tag":"COPD"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":116,"end":125,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{}},"id":"413335810033733632","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T15:51:51.000Z","conversation_id":"413335810033733632","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: Report from #EUCOPDBrx13 is out now! Read more about lively discussion we had on #COPD within the @EU_H2020 http://t.co/J…","referenced_tweets":[{"type":"retweeted","id":"413333619768557568"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/BYIfscGQlp","expanded_url":"http://www.efsa.europa.eu/en/efsajournal/pub/3501.htm","display_url":"efsa.europa.eu/en/efsajournal…"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":40,"end":51,"tag":"carbapenem"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"id":"413335308982185985","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T15:49:51.000Z","conversation_id":"413335308982185985","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #EFSA publishes opinion on #carbapenem resistance in food-producing animals and derived food. http://t.co/BYIfscGQlp","referenced_tweets":[{"type":"retweeted","id":"413333605486579714"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/UCJpGbOwTb","expanded_url":"http://bit.ly/IV9zw5","display_url":"bit.ly/IV9zw5"}],"hashtags":[{"start":127,"end":136,"tag":"vaccines"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":111,"end":126,"username":"VaccinesEurope","id":"1262320285"}],"annotations":[{"start":11,"end":18,"probability":0.4196,"type":"Organization","normalized_text":"Stanford"}]},"id":"413327405718056960","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T15:18:27.000Z","conversation_id":"413327405718056960","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Stanford researchers take a step toward developing a 'universal' flu vaccine http://t.co/UCJpGbOwTb @VaccinesEurope #vaccines","referenced_tweets":[{"type":"retweeted","id":"413323651501416448"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/DMg2SNPdNc","expanded_url":"http://bit.ly/1fmIjB1","display_url":"bit.ly/1fmIjB1"}],"hashtags":[{"start":63,"end":67,"tag":"GMP"},{"start":99,"end":109,"tag":"EudraGMDP"}],"mentions":{},"annotations":{}},"id":"413320907516805121","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T14:52:38.000Z","conversation_id":"413320907516805121","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"Statements of non-compliance with good manufacturing practice (#GMP) are now publicly available on #EudraGMDP: http://t.co/DMg2SNPdNc","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"annotations":{}},"id":"413308314198368256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T14:02:35.000Z","conversation_id":"413308314198368256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IlaeWeb: There's still time to add your voice to the discussion on the Organization of the Epilepsies. See new quick overview: http://t…","referenced_tweets":[{"type":"retweeted","id":"413303792260497408"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/q7szO133Tt","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":31,"end":45,"tag":"Communication"},{"start":115,"end":123,"tag":"vacancy"},{"start":124,"end":136,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"413277876297805824","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T12:01:38.000Z","conversation_id":"413277876297805824","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting a Head of our #Communication Department. Application deadline 29/01/2014: http://t.co/q7szO133Tt  #vacancy #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/zH209hivfg","expanded_url":"http://bit.ly/1cyn2RL","display_url":"bit.ly/1cyn2RL"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413275739375419392","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:53:09.000Z","conversation_id":"413275739375419392","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Management Board endorsed work programme 2014: http://t.co/zH209hivfg","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/G85JlX8YjO","expanded_url":"http://bit.ly/1djP1pM","display_url":"bit.ly/1djP1pM"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413275498882404352","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:52:11.000Z","conversation_id":"413275498882404352","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We publish meeting agendas for all scientific committees: http://t.co/G85JlX8YjO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/FawYjI5BQg","expanded_url":"http://bit.ly/18O0Py5","display_url":"bit.ly/18O0Py5"}],"hashtags":[{"start":79,"end":86,"tag":"CTdata"}],"mentions":{},"annotations":{}},"id":"413275234859360256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:51:08.000Z","conversation_id":"413275234859360256","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Yesterday we published update on publication and access to clinical trial data #CTdata: http://t.co/FawYjI5BQg","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"annotations":{}},"id":"413273558370877440","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:44:29.000Z","conversation_id":"413273558370877440","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @NICEcomms: Find out how we are encouraging GPs to become more involved in the development of our guidance and standards: http://t.co/Mu…","referenced_tweets":[{"type":"retweeted","id":"413266495670460416"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/qCjQwPvsZP","expanded_url":"http://lnkd.in/dbESYC8","display_url":"lnkd.in/dbESYC8"}],"hashtags":[{"start":98,"end":103,"tag":"jobs"},{"start":104,"end":107,"tag":"EU"}],"mentions":[{"start":3,"end":17,"username":"karlosponders","id":"17485749"}],"annotations":[{"start":23,"end":47,"probability":0.5101,"type":"Organization","normalized_text":"European Medicines Agency"}]},"id":"413272962607771648","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:42:07.000Z","conversation_id":"413272962607771648","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @karlosponders: The European Medicines Agency is recruiting: Head of Communications Department #jobs #EU http://t.co/qCjQwPvsZP","referenced_tweets":[{"type":"retweeted","id":"413259518722973696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":49,"end":59,"tag":"arthritis"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":{}},"id":"413272926469640192","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:41:58.000Z","conversation_id":"413272926469640192","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: Biological therapy for rheumatoid #arthritis patients: is personalised medicine possible? New EJHP article http://t.co/8H7Sp…","referenced_tweets":[{"type":"retweeted","id":"413258607166119937"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/t7ZrtY6O0z","expanded_url":"http://bit.ly/1cQrnTQ","display_url":"bit.ly/1cQrnTQ"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"413272795687047168","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:41:27.000Z","conversation_id":"413272795687047168","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Skin cancer: new molecular targets identified http://t.co/t7ZrtY6O0z","referenced_tweets":[{"type":"retweeted","id":"413254879948193792"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/lWifgHUnAO","expanded_url":"http://bit.ly/18yrMev","display_url":"bit.ly/18yrMev"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"id":"413271855496060928","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:37:43.000Z","conversation_id":"413271855496060928","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Voluntary recall of batches of the drug sodium chloride 0.9% Viaflo 9 mg/ml, solution for infusion\nhttp://t.co/lWifgHUnAO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"413268642583683072","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:24:57.000Z","conversation_id":"413248888129081344","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk MabThera is not included in the December CHMP agenda so it is not scheduled for discussion this month: http://t.co/vvjHnoel2U","referenced_tweets":[{"type":"replied_to","id":"413268315616718848"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"413268315616718848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:23:39.000Z","conversation_id":"413248888129081344","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk However, we do not include the outcomes in our 'highlights' press release on the Friday after the CHMP meeting.","referenced_tweets":[{"type":"replied_to","id":"413268133458087936"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"id":"413268133458087936","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:22:55.000Z","conversation_id":"413248888129081344","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@FinansciCenk New routes of administration (= line extensions) to be discussed at the meeting are in the agenda, yes:http://t.co/vvjHnoel2U","referenced_tweets":[{"type":"replied_to","id":"413248888129081344"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":25,"end":32,"tag":"London"},{"start":39,"end":47,"tag":"vacancy"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"413267385265557504","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:19:57.000Z","conversation_id":"413267385265557504","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EURLex: @EMA_News in #London has a #vacancy for a head of Communication Department, Stakeholder and Communication Division http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"413249085882118144"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/zxqfSWRmuj","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":35,"end":49,"tag":"Communication"},{"start":111,"end":119,"tag":"vacancy"},{"start":120,"end":132,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"413266343551827968","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T11:15:49.000Z","conversation_id":"413266343551827968","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"We're looking to recruit a Head of #Communication Department. Apply by 29 January 2014: http://t.co/zxqfSWRmuj #vacancy #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"id":"413247088135127040","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T09:59:18.000Z","conversation_id":"413247088135127040","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA’s Management Board endorsed work programme and endorsed principles for revision of conflicts-of-interests policy: http://t…","referenced_tweets":[{"type":"retweeted","id":"413245543846907904"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/hTLDhpz6Wr","expanded_url":"http://bit.ly/1bMUtyV","display_url":"bit.ly/1bMUtyV"}],"hashtags":[{"start":13,"end":20,"tag":"Fluenz"},{"start":31,"end":41,"tag":"influenza"}],"mentions":{},"annotations":{}},"id":"413239929431273474","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T09:30:51.000Z","conversation_id":"413239929431273474","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Fluenz Tetra, an #influenza vaccine for use in children, is now available on our website: http://t.co/hTLDhpz6Wr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/f4jvX1ltxo","expanded_url":"http://bit.ly/18yiuPE","display_url":"bit.ly/18yiuPE"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"id":"413238023891845120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T09:23:17.000Z","conversation_id":"413238023891845120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: New issue of Information from the Swedish medicines agency http://t.co/f4jvX1ltxo","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":17,"end":29,"username":"BrandonUK07","id":"40239703"}],"annotations":{}},"id":"413237154769154048","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-18T09:19:49.000Z","conversation_id":"412985909458374657","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@forensicinvstor @BrandonUK07 We're afraid we can't comment on any ongoing applications.","referenced_tweets":[{"type":"replied_to","id":"413004628280635392"}],"in_reply_to_user_id":"1136859602","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/xi84gLmQsm","expanded_url":"http://bit.ly/1emfN6m","display_url":"bit.ly/1emfN6m"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413005009979064320","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T17:57:22.000Z","conversation_id":"412997140257185792","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@PinkyG123 We aim to publish at the start of the meeting. See our press release:  http://t.co/xi84gLmQsm","referenced_tweets":[{"type":"replied_to","id":"413004165372444672"}],"in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"413003863570915328","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T17:52:48.000Z","conversation_id":"412997140257185792","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@PinkyG123 This item is not on the Dec 2013 CHMP agenda published here: http://t.co/vvjHnoel2U","referenced_tweets":[{"type":"replied_to","id":"412997140257185792"}],"in_reply_to_user_id":"1506550260","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"BrandonUK07","id":"40239703"}],"annotations":{}},"id":"413002942203965440","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T17:49:09.000Z","conversation_id":"412985909458374657","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"@BrandonUK07 Yes, line extensions to be discussed at committee are included in the agenda, which is published here: http://t.co/vvjHnoel2U","referenced_tweets":[{"type":"replied_to","id":"412985909458374657"}],"in_reply_to_user_id":"40239703","attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/zBGAIurk6D","expanded_url":"http://bit.ly/1bMUtyV","display_url":"bit.ly/1bMUtyV"}],"hashtags":[{"start":59,"end":69,"tag":"influenza"}],"mentions":{},"annotations":[{"start":42,"end":53,"probability":0.5567,"type":"Person","normalized_text":"Fluenz Tetra"}]},"id":"412984358484856834","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T16:35:18.000Z","conversation_id":"412984358484856834","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for Fluenz Tetra, an #influenza vaccine for use in children: http://t.co/zBGAIurk6D","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"412973124032790529","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T15:50:40.000Z","conversation_id":"412973124032790529","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): Methotrexate 25mg/ml Injection, 1 x 2ml - Teva UK Limited (... http:/…","referenced_tweets":[{"type":"retweeted","id":"412916020831997952"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"412973010241351680","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T15:50:12.000Z","conversation_id":"412973010241351680","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI project successes demonstrate success of public-private partnership model in drug dvpt, article in @CSBJournal http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"412917340032868352"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":6,"username":"UN","id":"14159148"},{"start":103,"end":111,"username":"FAOnews","id":"994571434382053376"}],"annotations":{}},"id":"412972549073403905","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T15:48:23.000Z","conversation_id":"412972549073403905","public_metrics":{"retweet_count":140,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @UN: 70% of the new diseases that have emerged in humans over recent decades are of animal origin - @FAOnews report: http://t.co/o2MbMsk…","referenced_tweets":[{"type":"retweeted","id":"412945669717241856"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/M0acRtVqBe","expanded_url":"http://bit.ly/11NvyeK","display_url":"bit.ly/11NvyeK"}],"hashtags":[{"start":90,"end":105,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"id":"412961044345389056","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T15:02:40.000Z","conversation_id":"412961044345389056","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft guideline on adjustment for baseline covariates in #clinicaltrials: http://t.co/M0acRtVqBe","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/5kO595f4wL","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":[{"start":97,"end":104,"tag":"dosage"}],"mentions":{},"annotations":{}},"id":"412960474423365632","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T15:00:24.000Z","conversation_id":"412960474423365632","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on concept paper on need to revise guidance on manufacture of finished #dosage form : http://t.co/5kO595f4wL","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/prVEM5l5Jv","expanded_url":"http://bit.ly/19PU8f0","display_url":"bit.ly/19PU8f0"}],"hashtags":[{"start":93,"end":110,"tag":"gastrointestinal"}],"mentions":{},"annotations":{}},"id":"412959939339247616","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T14:58:16.000Z","conversation_id":"412959939339247616","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to comment on concept paper on showing therapeutic equivalence for products in the #gastrointestinal tract: http://t.co/prVEM5l5Jv","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/vUKmgNkJl3","expanded_url":"http://bit.ly/1c9mVB3","display_url":"bit.ly/1c9mVB3"}],"hashtags":[{"start":100,"end":107,"tag":"asthma"}],"mentions":{},"annotations":{}},"id":"412958975773396993","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T14:54:26.000Z","conversation_id":"412958975773396993","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft note for guidance on clinical investigation of medicines for #asthma: http://t.co/vUKmgNkJl3","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/BJJBWVzXSh","expanded_url":"http://bit.ly/1djP1pM","display_url":"bit.ly/1djP1pM"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"412918888540962818","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T12:15:09.000Z","conversation_id":"412918888540962818","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We're publishing meeting agendas for all scientific committees: http://t.co/BJJBWVzXSh","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/63ditFg8pr","expanded_url":"http://bit.ly/1cyn2RL","display_url":"bit.ly/1cyn2RL"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"412898795308216320","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T10:55:18.000Z","conversation_id":"412898795308216320","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Management Board endorses work programme 2014: http://t.co/63ditFg8pr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/na92LvH8bT","expanded_url":"http://bit.ly/1bKGY6b","display_url":"bit.ly/1bKGY6b"}],"hashtags":[{"start":30,"end":40,"tag":"Memantine"},{"start":62,"end":68,"tag":"Axura"},{"start":73,"end":83,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"id":"412896738521796608","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T10:47:08.000Z","conversation_id":"412896738521796608","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR is now available for #Memantine Accord, a generic of #Axura for #Alzheimer's disease: http://t.co/na92LvH8bT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/0i0R8NJl9p","expanded_url":"http://bit.ly/1el1nTW","display_url":"bit.ly/1el1nTW"}],"hashtags":[{"start":39,"end":57,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"412892965322129408","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T10:32:08.000Z","conversation_id":"412892965322129408","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've issued a draft recommendation on #pharmacovigilance surveillance and signal detection of veterinary medicines: http://t.co/0i0R8NJl9p","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/gfCDtleJ53","expanded_url":"http://bit.ly/1fiZXpk","display_url":"bit.ly/1fiZXpk"}],"hashtags":[{"start":76,"end":91,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"id":"412892649876885504","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T10:30:53.000Z","conversation_id":"412892649876885504","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've issued a draft guideline on data requirements for in vivo blood level #bioequivalence for veterinary medicines: http://t.co/gfCDtleJ53","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/dh1IUf02dy","expanded_url":"http://bit.ly/18O0Py5","display_url":"bit.ly/18O0Py5"}],"hashtags":[{"start":77,"end":84,"tag":"CTdata"}],"mentions":{},"annotations":{}},"id":"412889939563794432","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-17T10:20:07.000Z","conversation_id":"412889939563794432","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"We've just published update on publication and access to clinical trial data #CTdata: http://t.co/dh1IUf02dy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/nQwHuqrpnr","expanded_url":"http://bit.ly/19ulYBT","display_url":"bit.ly/19ulYBT"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"id":"412640244052135937","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T17:47:55.000Z","conversation_id":"412615439596781568","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@louis_ide Full details of the ongoing review are here: http://t.co/nQwHuqrpnr","referenced_tweets":[{"type":"replied_to","id":"412640030633385984"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"id":"412640030633385984","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T17:47:04.000Z","conversation_id":"412615439596781568","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"@louis_ide We are reviewing the benefits and the risks thoroughly. Any concerns in the meantime, please speak to your doctor or pharmacist.","referenced_tweets":[{"type":"replied_to","id":"412621529583599616"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"}],"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"id":"412620192955383808","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T16:28:14.000Z","conversation_id":"412615439596781568","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@louis_ide Some issues remain outstanding; recommendation from #pharmacovigilance committee now expected in March: http://t.co/fbKo4AMP7U","referenced_tweets":[{"type":"replied_to","id":"412618955539238913"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/wZW9qCivOf","expanded_url":"http://www.mhra.gov.uk/home/groups/dsu/documents/publication/con355482.pdf","display_url":"mhra.gov.uk/home/groups/ds…"},{"start":77,"end":99,"url":"http://t.co/67Xsn586nU","expanded_url":"https://twitter.com/FrancoisMaignen/status/412617802005364736/photo/1","display_url":"pic.twitter.com/67Xsn586nU"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"412618900925194240","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T16:23:06.000Z","conversation_id":"412618900925194240","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Drug Safety Update December 2013 http://t.co/wZW9qCivOf http://t.co/67Xsn586nU","referenced_tweets":[{"type":"retweeted","id":"412617802005364736"}],"attachments":{"media_keys":["3_412617801841795072"]}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/zF2VjtG0Jt","expanded_url":"http://bit.ly/1bKIN31","display_url":"bit.ly/1bKIN31"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"id":"412615439596781568","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T16:09:21.000Z","conversation_id":"412615439596781568","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Message to healthcare professionals on severe skin reactions after using the medicine Xeloda® \nhttp://t.co/zF2VjtG0Jt","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/lfM6ef1zr9","expanded_url":"http://bit.ly/1bKGY6b","display_url":"bit.ly/1bKGY6b"}],"hashtags":[{"start":42,"end":52,"tag":"Memantine"},{"start":74,"end":80,"tag":"Axura"},{"start":85,"end":95,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"id":"412612464715792385","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:57:32.000Z","conversation_id":"412612464715792385","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Memantine Accord, a generic of #Axura for #Alzheimer's disease: http://t.co/lfM6ef1zr9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/uy47KTe6YU","expanded_url":"http://tinyurl.com/lktqhcn","display_url":"tinyurl.com/lktqhcn"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"412611570028404736","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:53:58.000Z","conversation_id":"412611570028404736","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Drug Safety Update, December 2013 (Volume 7, Issue 5) http://t.co/uy47KTe6YU","referenced_tweets":[{"type":"retweeted","id":"412606918478536704"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":{}},"id":"412611465078517760","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:53:33.000Z","conversation_id":"412611465078517760","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAMedWatch: Soliris (Eculizumab) Concentrated Solution for Intravenous Infusion by Alexion: Recall - Visible Particles http://t.co/AbX…","referenced_tweets":[{"type":"retweeted","id":"412605421506281473"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/qI1FcVo2aY","expanded_url":"http://gu.com/p/3y85x/tw","display_url":"gu.com/p/3y85x/tw"}],"hashtags":[{"start":18,"end":24,"tag":"China"},{"start":78,"end":83,"tag":"fake"},{"start":84,"end":94,"tag":"medicines"}],"mentions":[{"start":122,"end":131,"username":"guardian","id":"87818409"}],"annotations":{}},"id":"412611442068979712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:53:28.000Z","conversation_id":"412611442068979712","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #China arrests 1,300 people suspected of making and selling #fake #medicines http://t.co/qI1FcVo2aY via @guardian","referenced_tweets":[{"type":"retweeted","id":"412604959117430784"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/zvTruqhBJS","expanded_url":"http://bit.ly/webinars11","display_url":"bit.ly/webinars11"}],"hashtags":[{"start":119,"end":129,"tag":"IMICall11"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"412611038727520256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:51:52.000Z","conversation_id":"412611038727520256","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Dates for IMI's 11th Call topic webinars are set. See the schedule and register at http://t.co/zvTruqhBJS  #IMICall11","referenced_tweets":[{"type":"retweeted","id":"412599997805232128"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/xRBafgL8BT","expanded_url":"http://bit.ly/1bKAeoQ","display_url":"bit.ly/1bKAeoQ"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"id":"412600636866166784","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:10:32.000Z","conversation_id":"412600636866166784","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: Monthly report from the PRAC (December 2013) http://t.co/xRBafgL8BT","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/VjKPo3cuyV","expanded_url":"http://bit.ly/1bTmzgj","display_url":"bit.ly/1bTmzgj"}],"hashtags":[{"start":11,"end":18,"tag":"Pharma"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"412600433522122752","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T15:09:43.000Z","conversation_id":"412600433522122752","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: #Pharma : The year in review 2013 http://t.co/VjKPo3cuyV","referenced_tweets":[{"type":"retweeted","id":"412572440636555264"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":45,"end":57,"tag":"RareDisease"},{"start":109,"end":122,"tag":"rarediseases"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"annotations":{}},"id":"412566749901357056","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T12:55:52.000Z","conversation_id":"412566749901357056","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @rarediseaseday: The overall objective of #RareDisease Day is to raise awareness amongst the\npublic about #rarediseases and their impact…","referenced_tweets":[{"type":"retweeted","id":"412562935882723328"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/bBiFRH8ygf","expanded_url":"http://bit.ly/1gBnIwO","display_url":"bit.ly/1gBnIwO"}],"hashtags":[{"start":74,"end":77,"tag":"ct"},{"start":78,"end":93,"tag":"clinicaltrials"},{"start":94,"end":108,"tag":"digitalhealth"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"412557234007068673","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T12:18:04.000Z","conversation_id":"412557234007068673","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"ca","text":"RT @EFPIA: Digital recruitment for clinical trials http://t.co/bBiFRH8ygf #ct #clinicaltrials #digitalhealth","referenced_tweets":[{"type":"retweeted","id":"412556743583883265"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/MyO2org1oP","expanded_url":"http://youtu.be/aq-m5VWfzFk","display_url":"youtu.be/aq-m5VWfzFk"}],"hashtags":[{"start":42,"end":54,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":{}},"id":"412556945719963649","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T12:16:55.000Z","conversation_id":"412556945719963649","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: How to search databases for #raredisease information http://t.co/MyO2org1oP","referenced_tweets":[{"type":"retweeted","id":"412556685782552576"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/lZh2qolZve","expanded_url":"http://bit.ly/IZvhyg","display_url":"bit.ly/IZvhyg"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"id":"412555626003177472","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T12:11:40.000Z","conversation_id":"412555626003177472","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AEMPSGOB: Publication of the monthly bulletin of the Spanish medicines agency for the month of November 2013 http://t.co/lZh2qolZve","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/TYlqiVVumY","expanded_url":"http://youtu.be/BzbR4ZJ0Cbw","display_url":"youtu.be/BzbR4ZJ0Cbw"}],"hashtags":[{"start":73,"end":85,"tag":"raredisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":14,"end":29,"username":"rarediseaseday","id":"19982434"}],"annotations":{}},"id":"412547648881561600","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T11:39:58.000Z","conversation_id":"412547648881561600","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: @rarediseaseday info pack explained http://t.co/TYlqiVVumY #raredisease","referenced_tweets":[{"type":"retweeted","id":"412545643635544064"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/eFlvhv3Lfr","expanded_url":"http://ow.ly/rNxIa","display_url":"ow.ly/rNxIa"}],"hashtags":[{"start":33,"end":45,"tag":"RareDisease"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"annotations":{}},"id":"412543563382018049","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T11:23:44.000Z","conversation_id":"412543563382018049","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @rarediseaseday: Download the #RareDisease Day infopack http://t.co/eFlvhv3Lfr\n74 days to go","referenced_tweets":[{"type":"retweeted","id":"412538234074591232"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"412543468687200256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T11:23:22.000Z","conversation_id":"412543468687200256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA's latest webpage: Evolving R&amp;D and regulatory pathways: exploiting the potential of new science and technology http://t.co…","referenced_tweets":[{"type":"retweeted","id":"412537668505833472"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/35IEvyPaDa","expanded_url":"http://www.adrreports.eu","display_url":"adrreports.eu"},{"start":81,"end":103,"url":"http://t.co/dDF84KqqOQ","expanded_url":"https://twitter.com/FrancoisMaignen/status/411523332975390721/photo/1","display_url":"pic.twitter.com/dDF84KqqOQ"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"id":"412516056431742976","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-16T09:34:26.000Z","conversation_id":"412516056431742976","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: European Database of Adverse Drug Reactions: http://t.co/35IEvyPaDa http://t.co/dDF84KqqOQ","referenced_tweets":[{"type":"retweeted","id":"412514669732306944"}],"attachments":{"media_keys":["3_411523332828585984"]}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/kGGR1sTsq8","expanded_url":"http://www.adrreports.eu","display_url":"adrreports.eu"},{"start":88,"end":110,"url":"http://t.co/1YvvxgzLyt","expanded_url":"https://twitter.com/FrancoisMaignen/status/411523332975390721/photo/1","display_url":"pic.twitter.com/1YvvxgzLyt"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526413297000448","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:57.000Z","conversation_id":"411526413297000448","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: European Database of Adverse Drug Reactions http://t.co/kGGR1sTsq8 http://t.co/1YvvxgzLyt","referenced_tweets":[{"type":"retweeted","id":"411523332975390721"}],"attachments":{"media_keys":["3_411523332828585984"]}},{"source":"TweetDeck","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/TJZA24sFzE","expanded_url":"http://www.mhra.gov.uk/Safetyinformation/Medicinesinformation/index.htm","display_url":"mhra.gov.uk/Safetyinformat…"},{"start":71,"end":93,"url":"http://t.co/mxuakkuIuf","expanded_url":"https://twitter.com/FrancoisMaignen/status/411522920633360384/photo/1","display_url":"pic.twitter.com/mxuakkuIuf"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526396540747776","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:53.000Z","conversation_id":"411526396540747776","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"RT @FrancoisMaignen: MHRA Medicines information http://t.co/TJZA24sFzE http://t.co/mxuakkuIuf","referenced_tweets":[{"type":"retweeted","id":"411522920633360384"}],"attachments":{"media_keys":["3_411522920373301251"]}},{"source":"TweetDeck","entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/mvUL6HQSe7","expanded_url":"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/DrugSafetyUpdatePDFarchive/index.htm","display_url":"mhra.gov.uk/Safetyinformat…"},{"start":68,"end":90,"url":"http://t.co/Ku8CrsI2Is","expanded_url":"https://twitter.com/FrancoisMaignen/status/411522405711245312/photo/1","display_url":"pic.twitter.com/Ku8CrsI2Is"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526368329887744","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:46.000Z","conversation_id":"411526368329887744","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: MHRA Drug Safety Update http://t.co/mvUL6HQSe7 http://t.co/Ku8CrsI2Is","referenced_tweets":[{"type":"retweeted","id":"411522405711245312"}],"attachments":{"media_keys":["3_411522405459570688"]}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/XKB3VrhNsm","expanded_url":"http://link.springer.com/journal/40278","display_url":"link.springer.com/journal/40278"},{"start":79,"end":101,"url":"http://t.co/YrOQyE4OiR","expanded_url":"https://twitter.com/FrancoisMaignen/status/411521923513073664/photo/1","display_url":"pic.twitter.com/YrOQyE4OiR"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526356866834432","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:43.000Z","conversation_id":"411526356866834432","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Grey literature : Reactions weekly http://t.co/XKB3VrhNsm http://t.co/YrOQyE4OiR","referenced_tweets":[{"type":"retweeted","id":"411521923513073664"}],"attachments":{"media_keys":["3_411521923383046144"]}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/v6814Eo5Ot","expanded_url":"http://www.mhra.gov.uk/ConferencesLearningCentre/LearningCentre/Medicineslearningmodules/Pharmacovigilancelearningmodule/index.htm","display_url":"mhra.gov.uk/ConferencesLea…"},{"start":83,"end":105,"url":"http://t.co/cOSC76sldi","expanded_url":"https://twitter.com/FrancoisMaignen/status/411521136577757184/photo/1","display_url":"pic.twitter.com/cOSC76sldi"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526283579764737","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:26.000Z","conversation_id":"411526283579764737","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: MHRA Pharmacovigilance learning module http://t.co/v6814Eo5Ot http://t.co/cOSC76sldi","referenced_tweets":[{"type":"retweeted","id":"411521136577757184"}],"attachments":{"media_keys":["3_411521136422580224"]}},{"source":"TweetDeck","entities":{"urls":[{"start":43,"end":65,"url":"http://t.co/EGVamuIpcl","expanded_url":"http://yellowcard.mhra.gov.uk","display_url":"yellowcard.mhra.gov.uk"},{"start":66,"end":88,"url":"http://t.co/aCPcXaGi5P","expanded_url":"https://twitter.com/FrancoisMaignen/status/411520231576965120/photo/1","display_url":"pic.twitter.com/aCPcXaGi5P"}],"hashtags":[{"start":24,"end":35,"tag":"YellowCard"}],"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":21,"end":22,"probability":0.8016,"type":"Place","normalized_text":"UK"}]},"id":"411526245080264705","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:17.000Z","conversation_id":"411526245080264705","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: UK #YellowCard scheme http://t.co/EGVamuIpcl http://t.co/aCPcXaGi5P","referenced_tweets":[{"type":"retweeted","id":"411520231576965120"}],"attachments":{"media_keys":["3_411520231258210304"]}},{"source":"TweetDeck","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/6RZpmjcu0Q","expanded_url":"http://ansm.sante.fr/content/download/55413/713865/version/3/file/20131205Formulaire_Declaration-EI_PS3.pdf","display_url":"ansm.sante.fr/content/downlo…"},{"start":70,"end":92,"url":"http://t.co/KKfzBBrsd4","expanded_url":"https://twitter.com/FrancoisMaignen/status/411519882896089088/photo/1","display_url":"pic.twitter.com/KKfzBBrsd4"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526233290051584","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:14.000Z","conversation_id":"411526233290051584","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: French ADR reporting form http://t.co/6RZpmjcu0Q http://t.co/KKfzBBrsd4","referenced_tweets":[{"type":"retweeted","id":"411519882896089088"}],"attachments":{"media_keys":["3_411519882740891648"]}},{"source":"TweetDeck","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/CmJEmTQmHF","expanded_url":"http://ansm.sante.fr/Declarer-un-effet-indesirable/Pharmacovigilance/Centres-regionaux-de-pharmacovigilance/(offset)/4#paragraph_2037","display_url":"ansm.sante.fr/Declarer-un-ef…"},{"start":86,"end":108,"url":"http://t.co/qa0okyqFOC","expanded_url":"https://twitter.com/FrancoisMaignen/status/411519647562072064/photo/1","display_url":"pic.twitter.com/qa0okyqFOC"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411526211743924224","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T16:01:09.000Z","conversation_id":"411526211743924224","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"und","text":"RT @FrancoisMaignen: French Regional Pharmacovigilance Centres http://t.co/CmJEmTQmHF http://t.co/qa0okyqFOC","referenced_tweets":[{"type":"retweeted","id":"411519647562072064"}],"attachments":{"media_keys":["3_411519647360765953"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":49,"end":54,"tag":"H7N9"},{"start":59,"end":64,"tag":"MERS"},{"start":106,"end":110,"tag":"flu"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":[{"start":123,"end":128,"probability":0.9879,"type":"Place","normalized_text":"Europe"}]},"id":"411525790249922560","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T15:59:28.000Z","conversation_id":"411525790249922560","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: ECDC weekly threat report looks at #H7N9 and #MERS-CoV among other threats; little seasonal #flu activity in Europe: http://t…","referenced_tweets":[{"type":"retweeted","id":"411493681976180736"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":35,"end":75,"probability":0.5121,"type":"Other","normalized_text":"UNDERSTANDING CLINICAL RESEARCH IN CANCER"}]},"id":"411481998834667520","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T13:05:28.000Z","conversation_id":"411481998834667520","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @cancereu: The patient course \" UNDERSTANDING CLINICAL RESEARCH IN CANCER” is now open for registration.\n\nThe course will... http://t.co…","referenced_tweets":[{"type":"retweeted","id":"411480174257926144"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/cS7GhxrnBa","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON355476","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"annotations":[{"start":69,"end":76,"probability":0.5792,"type":"Organization","normalized_text":"Novartis"}]},"id":"411481861928415232","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T13:04:55.000Z","conversation_id":"411481861928415232","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRApress: Specific Tixylix cough and cold medicines recalled by Novartis http://t.co/cS7GhxrnBa","referenced_tweets":[{"type":"retweeted","id":"411477551492509696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411474130274234368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:34:12.000Z","conversation_id":"411474130274234368","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Pharmacovigilance (resources on internet to learn and improve yor skills in pharmacovigilance) on Flipboard. http://t.…","referenced_tweets":[{"type":"retweeted","id":"411471703685234688"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/gLDuRONgts","expanded_url":"http://apps.who.int/medicinedocs/en/d/Jh2934e/","display_url":"apps.who.int/medicinedocs/e…"},{"start":88,"end":110,"url":"http://t.co/eqKnqgTFyQ","expanded_url":"https://twitter.com/FrancoisMaignen/status/411470837293002752/photo/1","display_url":"pic.twitter.com/eqKnqgTFyQ"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411474034904141824","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:33:49.000Z","conversation_id":"411474034904141824","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: WHO Safety Monitoring of Medicinal Products http://t.co/gLDuRONgts http://t.co/eqKnqgTFyQ","referenced_tweets":[{"type":"retweeted","id":"411470837293002752"}],"attachments":{"media_keys":["3_411470837079113728"]}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/kQHbFTfyub","expanded_url":"http://www.who-umc.org/DynPage.aspx?id=98088&mn1=7347&mn2=7252&mn3=7253&mn4=7329","display_url":"who-umc.org/DynPage.aspx?i…"},{"start":89,"end":111,"url":"http://t.co/uF0BxHxpHH","expanded_url":"https://twitter.com/FrancoisMaignen/status/411469259165155328/photo/1","display_url":"pic.twitter.com/uF0BxHxpHH"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411469339443728385","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:15:09.000Z","conversation_id":"411469339443728385","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: WHO setting up a pharmacovigilance programme http://t.co/kQHbFTfyub http://t.co/uF0BxHxpHH","referenced_tweets":[{"type":"retweeted","id":"411469259165155328"}],"attachments":{"media_keys":["3_411469258997383168"]}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/K8f9sUaHIl","expanded_url":"http://www.who-umc.org/DynPage.aspx?id=97219&mn1=7347&mn2=7252&mn3=7253","display_url":"who-umc.org/DynPage.aspx?i…"},{"start":107,"end":129,"url":"http://t.co/rcs4F0KUhl","expanded_url":"https://twitter.com/FrancoisMaignen/status/411468815118368768/photo/1","display_url":"pic.twitter.com/rcs4F0KUhl"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411469318832914432","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:15:05.000Z","conversation_id":"411469318832914432","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Practical pharmacovigilance from WHO Uppsala Monitoring Centre http://t.co/K8f9sUaHIl http://t.co/rcs4F0KUhl","referenced_tweets":[{"type":"retweeted","id":"411468815118368768"}],"attachments":{"media_keys":["3_411468814849933312"]}},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/nmQZgNRPKb","expanded_url":"http://www.iarc.fr/en/publications/pdfs-online/epi/index.php","display_url":"iarc.fr/en/publication…"},{"start":97,"end":119,"url":"http://t.co/ndlFZPexlj","expanded_url":"https://twitter.com/FrancoisMaignen/status/411467934964662273/photo/1","display_url":"pic.twitter.com/ndlFZPexlj"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411468416369717248","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:11:29.000Z","conversation_id":"411468416369717248","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: WHO/IARC Cancer epidemiology principles and methods. http://t.co/nmQZgNRPKb http://t.co/ndlFZPexlj","referenced_tweets":[{"type":"retweeted","id":"411467934964662273"}],"attachments":{"media_keys":["3_411467934297759744"]}},{"source":"Twitter Web Client","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/z63t2E7hrW","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":52,"end":55,"tag":"IT"},{"start":92,"end":104,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"411467536505397248","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:08:00.000Z","conversation_id":"411467536505397248","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our #vacancy for Head of #IT Operations: http://t.co/z63t2E7hrW  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/wQGvoupB0A","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":52,"end":67,"tag":"HumanResources"},{"start":69,"end":72,"tag":"HR"},{"start":99,"end":111,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"411467158741200898","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:06:29.000Z","conversation_id":"411467158741200898","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for our #vacancy for Head of #HumanResources (#HR): http://t.co/wQGvoupB0A  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/xEgdp0ambZ","expanded_url":"http://www.iarc.fr/en/publications/pdfs-online/stat/index.php","display_url":"iarc.fr/en/publication…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411466958626770944","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:05:42.000Z","conversation_id":"411466958626770944","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: WHO/IARC Epidemiology series stats methods in cancer research (case control / cohort) http://t.co/xEgdp0ambZ http://t.…","referenced_tweets":[{"type":"retweeted","id":"411466789181468672"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/xd8aAzxm17","expanded_url":"http://bit.ly/IHgxUu","display_url":"bit.ly/IHgxUu"}],"hashtags":[{"start":46,"end":53,"tag":"herbal"},{"start":67,"end":74,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"411466906034388995","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:05:29.000Z","conversation_id":"411466906034388995","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft Community #herbal monograph on #Arnica flower: http://t.co/xd8aAzxm17","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/9H9H3NCimf","expanded_url":"http://bit.ly/1jt7mWB","display_url":"bit.ly/1jt7mWB"}],"hashtags":[{"start":61,"end":71,"tag":"Melaleuca"},{"start":73,"end":81,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"411466680305324033","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:04:35.000Z","conversation_id":"411466680305324033","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft Community list entry for #Melaleuca (#teatree oil): http://t.co/9H9H3NCimf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/xRWaQstSUP","expanded_url":"http://bit.ly/1bM6WbY","display_url":"bit.ly/1bM6WbY"}],"hashtags":[{"start":46,"end":53,"tag":"herbal"},{"start":67,"end":77,"tag":"Melaleuca"},{"start":79,"end":87,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"411466608079417344","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:04:18.000Z","conversation_id":"411466608079417344","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/xRWaQstSUP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/zQbVTjAMbJ","expanded_url":"http://bit.ly/1950mel","display_url":"bit.ly/1950mel"}],"hashtags":[{"start":46,"end":53,"tag":"herbal"},{"start":67,"end":74,"tag":"Ononis"},{"start":76,"end":87,"tag":"restharrow"}],"mentions":{},"annotations":{}},"id":"411466501271470080","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:03:53.000Z","conversation_id":"411466501271470080","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft Community #herbal monograph on #Ononis (#restharrow root): http://t.co/zQbVTjAMbJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/d8lkUPOEAA","expanded_url":"http://bit.ly/19lLTel","display_url":"bit.ly/19lLTel"}],"hashtags":[{"start":55,"end":60,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"411466390223065089","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:03:26.000Z","conversation_id":"411466390223065089","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The plenary meeting from our human medicine committee, #CHMP, is next week. We're publishing highlights on Friday: http://t.co/d8lkUPOEAA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/sk00nB4tLG","expanded_url":"http://bit.ly/1crE9EP","display_url":"bit.ly/1crE9EP"},{"start":89,"end":111,"url":"http://t.co/A214473IJi","expanded_url":"http://bit.ly/1hQPd5B","display_url":"bit.ly/1hQPd5B"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":21,"end":32,"probability":0.9895,"type":"Person","normalized_text":"Pierre Biron"},{"start":35,"end":51,"probability":0.5009,"type":"Person","normalized_text":"Pharmacovigilance"}]},"id":"411466007987748864","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:01:55.000Z","conversation_id":"411466007987748864","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Pierre Biron. Pharmacovigilance from A to Z. http://t.co/sk00nB4tLG http://t.co/A214473IJi","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/GYeHuEMhL4","expanded_url":"http://bbc.in/1bKFA4D","display_url":"bbc.in/1bKFA4D"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":[{"start":73,"end":97,"probability":0.7671,"type":"Organization","normalized_text":"World Health Organization"}]},"id":"411465785035345920","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T12:01:02.000Z","conversation_id":"411465785035345920","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: In the news: Global cancer cases reach 14 million - World Health Organization says http://t.co/GYeHuEMhL4","referenced_tweets":[{"type":"retweeted","id":"411465584438571008"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":34,"end":56,"url":"http://t.co/k5bTk63o06","expanded_url":"http://www.fda.gov/safety/medwatch/default.htm","display_url":"fda.gov/safety/medwatc…"},{"start":57,"end":79,"url":"http://t.co/OZKTCeDTd1","expanded_url":"https://twitter.com/FrancoisMaignen/status/411465124206358528/photo/1","display_url":"pic.twitter.com/OZKTCeDTd1"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411465165662457857","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:58:34.000Z","conversation_id":"411465165662457857","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"sl","text":"RT @FrancoisMaignen: FDA MedWatch http://t.co/k5bTk63o06 http://t.co/OZKTCeDTd1","referenced_tweets":[{"type":"retweeted","id":"411465124206358528"}],"attachments":{"media_keys":["3_411465124017623040"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":30,"end":38,"tag":"measles"},{"start":39,"end":47,"tag":"rubella"},{"start":48,"end":54,"tag":"polio"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"annotations":{}},"id":"411464895029198848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:57:30.000Z","conversation_id":"411464895029198848","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: Update on #measles #rubella #polio in European Region: 1 in 3 measles cases are adults – Are you protected? http://t.co…","referenced_tweets":[{"type":"retweeted","id":"411464768596103168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/rER3m1bgqv","expanded_url":"http://www.cioms.ch/index.php/publications/printable-publications?task=view&id=45&catid=58","display_url":"cioms.ch/index.php/publ…"},{"start":110,"end":132,"url":"http://t.co/RVQervGWoq","expanded_url":"https://twitter.com/FrancoisMaignen/status/411464697603706880/photo/1","display_url":"pic.twitter.com/RVQervGWoq"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411464790217732097","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:57:05.000Z","conversation_id":"411464790217732097","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: CIOMS Definition and application if terms in vaccine surveillance http://t.co/rER3m1bgqv http://t.co/RVQervGWoq","referenced_tweets":[{"type":"retweeted","id":"411464697603706880"}],"attachments":{"media_keys":["3_411464697511424000"]}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/ibXbSMTWHs","expanded_url":"http://www.cioms.ch/index.php/publications/printable-publications?task=view&id=44&catid=58","display_url":"cioms.ch/index.php/publ…"},{"start":107,"end":129,"url":"http://t.co/8xleKEv3hL","expanded_url":"https://twitter.com/FrancoisMaignen/status/411463536981061632/photo/1","display_url":"pic.twitter.com/8xleKEv3hL"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411464759850975232","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:56:58.000Z","conversation_id":"411464759850975232","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: CIOMS Definition and criteria of use of adverse reaction terms http://t.co/ibXbSMTWHs http://t.co/8xleKEv3hL","referenced_tweets":[{"type":"retweeted","id":"411463536981061632"}],"attachments":{"media_keys":["3_411463536809115648"]}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/HK9hdtcoVg","expanded_url":"http://www.cioms.ch/index.php/component/booklibrary/?task=view&Itemid=&id=47&catid=58","display_url":"cioms.ch/index.php/comp…"},{"start":101,"end":123,"url":"http://t.co/2grtmAfm2B","expanded_url":"https://twitter.com/FrancoisMaignen/status/411462549788721153/photo/1","display_url":"pic.twitter.com/2grtmAfm2B"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411462748917075968","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:48:58.000Z","conversation_id":"411462748917075968","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"RT @FrancoisMaignen: CIOMS Current challenges in Pharmacovigilance (guidance) http://t.co/HK9hdtcoVg http://t.co/2grtmAfm2B","referenced_tweets":[{"type":"retweeted","id":"411462549788721153"}],"attachments":{"media_keys":["3_411462549566410752"]}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/l7UrSXWaYh","expanded_url":"http://flip.it/ar8pT","display_url":"flip.it/ar8pT"},{"start":94,"end":116,"url":"http://t.co/Up36Qf82gR","expanded_url":"https://twitter.com/FrancoisMaignen/status/411458564671426560/photo/1","display_url":"pic.twitter.com/Up36Qf82gR"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":61,"end":69,"probability":0.4261,"type":"Organization","normalized_text":"Flipboard"}]},"id":"411459677797380096","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:36:46.000Z","conversation_id":"411459677797380096","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Pharmacovigilance, drug interactions on Flipboard http://t.co/l7UrSXWaYh http://t.co/Up36Qf82gR","referenced_tweets":[{"type":"retweeted","id":"411458564671426560"}],"attachments":{"media_keys":["3_411458564302311424"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":38,"end":49,"tag":"Nanosilver"},{"start":51,"end":58,"tag":"safety"},{"start":60,"end":67,"tag":"health"},{"start":105,"end":119,"tag":"antimicrobial"},{"start":120,"end":131,"tag":"resistance"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"411459538701651970","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:36:13.000Z","conversation_id":"411459538701651970","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #PublicConsultation on #Nanosilver: #safety, #health, environmental effects &amp; role in #antimicrobial #resistance http://t.co…","referenced_tweets":[{"type":"retweeted","id":"411457557006258176"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/2zDRAnSt8h","expanded_url":"http://bit.ly/1crCbnR","display_url":"bit.ly/1crCbnR"},{"start":87,"end":109,"url":"http://t.co/m47aJ9joiW","expanded_url":"http://bit.ly/1hQMitV","display_url":"bit.ly/1hQMitV"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411458701485031424","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:32:53.000Z","conversation_id":"411458701485031424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Medicinal interactions, CYP450 and Pgp via http://t.co/2zDRAnSt8h http://t.co/m47aJ9joiW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/naGImeJ7ge","expanded_url":"http://bit.ly/19EKf3I","display_url":"bit.ly/19EKf3I"}],"hashtags":[{"start":72,"end":86,"tag":"antimicrobial"}],"mentions":{},"annotations":{}},"id":"411455888415666177","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:21:42.000Z","conversation_id":"411455888415666177","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The report from our workshop on regulatory options in the fight against #antimicrobial resistance is now available: http://t.co/naGImeJ7ge","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/JHQcXaUDTD","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":115,"end":137,"url":"http://t.co/SlmgaVAc2O","expanded_url":"https://twitter.com/FrancoisMaignen/status/411455597188771840/photo/1","display_url":"pic.twitter.com/SlmgaVAc2O"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411455705317511168","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:20:59.000Z","conversation_id":"411455705317511168","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Thesaurus of centrally authorised medicinal products (SPCs, PL, EPARs) http://t.co/JHQcXaUDTD http://t.co/SlmgaVAc2O","referenced_tweets":[{"type":"retweeted","id":"411455597188771840"}],"attachments":{"media_keys":["3_411455597029371905"]}},{"source":"Twitter Web Client","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/z63t2E7hrW","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":52,"end":55,"tag":"IT"},{"start":91,"end":103,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"411455336898256896","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:19:31.000Z","conversation_id":"411455336898256896","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for Head of #IT Operations: http://t.co/z63t2E7hrW #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/wQGvoupB0A","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":52,"end":67,"tag":"HumanResources"},{"start":69,"end":72,"tag":"HR"},{"start":99,"end":111,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"411455215942909952","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:19:02.000Z","conversation_id":"411455215942909952","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for Head of #HumanResources (#HR): http://t.co/wQGvoupB0A  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/FZbBNupjud","expanded_url":"http://www.medicines.org.uk/emcmobile/","display_url":"medicines.org.uk/emcmobile/"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":[{"start":21,"end":22,"probability":0.7979,"type":"Place","normalized_text":"UK"}]},"id":"411454688949587968","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:16:57.000Z","conversation_id":"411454688949587968","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: UK thesaurus of medicinal products http://t.co/FZbBNupjud","referenced_tweets":[{"type":"retweeted","id":"411454617147682816"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/xd8aAzxm17","expanded_url":"http://bit.ly/IHgxUu","display_url":"bit.ly/IHgxUu"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"411454109070266369","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:14:38.000Z","conversation_id":"411454109070266369","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft Community #herbal monograph on #Arnica flower: http://t.co/xd8aAzxm17","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/5q2Su5QsOE","expanded_url":"http://base-donnees-publique.medicaments.gouv.fr","display_url":"…-donnees-publique.medicaments.gouv.fr"},{"start":82,"end":104,"url":"http://t.co/t9Qz4Ma1wb","expanded_url":"https://twitter.com/FrancoisMaignen/status/411453577912393728/photo/1","display_url":"pic.twitter.com/t9Qz4Ma1wb"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411453893982167041","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:13:47.000Z","conversation_id":"411453893982167041","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: French database of medicinal products http://t.co/5q2Su5QsOE http://t.co/t9Qz4Ma1wb","referenced_tweets":[{"type":"retweeted","id":"411453577912393728"}],"attachments":{"media_keys":["3_411453577623011328"]}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/9H9H3NCimf","expanded_url":"http://bit.ly/1jt7mWB","display_url":"bit.ly/1jt7mWB"}],"hashtags":[{"start":63,"end":73,"tag":"Melaleuca"},{"start":75,"end":83,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"411453507787452416","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:12:15.000Z","conversation_id":"411453507787452416","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft Community list entry for #Melaleuca (#teatree oil): http://t.co/9H9H3NCimf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/xRWaQstSUP","expanded_url":"http://bit.ly/1bM6WbY","display_url":"bit.ly/1bM6WbY"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":79,"tag":"Melaleuca"},{"start":81,"end":89,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"411453405370916864","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:11:50.000Z","conversation_id":"411453405370916864","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/xRWaQstSUP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/JyB0NRzNVu","expanded_url":"http://campus.prescrire.org/fr/DownloadPharmacoVig.aspx?name=PrescrireManuelPharmacovig","display_url":"campus.prescrire.org/fr/DownloadPha…"},{"start":112,"end":134,"url":"http://t.co/i9yc6arecz","expanded_url":"https://twitter.com/FrancoisMaignen/status/411453163569700864/photo/1","display_url":"pic.twitter.com/i9yc6arecz"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411453223937900544","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:11:07.000Z","conversation_id":"411453223937900544","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Handbook of Pharmacovigilance and clinical pharmacology (in French) http://t.co/JyB0NRzNVu http://t.co/i9yc6arecz","referenced_tweets":[{"type":"retweeted","id":"411453163569700864"}],"attachments":{"media_keys":["3_411453163292876800"]}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/PuKPQSAxu9","expanded_url":"https://twitter.com/FrancoisMaignen/status/411452769128939520/photo/1","display_url":"pic.twitter.com/PuKPQSAxu9"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411453021936046080","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:10:19.000Z","conversation_id":"411453021936046080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Overview of CYP450 isoenzymes genetics http://t.co/PuKPQSAxu9","referenced_tweets":[{"type":"retweeted","id":"411452769128939520"}],"attachments":{"media_keys":["3_411452768952811520"]}},{"source":"TweetDeck","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/HDLLDeqnEw","expanded_url":"https://twitter.com/FrancoisMaignen/status/411452619732029440/photo/1","display_url":"pic.twitter.com/HDLLDeqnEw"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411453001186803712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:10:14.000Z","conversation_id":"411453001186803712","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: CYP450 inducers and inhibitors http://t.co/HDLLDeqnEw","referenced_tweets":[{"type":"retweeted","id":"411452619732029440"}],"attachments":{"media_keys":["3_411452619572658176"]}},{"source":"TweetDeck","entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/h5zXfRWcwb","expanded_url":"https://twitter.com/FrancoisMaignen/status/411452461439025152/photo/1","display_url":"pic.twitter.com/h5zXfRWcwb"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411452979149938688","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:10:09.000Z","conversation_id":"411452979149938688","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Other CYP3A4 substrates http://t.co/h5zXfRWcwb","referenced_tweets":[{"type":"retweeted","id":"411452461439025152"}],"attachments":{"media_keys":["3_411452461279637504"]}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/kccYze5Vw8","expanded_url":"http://medicine.iupui.edu/clinpharm/ddis/clinical-table/","display_url":"medicine.iupui.edu/clinpharm/ddis…"},{"start":80,"end":102,"url":"http://t.co/5SCJwv8RYj","expanded_url":"https://twitter.com/FrancoisMaignen/status/411452373920677888/photo/1","display_url":"pic.twitter.com/5SCJwv8RYj"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"id":"411452936628101120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:09:59.000Z","conversation_id":"411452936628101120","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FrancoisMaignen: Isoenzymes of CYP450 substrates via http://t.co/kccYze5Vw8 http://t.co/5SCJwv8RYj","referenced_tweets":[{"type":"retweeted","id":"411452373920677888"}],"attachments":{"media_keys":["3_411452373719334912"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":98,"end":124,"probability":0.6765,"type":"Organization","normalized_text":"Novartis Consumer Health UK"}]},"id":"411452561435004929","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:08:29.000Z","conversation_id":"411452561435004929","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): Tixylix® liquid medicines - Novartis Consumer Health UK Lt... http://…","referenced_tweets":[{"type":"retweeted","id":"411445422734192640"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/MYJdGEEnOP","expanded_url":"http://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2013:365:SOM:EN:HTML","display_url":"eur-lex.europa.eu/JOHtml.do?uri=…"}],"hashtags":[{"start":64,"end":67,"tag":"EU"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":27,"end":41,"username":"EUAuditorsECA","id":"803430727844888576"}],"annotations":{}},"id":"411452151336947712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:06:51.000Z","conversation_id":"411452151336947712","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EURLex: Reports by the @EUAuditorsECA on annual accounts of #EU agencies and bodies http://t.co/MYJdGEEnOP","referenced_tweets":[{"type":"retweeted","id":"411435587279650816"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/Q0AfhJFySm","expanded_url":"http://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2013:363A:SOM:EN:HTML","display_url":"eur-lex.europa.eu/JOHtml.do?uri=…"}],"hashtags":[{"start":12,"end":20,"tag":"Vacancy"},{"start":27,"end":34,"tag":"doctor"},{"start":58,"end":67,"tag":"Brussels"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":42,"end":54,"username":"Europarl_EN","id":"36329597"}],"annotations":{}},"id":"411452101793812480","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:06:40.000Z","conversation_id":"411452101793812480","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EURLex: #Vacancy for a #doctor at the @Europarl_EN in #Brussels http://t.co/Q0AfhJFySm","referenced_tweets":[{"type":"retweeted","id":"411434624577847298"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/q6G2gwQKxL","expanded_url":"http://bit.ly/18G22Y7#H2020","display_url":"bit.ly/18G22Y7#H2020"}],"hashtags":[{"start":84,"end":88,"tag":"IMI"},{"start":89,"end":102,"tag":"GlobalHealth"},{"start":103,"end":112,"tag":"Research"},{"start":113,"end":120,"tag":"Greece"},{"start":121,"end":129,"tag":"Malaria"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":130,"end":137,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"411451318981505024","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:03:33.000Z","conversation_id":"411451318981505024","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: It's Friday! EFPIA's Weekly Newsletter is *out* ! http://t.co/q6G2gwQKxL #IMI #GlobalHealth #Research #Greece #Malaria @IMI_JU @…","referenced_tweets":[{"type":"retweeted","id":"411429114067701760"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/hpoEQASQpz","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/12/news_detail_001988.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":13,"end":15,"probability":0.5201,"type":"Organization","normalized_text":"EMA"}]},"id":"411450949094219776","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T11:02:05.000Z","conversation_id":"411450949094219776","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA published report on workshop on regulatory options in the fight against antimicrobial resistance: http://t.co/hpoEQASQpz","referenced_tweets":[{"type":"retweeted","id":"411428009280045056"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zQbVTjAMbJ","expanded_url":"http://bit.ly/1950mel","display_url":"bit.ly/1950mel"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Ononis"},{"start":78,"end":89,"tag":"restharrow"}],"mentions":{},"annotations":{}},"id":"411423840380538880","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T09:14:22.000Z","conversation_id":"411423840380538880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last few days to comment on our draft Community #herbal monograph on #Ononis (#restharrow root): http://t.co/zQbVTjAMbJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/GE7mdAWXzz","expanded_url":"http://bit.ly/19lLTel","display_url":"bit.ly/19lLTel"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"411423347470524416","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-13T09:12:24.000Z","conversation_id":"411423347470524416","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Our human medicine committee, #CHMP is meeting next week. We're publishing the highlights on Friday: http://t.co/GE7mdAWXzz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/GA34av7sMl","expanded_url":"http://bit.ly/19EKf3I","display_url":"bit.ly/19EKf3I"}],"hashtags":[{"start":86,"end":100,"tag":"antimicrobial"}],"mentions":{},"annotations":{}},"id":"411176879451013120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-12T16:53:02.000Z","conversation_id":"411176879451013120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the report of our workshop on regulatory options in the fight against #antimicrobial resistance: http://t.co/GA34av7sMl","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":16,"end":23,"tag":"cancer"},{"start":110,"end":123,"tag":"GLOBOCAN2012"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"411104204418064384","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-12T12:04:14.000Z","conversation_id":"411104204418064384","public_metrics":{"retweet_count":68,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Global #cancer burden risen to 14.1 million new cases and 8.2 million cancer-related deaths in 2012: #GLOBOCAN2012 http://t.co/Ftq…","referenced_tweets":[{"type":"retweeted","id":"411079485119680513"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/5qqekRVAWL","expanded_url":"http://bit.ly/1afAtpV","display_url":"bit.ly/1afAtpV"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"id":"410825286364577793","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-11T17:35:55.000Z","conversation_id":"410750808431415296","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@HJF29088181 We're aiming to  achieve it by the end of the year: http://t.co/5qqekRVAWL","referenced_tweets":[{"type":"replied_to","id":"410802532873555968"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"id":"410793447553892352","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-11T15:29:24.000Z","conversation_id":"410750808431415296","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@HJF29088181 Thanks for your tweet, they are not published yet. Please continue to check our website, this will be highlighted.","referenced_tweets":[{"type":"replied_to","id":"410750808431415296"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":34,"end":42,"probability":0.5065,"type":"Other","normalized_text":"Alzheimer"}]},"id":"410760576298528769","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-11T13:18:47.000Z","conversation_id":"410760576298528769","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI has 3 projects on Alzheimer's, with experts from industry, unis, small companies &amp; patient groups working together. #G8deme…","referenced_tweets":[{"type":"retweeted","id":"410742658697818112"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"alljoinjack","id":"554667907"}],"annotations":{}},"id":"410705461575299072","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-11T09:39:47.000Z","conversation_id":"410505588242939905","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@alljoinjack Thanks for your tweet, for details please send us a question via our site and we'll get back to you: http://t.co/PXIKAo9uV4","referenced_tweets":[{"type":"replied_to","id":"410505588242939905"}],"in_reply_to_user_id":"554667907","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/n7DOjt1T6x","expanded_url":"http://bit.ly/9m6Tpb","display_url":"bit.ly/9m6Tpb"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"id":"410459276012814336","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T17:21:32.000Z","conversation_id":"410459276012814336","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: Search our database of approved animal drugs http://t.co/n7DOjt1T6x","referenced_tweets":[{"type":"retweeted","id":"410459201907863552"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/cnvG2xWdZM","expanded_url":"http://bit.ly/1cyOVwj","display_url":"bit.ly/1cyOVwj"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"id":"410455059525169152","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T17:04:46.000Z","conversation_id":"410455059525169152","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: Monthly medicinal-product newsletter published for November 2013. http://t.co/cnvG2xWdZM","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":98,"end":107,"tag":"MHRAtest"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"},{"start":54,"end":60,"username":"GOVUK","id":"17481977"}],"annotations":{}},"id":"410437423324078080","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T15:54:41.000Z","conversation_id":"410437423324078080","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: Help us, help you. We’re moving to the @GOVUK website. Be part of our user testing #MHRAtest, register today: http://t.co/kb…","referenced_tweets":[{"type":"retweeted","id":"410437225894412289"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"PeterJTCoe","id":"610961115"}],"annotations":{}},"id":"410435088040460288","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T15:45:25.000Z","conversation_id":"410434088562987008","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@PeterJTCoe Thanks for letting us know!! We'll get it corrected as soon as we can...","referenced_tweets":[{"type":"replied_to","id":"410434088562987008"}],"in_reply_to_user_id":"610961115","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/10OzgEBZIB","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Whatsnew/CON350677","display_url":"mhra.gov.uk/NewsCentre/Wha…"}],"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":[{"start":33,"end":47,"probability":0.6317,"type":"Organization","normalized_text":"Human Medicines"}]},"id":"410430929111228417","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T15:28:53.000Z","conversation_id":"410430929111228417","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Commission on Human Medicines recruiting for new members http://t.co/10OzgEBZIB","referenced_tweets":[{"type":"retweeted","id":"410429375876562944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":19,"end":29,"tag":"Antitrust"},{"start":134,"end":143,"tag":"fentanyl"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":31,"end":45,"username":"EU_Commission","id":"157981564"}],"annotations":[{"start":52,"end":58,"probability":0.5322,"type":"Person","normalized_text":"Johnson"},{"start":60,"end":66,"probability":0.422,"type":"Person","normalized_text":"Johnson"},{"start":70,"end":77,"probability":0.4904,"type":"Organization","normalized_text":"Novartis"}]},"id":"410430828108201984","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T15:28:29.000Z","conversation_id":"410430828108201984","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: #Antitrust: @EU_Commission fines Johnson&amp;Johnson &amp; Novartis €16m for delaying entry of generic pain-killer #fentanyl htt…","referenced_tweets":[{"type":"retweeted","id":"410429244666544129"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"annotations":[{"start":16,"end":24,"probability":0.4352,"type":"Organization","normalized_text":"Antitrust"},{"start":44,"end":50,"probability":0.7277,"type":"Person","normalized_text":"Johnson"},{"start":54,"end":60,"probability":0.4185,"type":"Person","normalized_text":"Johnson"},{"start":66,"end":73,"probability":0.7308,"type":"Organization","normalized_text":"Novartis"}]},"id":"410423015445258240","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T14:57:26.000Z","conversation_id":"410423015445258240","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Berlaymont: Antitrust: Commission fines Johnson &amp; Johnson and Novartis € 16 million for delaying market entry of generic p... http://t.…","referenced_tweets":[{"type":"retweeted","id":"410421591273521152"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/3xtt2KccmD","expanded_url":"http://www.medicalnewstoday.com/releases/269850.php#.UqcmIm8U9AU.twitter","display_url":"medicalnewstoday.com/releases/26985…"}],"hashtags":[{"start":18,"end":24,"tag":"Study"},{"start":34,"end":39,"tag":"drug"},{"start":40,"end":49,"tag":"labeling"},{"start":54,"end":63,"tag":"exposure"}],"mentions":{},"annotations":{}},"id":"410418642895908864","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T14:40:04.000Z","conversation_id":"410418642895908864","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #Study examines #drug #labeling and #exposure in infants - Medical News Today: http://t.co/3xtt2KccmD","referenced_tweets":[{"type":"retweeted","id":"410416951614115840"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":15,"end":21,"tag":"EPSCO"},{"start":34,"end":49,"tag":"clinicaltrials"},{"start":50,"end":54,"tag":"TPD"},{"start":56,"end":74,"tag":"pharmacovigilance"},{"start":81,"end":95,"tag":"healthsystems"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":22,"end":30,"username":"borgton","id":"1605512862"},{"start":99,"end":109,"username":"EUCouncil","id":"206717989"}],"annotations":{}},"id":"410413137305665536","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T14:18:11.000Z","conversation_id":"410413137305665536","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #EPSCO @borgton on #clinicaltrials #TPD, #pharmacovigilance &amp; #healthsystems at @EUCouncil press conference http://t.co/fHZb…","referenced_tweets":[{"type":"retweeted","id":"410413069240504320"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"id":"410398595079090176","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T13:20:24.000Z","conversation_id":"410398595079090176","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IFAHEurope: Looking forward to hearing update on 5 year action plan at tomorrow’s Joint Conf on Antimicrobial Resistance #ResponsibleUs…","referenced_tweets":[{"type":"retweeted","id":"410396193991036929"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Xi9qw10Rnb","expanded_url":"http://bit.ly/19eyqFa","display_url":"bit.ly/19eyqFa"}],"hashtags":[{"start":26,"end":41,"tag":"counterfeiting"},{"start":42,"end":47,"tag":"drug"},{"start":58,"end":70,"tag":"infographic"},{"start":95,"end":105,"tag":"pinterest"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":71,"end":78,"username":"EU_ESM","id":"1949283199"}],"annotations":{}},"id":"410379656152367104","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T12:05:09.000Z","conversation_id":"410379656152367104","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: How big is the #counterfeiting #drug industry? #infographic @EU_ESM Follow EFPIA on #pinterest http://t.co/Xi9qw10Rnb http://t.c…","referenced_tweets":[{"type":"retweeted","id":"410379572178202626"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/A3nwUgSaaO","expanded_url":"http://bit.ly/1dkPlFf","display_url":"bit.ly/1dkPlFf"}],"hashtags":[{"start":13,"end":20,"tag":"Relvar"},{"start":21,"end":29,"tag":"Ellipta"},{"start":31,"end":43,"tag":"fluticasone"},{"start":54,"end":65,"tag":"vilanterol"},{"start":83,"end":90,"tag":"asthma"},{"start":97,"end":102,"tag":"COPD"}],"mentions":{},"annotations":{}},"id":"410378618649333760","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T12:01:01.000Z","conversation_id":"410378618649333760","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Relvar #Ellipta (#fluticasone furoate / #vilanterol), a medicine for #asthma &amp; #COPD, is now available: http://t.co/A3nwUgSaaO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":18,"end":27,"tag":"Patients"},{"start":72,"end":77,"tag":"CHMP"},{"start":119,"end":137,"tag":"pharmacovigilance"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":44,"end":53,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"410374900470149120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T11:46:15.000Z","conversation_id":"410374900470149120","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: #Patients sitting in most @EMA_News committees but in #CHMP - what's the future? Pilot partic as for #pharmacovigilance? …","referenced_tweets":[{"type":"retweeted","id":"410374809537638400"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/dmynPWrhK0","expanded_url":"https://twitter.com/ehnheart/status/410371801416740864/photo/1","display_url":"pic.twitter.com/dmynPWrhK0"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ehnheart","id":"407008173"},{"start":76,"end":85,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":28,"end":36,"probability":0.8456,"type":"Person","normalized_text":"Christine"}]},"id":"410371937169190912","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T11:34:28.000Z","conversation_id":"410371937169190912","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ehnheart: W/ our expert Christine on patient experience at sag meetings @EMA_News http://t.co/dmynPWrhK0","referenced_tweets":[{"type":"retweeted","id":"410371801416740864"}],"attachments":{"media_keys":["3_410371801014099968"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":66,"end":75,"tag":"patients"},{"start":94,"end":103,"tag":"EMA_PCWP"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":116,"end":125,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"410371468011118593","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T11:32:36.000Z","conversation_id":"410371468011118593","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: 85% of scientific advisory groups meetings have #patients' representative - #EMA_PCWP training at @EMA_News - Patients' i…","referenced_tweets":[{"type":"retweeted","id":"410371393520271360"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":54,"end":64,"tag":"aspartame"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"id":"410366970379247616","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T11:14:44.000Z","conversation_id":"410366970379247616","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #EFSA completes first risk assessment of #aspartame and confirms the sweetener is safe at current levels of exposure http://t.…","referenced_tweets":[{"type":"retweeted","id":"410366716112171008"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/fyWQnznP34","expanded_url":"http://onforb.es/1glzGu6","display_url":"onforb.es/1glzGu6"}],"hashtags":[{"start":38,"end":44,"tag":"trust"},{"start":82,"end":97,"tag":"clinicaltrials"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"id":"410362110665687040","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:55:26.000Z","conversation_id":"410362110665687040","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @HAIEurope: Important questions on #trust and the potential emerging models of #clinicaltrials data sharing: http://t.co/fyWQnznP34 @eds…","referenced_tweets":[{"type":"retweeted","id":"410361738177937408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":108,"end":117,"tag":"EMA_PCWP"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":31,"end":44,"username":"EFA_Patients","id":"1299643704"},{"start":98,"end":107,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":18,"end":24,"probability":0.4808,"type":"Person","normalized_text":"Puhl M."}]},"id":"410356948727394304","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:34:55.000Z","conversation_id":"410356948727394304","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: Puhl M. from @EFA_Patients presenting patient's experience in scientific advice @EMA_News #EMA_PCWP","referenced_tweets":[{"type":"retweeted","id":"410356578257084416"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":18,"username":"laurentlouette","id":"207525510"},{"start":47,"end":56,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"410353569573765120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:21:29.000Z","conversation_id":"410353569573765120","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @laurentlouette: At the training meeting of @EMA_News good to jog memories on medicines regulation !","referenced_tweets":[{"type":"retweeted","id":"410350896502308864"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/OsABedmK9t","expanded_url":"http://bit.ly/1dkPlFf","display_url":"bit.ly/1dkPlFf"}],"hashtags":[{"start":42,"end":49,"tag":"Relvar"},{"start":50,"end":58,"tag":"Ellipta"},{"start":60,"end":72,"tag":"fluticasone"},{"start":83,"end":94,"tag":"vilanterol"},{"start":100,"end":107,"tag":"asthma"},{"start":114,"end":119,"tag":"COPD"}],"mentions":{},"annotations":{}},"id":"410353201326878720","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:20:01.000Z","conversation_id":"410353201326878720","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Relvar #Ellipta (#fluticasone furoate / #vilanterol) for #asthma &amp; #COPD:\n http://t.co/OsABedmK9t","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/pqpiPzIGKt","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2012/06/event_detail_000587.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":37,"end":55,"probability":0.4845,"type":"Organization","normalized_text":"EMA Managment Board"}]},"id":"410352270513930240","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:16:19.000Z","conversation_id":"410352270513930240","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: The next meeting of the EMA Managment Board will start tomorrow.  http://t.co/pqpiPzIGKt","referenced_tweets":[{"type":"retweeted","id":"410352117598392320"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"id":"410352114234167296","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:15:42.000Z","conversation_id":"410350258007199744","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@HJF29088181 It seems fine from our side. Please could you send a fuller description of the problem to us at http://t.co/rMxJXKOpHn.","referenced_tweets":[{"type":"replied_to","id":"410350258007199744"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":116,"end":125,"tag":"EMA_PCWP"}],"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":77,"end":110,"probability":0.4643,"type":"Organization","normalized_text":"Patients & Consumers Working Group"}]},"id":"410351300849590272","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:12:28.000Z","conversation_id":"410351300849590272","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @cancereu: ECPC today attends the training session for the members of the Patients &amp; Consumers Working Group #EMA_PCWP","referenced_tweets":[{"type":"retweeted","id":"410350935760572416"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":68,"end":77,"tag":"patients"},{"start":84,"end":94,"tag":"consumers"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"},{"start":45,"end":54,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"410351231119282176","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T10:12:12.000Z","conversation_id":"410351231119282176","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: Interesting discussions at @EMA_News training for #patients &amp; #consumers today: patients' involvement in regulatory proce…","referenced_tweets":[{"type":"retweeted","id":"410349948614356992"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/IoR8EMKrwB","expanded_url":"http://bit.ly/1ffBKkg","display_url":"bit.ly/1ffBKkg"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"id":"410342623254024192","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-10T09:37:59.000Z","conversation_id":"410342623254024192","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: Monthly report from the CHMP (November 2013) http://t.co/IoR8EMKrwB","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/c17vdG5Imu","expanded_url":"http://bit.ly/19vXKCI","display_url":"bit.ly/19vXKCI"}],"hashtags":[{"start":77,"end":89,"tag":"haemophilia"}],"mentions":{},"annotations":{}},"id":"410108752449110016","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T18:08:40.000Z","conversation_id":"410108752449110016","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR is now available for NovoEight, a medicine for use in patients with #haemophilia A: http://t.co/c17vdG5Imu","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/N0OghbL40A","expanded_url":"http://goo.gl/pYuu4I","display_url":"goo.gl/pYuu4I"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"},{"start":20,"end":31,"username":"IAPOtweets","id":"14682411"}],"annotations":{}},"id":"410108430901211136","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T18:07:24.000Z","conversation_id":"410108430901211136","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IAPOtweets: NEW @IAPOtweets PUBLICATION - Information and Advocacy Toolkit on Biological and Biosimilar Medicines http://t.co/N0OghbL40A","referenced_tweets":[{"type":"retweeted","id":"410083957888126976"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/OkO7Uh6VB9","expanded_url":"http://bit.ly/19vXKCI","display_url":"bit.ly/19vXKCI"}],"hashtags":[{"start":89,"end":101,"tag":"haemophilia"}],"mentions":{},"annotations":[{"start":42,"end":50,"probability":0.2587,"type":"Person","normalized_text":"NovoEight"}]},"id":"410056267164819456","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T14:40:07.000Z","conversation_id":"410056267164819456","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for NovoEight, a medicine for use in patients with #haemophilia A: http://t.co/OkO7Uh6VB9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Um4JRvtDk3","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36315","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":106,"end":114,"username":"uclnews","id":"40234732"}],"annotations":{}},"id":"410023806971830272","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T12:31:08.000Z","conversation_id":"410023806971830272","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Developing safe and effective drugs to relieve chronic pain in kids http://t.co/Um4JRvtDk3 \n@uclnews","referenced_tweets":[{"type":"retweeted","id":"410007140258947073"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"410023738407546880","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T12:30:51.000Z","conversation_id":"410023738407546880","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 2 Medicines Recall (action within 48 hours): Jext 300 and 150 micrograms solution for injection in pre-f... http:/…","referenced_tweets":[{"type":"retweeted","id":"410008693497798656"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":40,"end":62,"tag":"CrossBorderHealthcare"}],"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"},{"start":82,"end":98,"username":"eupatientsforum","id":"545343465"}],"annotations":[{"start":124,"end":130,"probability":0.5349,"type":"Product","normalized_text":"Twitter"}]},"id":"410023638021070848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T12:30:27.000Z","conversation_id":"410023638021070848","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eupatientsforum: Tonight starts our #CrossBorderHealthcare Conference! Follow @eupatientsforum live as from tomorrow on Twitter  #CBHea…","referenced_tweets":[{"type":"retweeted","id":"410011769067675650"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/yeH8W5Haqy","expanded_url":"http://bit.ly/J6hc3b","display_url":"bit.ly/J6hc3b"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"id":"410023502201122816","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T12:29:55.000Z","conversation_id":"410023502201122816","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Human medicines highlights - Issue 57 - November 2013 http://t.co/yeH8W5Haqy","referenced_tweets":[{"type":"retweeted","id":"410016579955331072"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/1JRbaywoZp","expanded_url":"http://bit.ly/IO6q0K","display_url":"bit.ly/IO6q0K"}],"hashtags":[{"start":27,"end":36,"tag":"Kogenate"},{"start":47,"end":56,"tag":"Helixate"}],"mentions":{},"annotations":{}},"id":"410004021064122368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T11:12:30.000Z","conversation_id":"410004021064122368","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"PRAC considers benefits of #Kogenate Bayer and #Helixate NexGen outweigh risks in previously untreated patients: http://t.co/1JRbaywoZp","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":36,"end":58,"url":"http://t.co/p4f90IWLqP","expanded_url":"http://bit.ly/195ekgu","display_url":"bit.ly/195ekgu"}],"hashtags":[{"start":18,"end":26,"tag":"Iclusig"}],"mentions":{},"annotations":{}},"id":"410003730247868417","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T11:11:21.000Z","conversation_id":"410003730247868417","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Further review of #Iclusig started: http://t.co/p4f90IWLqP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/EK9Y5Gmf63","expanded_url":"http://bit.ly/1aFuZ6e","display_url":"bit.ly/1aFuZ6e"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"410003578720243712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-09T11:10:45.000Z","conversation_id":"410003578720243712","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"On Friday we published the PRAC meeting highlights: http://t.co/EK9Y5Gmf63","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}],"annotations":[{"start":14,"end":21,"probability":0.7795,"type":"Organization","normalized_text":"DG SANCO"}]},"id":"409002833820651520","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T16:54:09.000Z","conversation_id":"409002833820651520","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @cancereu: DG SANCO has just launched a public consultation on patient safety and quality of care.\n\nResults of the... http://t.co/T2IO5v…","referenced_tweets":[{"type":"retweeted","id":"409002474054623232"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Hv5TSJXgGS","expanded_url":"http://bit.ly/Iwj1pr","display_url":"bit.ly/Iwj1pr"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"id":"409002743143997440","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T16:53:47.000Z","conversation_id":"409002743143997440","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: New requirements for notification of withdrawal of medicines http://t.co/Hv5TSJXgGS","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":35,"end":40,"tag":"H7N9"},{"start":45,"end":50,"tag":"MERS"},{"start":89,"end":93,"tag":"flu"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":120,"end":125,"probability":0.976,"type":"Place","normalized_text":"Europe"}]},"id":"409002654342193153","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T16:53:26.000Z","conversation_id":"409002654342193153","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: See latest updates on #H7N9 and #MERS-CoV in weekly threat report; seasonal #flu activity still low across Europe: http://t.co…","referenced_tweets":[{"type":"retweeted","id":"409000163756097536"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/cclbEJ3O9S","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/12/news_detail_001985.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":46,"end":88,"probability":0.4494,"type":"Organization","normalized_text":"Pharmacovigilance Risk Assessment Committee"}]},"id":"408994035336880129","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T16:19:11.000Z","conversation_id":"408994035336880129","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 December 2013\n\n http://t.co/cclbEJ3O9S","referenced_tweets":[{"type":"retweeted","id":"408993923991105536"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/GyGdLuMuX8","expanded_url":"http://bit.ly/R1cLZO","display_url":"bit.ly/R1cLZO"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"},{"start":27,"end":41,"tag":"presentations"},{"start":90,"end":108,"tag":"infectiousdisease"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"408981999819317248","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T15:31:21.000Z","conversation_id":"408981999819317248","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #ESCAIDE 2013 #presentations now online, see the latest materials on various #infectiousdisease topics: http://t.co/GyGdLuMuX8","referenced_tweets":[{"type":"retweeted","id":"408980800797831168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"annotations":{}},"id":"408976144260558848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T15:08:05.000Z","conversation_id":"408976144260558848","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAMedWatch: November 2013 Drug Safety Labeling Changes includes 27 products with revisions to Prescribing Information. http://t.co/juh…","referenced_tweets":[{"type":"retweeted","id":"408976091039027200"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/UGOs6WWmAH","expanded_url":"http://bit.ly/1d50QR7","display_url":"bit.ly/1d50QR7"}],"hashtags":[{"start":84,"end":87,"tag":"CT"},{"start":88,"end":92,"tag":"GHI"},{"start":93,"end":98,"tag":"Aids"},{"start":99,"end":107,"tag":"Malaria"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"408973802832281600","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T14:58:47.000Z","conversation_id":"408973802832281600","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: It's Friday! It's out ! It's EFPIA's Newsletter : http://t.co/UGOs6WWmAH #CT #GHI #Aids #Malaria","referenced_tweets":[{"type":"retweeted","id":"408973664185364480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"408971086655549440","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T14:48:00.000Z","conversation_id":"408971086655549440","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: EFPIA WEBINAR REPORT “How pharmaceutical companies are preparing to make clinical data more systematically available”http://t.co…","referenced_tweets":[{"type":"retweeted","id":"408970988815011840"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/yZSk3dH9Ng","expanded_url":"http://bit.ly/1eUXHnY","display_url":"bit.ly/1eUXHnY"}],"hashtags":[{"start":54,"end":69,"tag":"clinicaltrials"},{"start":117,"end":124,"tag":"ctdata"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":70,"end":77,"username":"pfizer","id":"56488059"},{"start":78,"end":86,"username":"ABPI_UK","id":"84296426"},{"start":87,"end":93,"username":"PhRMA","id":"116748080"}],"annotations":{}},"id":"408951414430253057","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T13:29:49.000Z","conversation_id":"408951414430253057","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Delivering on our Data Sharing commitments #clinicaltrials @pfizer @ABPI_UK @PhRMA http://t.co/yZSk3dH9Ng #ctdata","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/lUPVXtDNma","expanded_url":"http://bit.ly/IV2Fai","display_url":"bit.ly/IV2Fai"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":29,"end":34,"probability":0.8849,"type":"Organization","normalized_text":"ANVISA"},{"start":80,"end":88,"probability":0.9988,"type":"Place","normalized_text":"Amsterdam"},{"start":95,"end":105,"probability":0.8649,"type":"Place","normalized_text":"Netherlands"}]},"id":"408951272578891776","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T13:29:15.000Z","conversation_id":"408951272578891776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: AIFA and ANVISA signed memorandum of understanding today in Amsterdam, the Netherlands... http://t.co/lUPVXtDNma","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/IjnCXLxQRE","expanded_url":"http://bit.ly/IO6q0K","display_url":"bit.ly/IO6q0K"}],"hashtags":[{"start":27,"end":36,"tag":"Kogenate"},{"start":47,"end":56,"tag":"Helixate"}],"mentions":{},"annotations":{}},"id":"408944823736217600","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T13:03:38.000Z","conversation_id":"408944823736217600","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"PRAC considers benefits of #Kogenate Bayer and #Helixate NexGen outweigh risks in previously untreated patients: http://t.co/IjnCXLxQRE","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":36,"end":58,"url":"http://t.co/WvWHItxgqB","expanded_url":"http://bit.ly/195ekgu","display_url":"bit.ly/195ekgu"}],"hashtags":[{"start":18,"end":26,"tag":"Iclusig"}],"mentions":{},"annotations":{}},"id":"408944210772238336","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T13:01:12.000Z","conversation_id":"408944210772238336","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Further review of #Iclusig started: http://t.co/WvWHItxgqB","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/WXHcaYtE0q","expanded_url":"http://alzheimereurope.newsweaver.com/Newsletter/1qgc5i4fzxv","display_url":"alzheimereurope.newsweaver.com/Newsletter/1qg…"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"annotations":[{"start":21,"end":36,"probability":0.5842,"type":"Other","normalized_text":"Alzheimer Europe"}]},"id":"408939376450609153","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:41:59.000Z","conversation_id":"408939376450609153","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AlzheimerEurope: Alzheimer Europe November newsletter is now available online: http://t.co/WXHcaYtE0q","referenced_tweets":[{"type":"retweeted","id":"408933464017489920"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/Z1weTr9tXh","expanded_url":"http://bit.ly/1aFuZ6e","display_url":"bit.ly/1aFuZ6e"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"408932761358323712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:15:42.000Z","conversation_id":"408932761358323712","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've just published the PRAC meeting highlights: http://t.co/Z1weTr9tXh","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/z63t2E7hrW","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":53,"end":56,"tag":"IT"},{"start":93,"end":105,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408930278917156865","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:05:50.000Z","conversation_id":"408930278917156865","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our #vacancy for Head of #IT Operations: http://t.co/z63t2E7hrW  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/wQGvoupB0A","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":53,"end":68,"tag":"HumanResources"},{"start":70,"end":73,"tag":"HR"},{"start":100,"end":112,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408930081453535233","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:05:03.000Z","conversation_id":"408930081453535233","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our #vacancy for Head of #HumanResources (#HR): http://t.co/wQGvoupB0A  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/xd8aAzxm17","expanded_url":"http://bit.ly/IHgxUu","display_url":"bit.ly/IHgxUu"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"408929903392718848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:04:21.000Z","conversation_id":"408929903392718848","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our draft Community #herbal monograph on #Arnica flower: http://t.co/xd8aAzxm17","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/9H9H3NCimf","expanded_url":"http://bit.ly/1jt7mWB","display_url":"bit.ly/1jt7mWB"}],"hashtags":[{"start":63,"end":73,"tag":"Melaleuca"},{"start":75,"end":83,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"408929636093939714","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:03:17.000Z","conversation_id":"408929636093939714","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on our draft Community list entry for #Melaleuca (#teatree oil): http://t.co/9H9H3NCimf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/xRWaQstSUP","expanded_url":"http://bit.ly/1bM6WbY","display_url":"bit.ly/1bM6WbY"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":79,"tag":"Melaleuca"},{"start":81,"end":89,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"408929509325279232","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:02:47.000Z","conversation_id":"408929509325279232","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/xRWaQstSUP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zQbVTjAMbJ","expanded_url":"http://bit.ly/1950mel","display_url":"bit.ly/1950mel"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Ononis"},{"start":78,"end":89,"tag":"restharrow"}],"mentions":{},"annotations":{}},"id":"408929229074481152","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:01:40.000Z","conversation_id":"408929229074481152","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on our draft Community #herbal monograph on #Ononis (#restharrow root): http://t.co/zQbVTjAMbJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/y88MMsj1Ki","expanded_url":"http://bit.ly/18ntBZm","display_url":"bit.ly/18ntBZm"}],"hashtags":[{"start":4,"end":9,"tag":"CVMP"},{"start":15,"end":26,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"408929108878311424","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T12:01:11.000Z","conversation_id":"408929108878311424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #CVMP, our #veterinary committee has its plenary meeting next week. Highlights published on Friday: http://t.co/y88MMsj1Ki","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/cgxPBpvFF0","expanded_url":"http://bit.ly/19lmnC9","display_url":"bit.ly/19lmnC9"}],"hashtags":[{"start":25,"end":31,"tag":"EPSCO"},{"start":45,"end":60,"tag":"medicaldevices"},{"start":62,"end":77,"tag":"clinicaltrials"},{"start":84,"end":92,"tag":"tobacco"}],"mentions":[{"start":3,"end":16,"username":"EFA_Patients","id":"1299643704"}],"annotations":{}},"id":"408921193949827072","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T11:29:44.000Z","conversation_id":"408921193949827072","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFA_Patients: Next w #EPSCO will discuss #medicaldevices, #clinicaltrials &amp; #tobacco - http://t.co/cgxPBpvFF0 - EFA position here: http…","referenced_tweets":[{"type":"retweeted","id":"408920987149672448"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/rxSH6UxVbT","expanded_url":"http://bit.ly/1bmjrcE","display_url":"bit.ly/1bmjrcE"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":113,"end":127,"username":"FightTheFakes","id":"1860605736"},{"start":128,"end":134,"username":"IFPMA","id":"949399644"}],"annotations":{}},"id":"408916602197798912","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T11:11:29.000Z","conversation_id":"408916602197798912","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: IFPMA and Global Fund Collaborate to Help Protect Patients from Fake Medicines http://t.co/rxSH6UxVbT @FightTheFakes @IFPMA @EU_…","referenced_tweets":[{"type":"retweeted","id":"408916060151091200"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/yc9Ba29XxB","expanded_url":"http://bit.ly/1iMhB4Z","display_url":"bit.ly/1iMhB4Z"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":53,"end":56,"tag":"IT"},{"start":92,"end":104,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408902942738378752","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:17:13.000Z","conversation_id":"408902942738378752","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our #vacancy for Head of #IT Operations: http://t.co/yc9Ba29XxB #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/cl7tW1hx6o","expanded_url":"http://bit.ly/HG8zLT","display_url":"bit.ly/HG8zLT"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"},{"start":53,"end":68,"tag":"HumanResources"},{"start":70,"end":73,"tag":"HR"},{"start":99,"end":111,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408902365274984448","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:14:55.000Z","conversation_id":"408902365274984448","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for our #vacancy for Head of #HumanResources (#HR): http://t.co/cl7tW1hx6o #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/qhXVDDGllu","expanded_url":"http://bit.ly/IHgxUu","display_url":"bit.ly/IHgxUu"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"408901279935909888","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:10:36.000Z","conversation_id":"408901279935909888","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to comment on our draft Community #herbal monograph on #Arnica flower: http://t.co/qhXVDDGllu","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/YLOkUyw2I4","expanded_url":"http://bit.ly/1jt7mWB","display_url":"bit.ly/1jt7mWB"}],"hashtags":[{"start":63,"end":73,"tag":"Melaleuca"},{"start":75,"end":83,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"408900978566770688","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:09:24.000Z","conversation_id":"408900978566770688","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our draft Community list entry for #Melaleuca (#teatree oil): http://t.co/YLOkUyw2I4","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/8lCOckPCMH","expanded_url":"http://bit.ly/1bM6WbY","display_url":"bit.ly/1bM6WbY"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":79,"tag":"Melaleuca"},{"start":81,"end":89,"tag":"teatree"}],"mentions":{},"annotations":{}},"id":"408900702959075328","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:08:19.000Z","conversation_id":"408900702959075328","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our draft Community #herbal monograph on #Melaleuca (#teatree oil): http://t.co/8lCOckPCMH","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/G6o3CBnLGY","expanded_url":"http://bit.ly/1950mel","display_url":"bit.ly/1950mel"}],"hashtags":[{"start":48,"end":55,"tag":"herbal"},{"start":69,"end":76,"tag":"Ononis"},{"start":78,"end":89,"tag":"restharrow"}],"mentions":{},"annotations":{}},"id":"408900273130962944","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:06:36.000Z","conversation_id":"408900273130962944","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to comment on our draft Community #herbal monograph on #Ononis (#restharrow root): http://t.co/G6o3CBnLGY","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/kiG3zZDYH7","expanded_url":"http://bit.ly/18ntBZm","display_url":"bit.ly/18ntBZm"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"408899820678840320","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T10:04:48.000Z","conversation_id":"408899820678840320","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Our #veterinary committee (#CVMP) is meeting next week. Highlights published on Friday: http://t.co/kiG3zZDYH7","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/N2Dls61YSi","expanded_url":"http://bit.ly/1cpHF5P","display_url":"bit.ly/1cpHF5P"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"id":"408896771947909120","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T09:52:42.000Z","conversation_id":"408896771947909120","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Voluntary recall injectable sodium bicarbonate solution 1.4 &amp; sodium bicarbonate 8.4% Braun  batches http://t.co/N2Dls61YSi","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/drKUANRjLx","expanded_url":"http://bit.ly/1ke7cQh","display_url":"bit.ly/1ke7cQh"}],"hashtags":[{"start":35,"end":43,"tag":"Horizon"},{"start":56,"end":59,"tag":"EU"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"id":"408893541939552256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-06T09:39:51.000Z","conversation_id":"408893541939552256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: Council adopts ''#Horizon 2020'': The #EU's research &amp; innovation programme for 2014-2020 - http://t.co/drKUANRjLx","referenced_tweets":[{"type":"retweeted","id":"408883623606382592"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/jRuICqwvFD","expanded_url":"http://bit.ly/1d0w37N","display_url":"bit.ly/1d0w37N"},{"start":104,"end":126,"url":"http://t.co/UODq4tvoud","expanded_url":"https://twitter.com/EFPIA/status/408590733612838914/photo/1","display_url":"pic.twitter.com/UODq4tvoud"}],"hashtags":[{"start":59,"end":71,"tag":"Infographic"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":95,"end":103,"username":"EFSA_EU","id":"84582815"}],"annotations":[{"start":11,"end":16,"probability":0.9773,"type":"Place","normalized_text":"Europe"}]},"id":"408614094975930368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-05T15:09:26.000Z","conversation_id":"408614094975930368","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Europe's Fight Against Antimicrobial Resistance #Infographic http://t.co/jRuICqwvFD @EFSA_EU http://t.co/UODq4tvoud","referenced_tweets":[{"type":"retweeted","id":"408590733612838914"}],"attachments":{"media_keys":["3_408590733621227520"]}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"408548308106219520","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-05T10:48:01.000Z","conversation_id":"408548308106219520","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Class 4 Drug Alert (Caution in Use): 8.4% w/v Sodium Bicarbonate - B. Braun Melsungen AG - PL 03551/0069 http://t.co/hLy…","referenced_tweets":[{"type":"retweeted","id":"408548034436288512"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/evNlWFZo96","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"hashtags":[{"start":29,"end":37,"tag":"vacancy"},{"start":55,"end":66,"tag":"accountant"},{"start":92,"end":104,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408541052056788992","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-05T10:19:11.000Z","conversation_id":"408541052056788992","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last chance to apply for our #vacancy for a management #accountant: http://t.co/evNlWFZo96  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/yiOIu2kduF","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"hashtags":[{"start":29,"end":37,"tag":"vacancy"},{"start":73,"end":87,"tag":"antimicrobial"},{"start":88,"end":99,"tag":"resistance"},{"start":125,"end":137,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408540761752207360","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-05T10:18:02.000Z","conversation_id":"408540761752207360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last chance to apply for our #vacancy in the secretariat for opinions on #antimicrobial #resistance: http://t.co/yiOIu2kduF  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/8cI1saLeFn","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"hashtags":[{"start":25,"end":33,"tag":"vacancy"},{"start":73,"end":87,"tag":"Antimicrobial"},{"start":125,"end":137,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"408540575084736512","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-05T10:17:18.000Z","conversation_id":"408540575084736512","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last chance to apply for #vacancy in European Surveillance of Veterinary #Antimicrobial Consumption: http://t.co/8cI1saLeFn  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/G1pRoRtaCn","expanded_url":"http://1.usa.gov/1cY4POQ","display_url":"1.usa.gov/1cY4POQ"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"annotations":{}},"id":"408277705147158528","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T16:52:45.000Z","conversation_id":"408277705147158528","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDAanimalhealth: Animal Drug Approvals, December 2013 Update http://t.co/G1pRoRtaCn","referenced_tweets":[{"type":"retweeted","id":"408277260056006656"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/4EHiiWfgX9","expanded_url":"http://europa.eu/rapid/press-release_MEMO-13-1085_en.htm","display_url":"europa.eu/rapid/press-re…"}],"hashtags":[{"start":21,"end":33,"tag":"Horizon2020"},{"start":105,"end":111,"tag":"H2020"}],"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"},{"start":112,"end":121,"username":"EU_H2020","id":"920249612329504768"}],"annotations":[{"start":37,"end":38,"probability":0.576,"type":"Organization","normalized_text":"EU"}]},"id":"408264669690728449","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T16:00:57.000Z","conversation_id":"408264669690728449","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DigitalAgendaEU: #Horizon2020 –  EU's new research &amp; innovation programme http://t.co/4EHiiWfgX9 #H2020 @EU_H2020","referenced_tweets":[{"type":"retweeted","id":"408263656908926977"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/wibY8IIwdR","expanded_url":"http://www.alz.co.uk/","display_url":"alz.co.uk"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"AlzDisInt","id":"198970635"}],"annotations":{}},"id":"408264205255450625","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T15:59:06.000Z","conversation_id":"408264205255450625","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @AlzDisInt: Our new global prevalance data will be available from tonight at 00.01 GMT. http://t.co/wibY8IIwdR","referenced_tweets":[{"type":"retweeted","id":"408261429934837760"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/EFm6yRFpOl","expanded_url":"http://goo.gl/tliO0O","display_url":"goo.gl/tliO0O"}],"hashtags":[{"start":126,"end":135,"tag":"WHOstats"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"408250863480631296","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T15:06:05.000Z","conversation_id":"408250863480631296","public_metrics":{"retweet_count":97,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: 2-3m deaths from diphtheria, tetanus, whooping cough, measles averted annually by vaccination http://t.co/EFm6yRFpOl #WHOstats","referenced_tweets":[{"type":"retweeted","id":"408234241713926144"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/z0EOiz4Fnp","expanded_url":"http://bit.ly/KBh8RJ","display_url":"bit.ly/KBh8RJ"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"annotations":[{"start":108,"end":116,"probability":0.6514,"type":"Place","normalized_text":"Amsterdam"}]},"id":"408250521464492032","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T15:04:43.000Z","conversation_id":"408250521464492032","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ESEndocrinology: ABSTRACT DEADLINE EXTENDED TO 8 DEC for ESE Basic Endocrinology Course 15-17 Jan 2014, Amsterdam http://t.co/z0EOiz4Fnp","referenced_tweets":[{"type":"retweeted","id":"408228821813321729"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/76U0yjubfn","expanded_url":"http://cordis.europa.eu/news/rcn/36304_en.html","display_url":"cordis.europa.eu/news/rcn/36304…"}],"hashtags":[{"start":43,"end":53,"tag":"influenza"},{"start":54,"end":62,"tag":"vaccine"},{"start":75,"end":82,"tag":"Europe"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":107,"end":121,"username":"EuropeVaccine","id":"321861975"}],"annotations":{}},"id":"408227962199080962","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T13:35:05.000Z","conversation_id":"408227962199080962","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Development of a 'universal' #influenza #vaccine underway in #Europe http://t.co/76U0yjubfn \n@EuropeVaccine","referenced_tweets":[{"type":"retweeted","id":"408226114343927809"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/vdHRhZc9fl","expanded_url":"http://bit.ly/18h7RhE","display_url":"bit.ly/18h7RhE"}],"hashtags":[{"start":46,"end":61,"tag":"bioequivalence"},{"start":75,"end":85,"tag":"sunitinib"}],"mentions":{},"annotations":{}},"id":"408205268917293056","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T12:04:54.000Z","conversation_id":"408205268917293056","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Send us your comments on our product-specific #bioequivalence guidance for #sunitinib. Consultation until 3 March: http://t.co/vdHRhZc9fl","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":60,"end":63,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"408203000100827136","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T11:55:53.000Z","conversation_id":"408203000100827136","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Unusual increase of S Mikawasima infections in #EU since Sept. No common source identified yet,investigations ongoing http://t…","referenced_tweets":[{"type":"retweeted","id":"408202843532050432"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/0KOgJBbFcE","expanded_url":"http://bit.ly/1hxGuoT","display_url":"bit.ly/1hxGuoT"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":66,"end":76,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"id":"408197091828432896","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T11:32:25.000Z","conversation_id":"408197091828432896","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @GCessak: In chair for press conference, noon, 5 December 2013 @URPLWMiPB: SIDE EFFECTS OF MEDICINES FROM A TO Z http://t.co/0KOgJBbFcE","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/VFqsSqp8sq","expanded_url":"http://bit.ly/18h7RhE","display_url":"bit.ly/18h7RhE"}],"hashtags":[{"start":39,"end":54,"tag":"bioequivalence"},{"start":68,"end":78,"tag":"sunitinib"}],"mentions":{},"annotations":{}},"id":"408177282503950336","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T10:13:42.000Z","conversation_id":"408177282503950336","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published draft product-specific #bioequivalence guidance for #sunitinib for public consultation until 3 March: http://t.co/VFqsSqp8sq","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":79,"end":91,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":114,"end":119,"probability":0.9649,"type":"Place","normalized_text":"Europe"}]},"id":"408168673388425216","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-04T09:39:29.000Z","conversation_id":"408168673388425216","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: NEW book: Experiences and Expectations of over 3,000 Patients on #RareDisease Patient Registries in Europe http://t.co/P8CfYN…","referenced_tweets":[{"type":"retweeted","id":"408163003025342464"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/2KmX4PDeTd","expanded_url":"http://bit.ly/1dN9acV","display_url":"bit.ly/1dN9acV"}],"hashtags":[{"start":64,"end":68,"tag":"CTD"}],"mentions":{},"annotations":{}},"id":"407925734213050368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T17:34:08.000Z","conversation_id":"407925734213050368","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comment on our concept paper on revising the guideline on using #CTD format for registration of herbal medicines: http://t.co/2KmX4PDeTd","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/VdduHmrQ7h","expanded_url":"http://bit.ly/1hv98H5","display_url":"bit.ly/1hv98H5"}],"hashtags":[{"start":77,"end":84,"tag":"orphan"}],"mentions":{},"annotations":{}},"id":"407925278254456832","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T17:32:19.000Z","conversation_id":"407925278254456832","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Read about the EMA fee-reductions available in 2014 for companies developing #orphan medicines: http://t.co/VdduHmrQ7h","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"id":"407875083319791616","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T14:12:52.000Z","conversation_id":"407875083319791616","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: €23M investment 2 analyse common pathways &amp; develop new ideas on preventive strategies 4 neurodegenerative diseases: http…","referenced_tweets":[{"type":"retweeted","id":"407859086437675008"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/HKwhopk9Rb","expanded_url":"https://ec.europa.eu/digital-agenda/news-redirect/13000","display_url":"ec.europa.eu/digital-agenda…"}],"hashtags":[{"start":53,"end":61,"tag":"eHealth"},{"start":63,"end":69,"tag":"H2020"},{"start":88,"end":94,"tag":"iLINC"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":71,"end":83,"username":"Get_eHealth","id":"2182048940"}],"annotations":{}},"id":"407874394707750912","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T14:10:08.000Z","conversation_id":"407874394707750912","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_eHealth: Special attention to SMEs working in #eHealth: #H2020, @Get_eHealth and #iLINC project - https://t.co/HKwhopk9Rb","referenced_tweets":[{"type":"retweeted","id":"407865592180252672"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/PXIKAo9uV4","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"loicrigal","id":"105275296"}],"annotations":{}},"id":"407866688751665154","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T13:39:31.000Z","conversation_id":"407822577571491840","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@LoicRigal Thanks for your tweet, if you'd like us to answer any questions please send us a question via our site:  http://t.co/PXIKAo9uV4","referenced_tweets":[{"type":"replied_to","id":"407825230250643456"}],"in_reply_to_user_id":"105275296","attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/HaEVwBW2Td","expanded_url":"http://bit.ly/1dN9acV","display_url":"bit.ly/1dN9acV"}],"hashtags":[{"start":64,"end":68,"tag":"CTD"}],"mentions":{},"annotations":{}},"id":"407828192117129216","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T11:06:32.000Z","conversation_id":"407828192117129216","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've issued a concept paper on revising the guideline on using #CTD format for registration of herbal medicines: http://t.co/HaEVwBW2Td","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/noAje7cQxJ","expanded_url":"http://bit.ly/1hv98H5","display_url":"bit.ly/1hv98H5"}],"hashtags":[{"start":70,"end":77,"tag":"orphan"}],"mentions":{},"annotations":{}},"id":"407822577571491840","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T10:44:14.000Z","conversation_id":"407822577571491840","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We're providing enhanced fee-reduction rates for companies developing #orphan medicines in 2014: http://t.co/noAje7cQxJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/UAFgYR7Ems","expanded_url":"http://bit.ly/1hsXsVn","display_url":"bit.ly/1hsXsVn"}],"hashtags":[{"start":44,"end":49,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"407811020220936192","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-03T09:58:18.000Z","conversation_id":"407811020220936192","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Companies with opinions adopted at December #CHMP meeting should note changes to the timetable for linguistic review: http://t.co/UAFgYR7Ems","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/wzBTAfcxR4","expanded_url":"http://www.uroweb.org/index.php?id=476","display_url":"uroweb.org/index.php?id=4…"}],"hashtags":[{"start":68,"end":83,"tag":"prostatecancer"}],"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"annotations":{}},"id":"407560096688783360","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T17:21:13.000Z","conversation_id":"407560096688783360","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Uroweb: Webinar on emerging evidence on PSA in the diagnosis of #prostatecancer is now on! http://t.co/wzBTAfcxR4 Register for free!","referenced_tweets":[{"type":"retweeted","id":"407551013025890305"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":[{"start":13,"end":37,"probability":0.7195,"type":"Organization","normalized_text":"Global Health Observatory"}]},"id":"407559978677833728","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T17:20:45.000Z","conversation_id":"407559978677833728","public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: WHO Global Health Observatory provides free public access thru a single internet page to data, analyses integrating abt 1k health …","referenced_tweets":[{"type":"retweeted","id":"407554784578002944"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":124,"end":134,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"id":"407541553293320192","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T16:07:32.000Z","conversation_id":"407541553293320192","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: Brand new strategic plan to take us through the next 2 years and bring us closer to our goal: eradicating #hepatitis http…","referenced_tweets":[{"type":"retweeted","id":"407541096533590016"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{}},"id":"407541337504755712","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T16:06:41.000Z","conversation_id":"407541337504755712","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ICH_news: SC furthered discussions on governance &amp; agreed to develop a 5-year plan for future ICH work. See last Press Release http://t…","referenced_tweets":[{"type":"retweeted","id":"407540330821451776"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/U3KfLD9emh","expanded_url":"http://bit.ly/1867b0S","display_url":"bit.ly/1867b0S"}],"hashtags":[{"start":55,"end":65,"tag":"ponatinib"},{"start":66,"end":73,"tag":"safety"},{"start":74,"end":84,"tag":"medicines"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"407535372390776833","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T15:42:59.000Z","conversation_id":"407535372390776833","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"fr","text":"RT @Aifa_ufficiale: Important information on Iclusig ▼ #ponatinib #safety #medicines http://t.co/U3KfLD9emh","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/yPQF9IexOE","expanded_url":"https://twitter.com/EFPIA/status/407508311034953729/photo/1","display_url":"pic.twitter.com/yPQF9IexOE"}],"hashtags":[{"start":25,"end":29,"tag":"HIV"},{"start":34,"end":39,"tag":"AIDS"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":50,"end":58,"username":"ECDC_EU","id":"204752573"}],"annotations":[{"start":43,"end":48,"probability":0.9931,"type":"Place","normalized_text":"Europe"}]},"id":"407510352146866177","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T14:03:33.000Z","conversation_id":"407510352146866177","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Infographics: #HIV and #AIDS in Europe @ECDC_EU http://t.co/yPQF9IexOE","referenced_tweets":[{"type":"retweeted","id":"407508311034953729"}],"attachments":{"media_keys":["3_407508311047536640"]}},{"source":"TweetDeck","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/xYm40t9sIB","expanded_url":"http://bit.ly/1cMhchl","display_url":"bit.ly/1cMhchl"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"407508063269040128","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T13:54:28.000Z","conversation_id":"407508063269040128","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: `'Nanoparticles: pills for the future\" - http://t.co/xYm40t9sIB","referenced_tweets":[{"type":"retweeted","id":"407507865008476160"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/zxfV0Nmz1M","expanded_url":"http://bit.ly/1hsXsVn","display_url":"bit.ly/1hsXsVn"}],"hashtags":[{"start":87,"end":92,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"407505490697281536","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T13:44:14.000Z","conversation_id":"407505490697281536","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're adjusting the timetable for linguistic review for opinions adopted at December's #CHMP meeting: http://t.co/zxfV0Nmz1M","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"annotations":{}},"id":"407504291163672576","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T13:39:28.000Z","conversation_id":"407504291163672576","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDACBER: #FDA Safety Communication Update: Boxed Warning &amp; additional warning for use of HES solutions in some settings http://t.co/8wD…","referenced_tweets":[{"type":"retweeted","id":"407501772387667968"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ev2NcwLImu","expanded_url":"http://ow.ly/rm9mI","display_url":"ow.ly/rm9mI"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"407503922463375360","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T13:38:00.000Z","conversation_id":"407503922463375360","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: @EMA_News recommends changes in use of ponatinib (leukaemia treatmt) to minimise risk of thrombosis http://t.co/ev2NcwLImu","referenced_tweets":[{"type":"retweeted","id":"407488550394142720"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/51Bng18U4o","expanded_url":"http://bit.ly/1b8z33n","display_url":"bit.ly/1b8z33n"}],"hashtags":[{"start":20,"end":30,"tag":"Pecorelli"},{"start":37,"end":42,"tag":"Pani"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":101,"end":117,"username":"stampaamblondra","id":"2363134615"}],"annotations":{}},"id":"407482101936582656","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T12:11:18.000Z","conversation_id":"407482101936582656","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: #Pecorelli &amp; #Pani at “adaptive pathways for personalised medicine” workshop @stampaamblondra http://t.co/51Bng18U4o","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"Vacancy"},{"start":25,"end":30,"tag":"EFSA"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"id":"407479534150119424","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T12:01:06.000Z","conversation_id":"407479534150119424","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: #Vacancy at #EFSA - Scientific Officer: Food/Feed Safety, Environmental Risk Assessment, Molecular Characterization http://t.c…","referenced_tweets":[{"type":"retweeted","id":"407474250082037760"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/Ua0sP6Icmz","expanded_url":"http://bit.ly/Iou6Zw","display_url":"bit.ly/Iou6Zw"}],"hashtags":[{"start":64,"end":71,"tag":"CTData"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"407466352450879488","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T11:08:43.000Z","conversation_id":"407466352450879488","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: WEBINAR: Implementing the EFPIA-PhRMA Commitments to #CTData Sharing http://t.co/Ua0sP6Icmz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/bi9WZlMUyR","expanded_url":"http://bit.ly/IqNUeo","display_url":"bit.ly/IqNUeo"}],"hashtags":[{"start":13,"end":22,"tag":"Levodopa"},{"start":23,"end":33,"tag":"Carbidopa"},{"start":34,"end":45,"tag":"Entacapone"},{"start":69,"end":79,"tag":"Parkinson"}],"mentions":{},"annotations":{}},"id":"407447868358656000","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:55:16.000Z","conversation_id":"407447868358656000","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR for #Levodopa/#Carbidopa/#Entacapone Sandoz, a medicine for #Parkinson's disease, is available: http://t.co/bi9WZlMUyR","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/3J33I4D20e","expanded_url":"http://bit.ly/1b1ccGL","display_url":"bit.ly/1b1ccGL"}],"hashtags":[{"start":13,"end":22,"tag":"Invokana"},{"start":24,"end":38,"tag":"canagliflozin"},{"start":56,"end":65,"tag":"diabetes"}],"mentions":{},"annotations":{}},"id":"407447569313193984","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:54:05.000Z","conversation_id":"407447569313193984","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR for #Invokana (#canagliflozin), a medicine for #diabetes, is available on our website: http://t.co/3J33I4D20e","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/fg2BL9YAJk","expanded_url":"http://bit.ly/1dFT4lj","display_url":"bit.ly/1dFT4lj"}],"hashtags":[{"start":13,"end":20,"tag":"Xofigo"},{"start":22,"end":29,"tag":"radium"},{"start":51,"end":71,"tag":"radiopharmaceutical"},{"start":76,"end":85,"tag":"prostate"},{"start":86,"end":93,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"407447215452323841","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:52:40.000Z","conversation_id":"407447215452323841","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR for #Xofigo (#radium Ra223 dichloride), a #radiopharmaceutical for #prostate #cancer is available: http://t.co/fg2BL9YAJk","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/c8v9tuWga7","expanded_url":"http://bit.ly/1goLYiE","display_url":"bit.ly/1goLYiE"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"407446707111075841","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:50:39.000Z","conversation_id":"407446707111075841","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're reminding applicants that we're closed from 23 December 2013 to 2 January 2014: http://t.co/c8v9tuWga7","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/2B05lrbOzd","expanded_url":"http://ow.ly/rlQNO","display_url":"ow.ly/rlQNO"}],"hashtags":[{"start":84,"end":96,"tag":"RareDisease"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"annotations":[{"start":61,"end":79,"probability":0.4851,"type":"Other","normalized_text":"European Conference"},{"start":102,"end":107,"probability":0.5364,"type":"Place","normalized_text":"Berlin"}]},"id":"407445053787758593","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:44:05.000Z","conversation_id":"407445053787758593","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eurordis: Less than 2 weeks to submit your poster to the European Conference on #RareDisease 2014 Berlin http://t.co/2B05lrbOzd Please …","referenced_tweets":[{"type":"retweeted","id":"407444947596759040"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/K48imH7P2X","expanded_url":"http://new.eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2013.320.01.0063.01.ENG","display_url":"new.eur-lex.europa.eu/legal-content/…"}],"hashtags":[{"start":16,"end":19,"tag":"EU"},{"start":20,"end":29,"tag":"Biobanks"},{"start":34,"end":47,"tag":"Biomolecular"},{"start":58,"end":67,"tag":"Research"},{"start":107,"end":112,"tag":"Graz"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"annotations":{}},"id":"407444859742478337","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:43:19.000Z","conversation_id":"407444859742478337","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EURLex: The #EU #Biobanks and #Biomolecular Resources #Research Infrastructure Consortium is set up in #Graz. http://t.co/K48imH7P2X @m…","referenced_tweets":[{"type":"retweeted","id":"407444278609076224"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/yjCtnu78zR","expanded_url":"http://bit.ly/1cMeWGH","display_url":"bit.ly/1cMeWGH"}],"hashtags":[{"start":25,"end":38,"tag":"WorldAIDSDay"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"407444225983135744","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-12-02T09:40:48.000Z","conversation_id":"407444225983135744","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Yesterday was #WorldAIDSDay - view EFPIA's dedicated Pinterest board http://t.co/yjCtnu78zR","referenced_tweets":[{"type":"retweeted","id":"407434676735713280"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/qKjcQJfUyA","expanded_url":"http://bit.ly/IqNUeo","display_url":"bit.ly/IqNUeo"}],"hashtags":[{"start":95,"end":105,"tag":"Parkinson"}],"mentions":{},"annotations":{}},"id":"406464975994359808","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:49:36.000Z","conversation_id":"406464975994359808","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for Levodopa/Carbidopa/Entacapone Sandoz, a medicine for #Parkinson's disease: http://t.co/qKjcQJfUyA","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/rX135KdjRr","expanded_url":"http://bit.ly/1b1ccGL","display_url":"bit.ly/1b1ccGL"}],"hashtags":[{"start":67,"end":76,"tag":"diabetes"}],"mentions":{},"annotations":[{"start":42,"end":49,"probability":0.2909,"type":"Person","normalized_text":"Invokana"}]},"id":"406464291492356096","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:46:53.000Z","conversation_id":"406464291492356096","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the assessment report for Invokana, a medicine for #diabetes:    http://t.co/rX135KdjRr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Mdnfi8lZmM","expanded_url":"http://bit.ly/1gozEil","display_url":"bit.ly/1gozEil"}],"hashtags":[{"start":49,"end":59,"tag":"monograph"},{"start":89,"end":96,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"406459498811752448","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:27:50.000Z","conversation_id":"406459498811752448","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Consultation closes in two weeks on draft herbal #monograph for Arnica montana L., flos (#Arnica Flower): http://t.co/Mdnfi8lZmM","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/pXPoPsYVgn","expanded_url":"http://bit.ly/Iq28fG","display_url":"bit.ly/Iq28fG"},{"start":122,"end":144,"url":"http://t.co/uXivXnyoGf","expanded_url":"http://bit.ly/180LVHs","display_url":"bit.ly/180LVHs"}],"hashtags":[{"start":40,"end":50,"tag":"monograph"},{"start":83,"end":91,"tag":"Teatree"}],"mentions":{},"annotations":{}},"id":"406459290904317952","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:27:01.000Z","conversation_id":"406459290904317952","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Consultation ends in two weeks on draft #monograph &amp; list entry for Melaleuca (#Teatree oil): http://t.co/pXPoPsYVgn, http://t.co/uXivXnyoGf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/OmQbThkwmI","expanded_url":"http://bit.ly/164YuMb","display_url":"bit.ly/164YuMb"}],"hashtags":[{"start":49,"end":59,"tag":"monograph"},{"start":90,"end":101,"tag":"Restharrow"}],"mentions":{},"annotations":{}},"id":"406458773528518656","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:24:57.000Z","conversation_id":"406458773528518656","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Consultation closes in two weeks on draft herbal #monograph for Ononis spinosa L., radix (#Restharrow root): http://t.co/OmQbThkwmI","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/5r1hc6n3pK","expanded_url":"http://bit.ly/18bd8UZ","display_url":"bit.ly/18bd8UZ"}],"hashtags":[{"start":91,"end":99,"tag":"biotech"}],"mentions":{},"annotations":{}},"id":"406458528769921024","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:23:59.000Z","conversation_id":"406458528769921024","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Consultation closes tomorrow on draft guideline on similar biological medicines containing #biotech-derived proteins: http://t.co/5r1hc6n3pK","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/7bEAo2oeDN","expanded_url":"http://bit.ly/IvKjeV","display_url":"bit.ly/IvKjeV"}],"hashtags":[{"start":110,"end":115,"tag":"pain"}],"mentions":{},"annotations":{}},"id":"406458382757806080","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:23:24.000Z","conversation_id":"406458382757806080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Consultation closes tomorrow on our draft guideline on the clinical development of medicines for treatment of #pain: http://t.co/7bEAo2oeDN","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/uzwNOBtB8a","expanded_url":"http://bit.ly/1dFJLBT","display_url":"bit.ly/1dFJLBT"}],"hashtags":[{"start":81,"end":92,"tag":"veterinary"},{"start":93,"end":108,"tag":"antimicrobials"}],"mentions":{},"annotations":{}},"id":"406458282694283264","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T16:23:00.000Z","conversation_id":"406458282694283264","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Consultation closes tomorrow on our draft guideline on demonstrating efficacy of #veterinary #antimicrobials: http://t.co/uzwNOBtB8a","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/2aNzJE7qEj","expanded_url":"http://bit.ly/Iw0xVw","display_url":"bit.ly/Iw0xVw"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"406446055132528640","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T15:34:25.000Z","conversation_id":"406446055132528640","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EMA website will be temporarily unavailable this Sunday 1 December due to essential maintenance: http://t.co/2aNzJE7qEj","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"406433380654264321","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T14:44:03.000Z","conversation_id":"406433380654264321","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: Nov. IMI Newsletter: highlights incl SUMMIT project’s new ultrasound technique to pick up heart attack/stroke risk http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"406422437840973824"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"annotations":{}},"id":"406433301524525057","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T14:43:44.000Z","conversation_id":"406433301524525057","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EMCDDA: Ahead of World AIDS day, just published a toolkit for *monitoring* infectious diseases among people who inject drugs: http://t.…","referenced_tweets":[{"type":"retweeted","id":"406424853349015552"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/uwDZNYBjvq","expanded_url":"http://bit.ly/1dFT4lj","display_url":"bit.ly/1dFT4lj"}],"hashtags":[{"start":54,"end":74,"tag":"radiopharmaceutical"},{"start":95,"end":104,"tag":"prostate"},{"start":105,"end":112,"tag":"cancer"}],"mentions":{},"annotations":[{"start":44,"end":49,"probability":0.3344,"type":"Person","normalized_text":"Xofigo"}]},"id":"406425670731202561","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T14:13:25.000Z","conversation_id":"406425670731202561","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We have published the assessment report for Xofigo, a #radiopharmaceutical for use in treating #prostate #cancer: http://t.co/uwDZNYBjvq","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/sX56xDdg4T","expanded_url":"http://bit.ly/1goLYiE","display_url":"bit.ly/1goLYiE"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"406421691188150272","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T13:57:36.000Z","conversation_id":"406421691188150272","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're reminding applicants of our closing dates over the forthcoming festive period: http://t.co/sX56xDdg4T","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Ms85WlqZ3G","expanded_url":"http://ow.ly/ri4nf","display_url":"ow.ly/ri4nf"}],"hashtags":[{"start":25,"end":30,"tag":"AIDS"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"id":"406401536894316544","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:37:31.000Z","conversation_id":"406401536894316544","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: World #AIDS Day 2013: The Fight Against HIV/AIDS by the EU http://t.co/Ms85WlqZ3G","referenced_tweets":[{"type":"retweeted","id":"406390152198897664"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/UKQE3bArGf","expanded_url":"http://bit.ly/1gozEil","display_url":"bit.ly/1gozEil"}],"hashtags":[{"start":95,"end":102,"tag":"Arnica"}],"mentions":{},"annotations":{}},"id":"406399614188027904","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:29:53.000Z","conversation_id":"406399614188027904","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on the draft Community herbal monograph for Arnica montana L., flos (#Arnica Flower): http://t.co/UKQE3bArGf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/pXPoPsYVgn","expanded_url":"http://bit.ly/Iq28fG","display_url":"bit.ly/Iq28fG"},{"start":115,"end":137,"url":"http://t.co/uXivXnyoGf","expanded_url":"http://bit.ly/180LVHs","display_url":"bit.ly/180LVHs"}],"hashtags":[{"start":75,"end":83,"tag":"Teatree"}],"mentions":{},"annotations":{}},"id":"406399182811852802","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:28:10.000Z","conversation_id":"406399182811852802","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on draft monograph and list entry for Melaleuca (#Teatree oil): http://t.co/pXPoPsYVgn   http://t.co/uXivXnyoGf","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/8b0v4Q1Caw","expanded_url":"http://bit.ly/164YuMb","display_url":"bit.ly/164YuMb"}],"hashtags":[{"start":56,"end":66,"tag":"monograph"},{"start":97,"end":108,"tag":"Restharrow"}],"mentions":{},"annotations":{}},"id":"406396704381227008","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:18:19.000Z","conversation_id":"406396704381227008","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to comment on the draft Community herbal #monograph for Ononis spinosa L., radix (#Restharrow root): http://t.co/8b0v4Q1Caw","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/zZitD0CWC2","expanded_url":"http://bit.ly/18bd8UZ","display_url":"bit.ly/18bd8UZ"}],"hashtags":[{"start":89,"end":97,"tag":"biotech"}],"mentions":{},"annotations":{}},"id":"406395964011057152","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:15:22.000Z","conversation_id":"406395964011057152","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft guideline on similar biological medicines containing #biotech-derived proteins: http://t.co/zZitD0CWC2","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/r6RnqDxIJ2","expanded_url":"http://bit.ly/IvKjeV","display_url":"bit.ly/IvKjeV"}],"hashtags":[{"start":104,"end":109,"tag":"pain"}],"mentions":{},"annotations":{}},"id":"406395341257576448","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:12:54.000Z","conversation_id":"406395341257576448","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft guideline on the clinical development of medicines for treatment of #pain: http://t.co/r6RnqDxIJ2","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/utA5itKS5x","expanded_url":"http://bit.ly/1dFJLBT","display_url":"bit.ly/1dFJLBT"}],"hashtags":[{"start":75,"end":86,"tag":"veterinary"},{"start":87,"end":102,"tag":"antimicrobials"}],"mentions":{},"annotations":{}},"id":"406394800787959808","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T12:10:45.000Z","conversation_id":"406394800787959808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last chance to comment on our draft guideline on demonstrating efficacy of #veterinary #antimicrobials: http://t.co/utA5itKS5x","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/DnCvAyd5TW","expanded_url":"http://bit.ly/1eD9CqZ","display_url":"bit.ly/1eD9CqZ"}],"hashtags":{},"mentions":{},"annotations":[{"start":62,"end":65,"probability":0.5506,"type":"Organization","normalized_text":"HTAs"}]},"id":"406381245703000064","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T11:16:53.000Z","conversation_id":"406381245703000064","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA-HTA workshop: A strong interaction between regulators and HTAs is critical to enable innovation to reach patients http://t.co/DnCvAyd5TW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/7z0ZaPRx0a","expanded_url":"http://bit.ly/18Hr5h6","display_url":"bit.ly/18Hr5h6"}],"hashtags":[{"start":28,"end":32,"tag":"HIV"},{"start":33,"end":38,"tag":"AIDS"},{"start":62,"end":70,"tag":"WAD2013"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":{}},"id":"406372024173744128","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:40:15.000Z","conversation_id":"406372024173744128","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe: Factsheet:  #HIV #AIDS in the European Region #WAD2013 http://t.co/7z0ZaPRx0a","referenced_tweets":[{"type":"retweeted","id":"406370017987403776"}],"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"annotations":[{"start":12,"end":35,"probability":0.8703,"type":"Organization","normalized_text":"IMI Scientific Committee"}]},"id":"406371964346191872","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:40:00.000Z","conversation_id":"406371964346191872","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI Scientific Committee welcomes 7 new experts. The ctee advises on sci priorities, Call topics &amp; project reviews http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"406369674687832064"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/kggzGrvc1R","expanded_url":"http://bit.ly/1hmxMcU","display_url":"bit.ly/1hmxMcU"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"406369914447208448","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:31:52.000Z","conversation_id":"406369914447208448","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Our #pharmacovigilance committee meets next week. Highlights out on Friday: http://t.co/kggzGrvc1R","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","entities":{"urls":{},"hashtags":[{"start":76,"end":86,"tag":"medicines"},{"start":105,"end":114,"tag":"diabetes"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":14,"end":29,"username":"IntDiabetesFed","id":"38393473"},{"start":36,"end":49,"username":"IDFEuropeBXL","id":"848831221"}],"annotations":[{"start":115,"end":120,"probability":0.9873,"type":"Place","normalized_text":"Europe"}]},"id":"406369824475185152","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:31:30.000Z","conversation_id":"406369824475185152","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EPHA_EU: .@IntDiabetesFed &amp; @IDFEuropeBxl report☛ Access to quality #medicines &amp; devices for #diabetes care in Europe:http://t.co/sGKfR…","referenced_tweets":[{"type":"retweeted","id":"406365357608140800"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/evNlWFZo96","expanded_url":"http://bit.ly/1gqZB3q","display_url":"bit.ly/1gqZB3q"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":57,"end":68,"tag":"accountant"},{"start":94,"end":106,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"406368207927119873","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:25:05.000Z","conversation_id":"406368207927119873","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy for a management #accountant: http://t.co/evNlWFZo96  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/8cI1saLeFn","expanded_url":"http://bit.ly/19CcFPb","display_url":"bit.ly/19CcFPb"}],"hashtags":[{"start":27,"end":35,"tag":"vacancy"},{"start":75,"end":89,"tag":"Antimicrobial"},{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"406368124334657536","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:24:45.000Z","conversation_id":"406368124334657536","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for #vacancy in European Surveillance of Veterinary #Antimicrobial Consumption: http://t.co/8cI1saLeFn  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/yiOIu2kduF","expanded_url":"http://bit.ly/HG8XKi","display_url":"bit.ly/HG8XKi"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":75,"end":89,"tag":"antimicrobial"},{"start":90,"end":101,"tag":"resistance"},{"start":127,"end":139,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"406368004494991360","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T10:24:16.000Z","conversation_id":"406368004494991360","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One more week to apply for our #vacancy in the secretariat for opinions on #antimicrobial #resistance: http://t.co/yiOIu2kduF  #recruitment","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/nUrlzgJe4J","expanded_url":"http://bit.ly/1eFfArF","display_url":"bit.ly/1eFfArF"}],"hashtags":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":98,"end":105,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"406356016566398976","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-29T09:36:38.000Z","conversation_id":"406356016566398976","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: IMI Welcomes New Scientific Experts to Its Scientific Committee http://t.co/nUrlzgJe4J @IMI_JU","referenced_tweets":[{"type":"retweeted","id":"406348702437998593"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/MQUmr8SOmi","expanded_url":"http://bit.ly/1b0TBtu","display_url":"bit.ly/1b0TBtu"}],"hashtags":[{"start":88,"end":102,"tag":"schizophrenia"}],"mentions":{},"annotations":[{"start":30,"end":45,"probability":0.3261,"type":"Product","normalized_text":"Abilify Maintena"}]},"id":"406106100694396929","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T17:03:34.000Z","conversation_id":"406106100694396929","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The EPAR is now available for Abilify Maintena, a medicine for maintenance treatment of #schizophrenia: http://t.co/MQUmr8SOmi","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zUUzoLZvRr","expanded_url":"http://bit.ly/1iWdAhb","display_url":"bit.ly/1iWdAhb"}],"hashtags":[{"start":11,"end":16,"tag":"AIDS"},{"start":91,"end":95,"tag":"HIV"}],"mentions":{},"annotations":{}},"id":"406105545859284992","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T17:01:21.000Z","conversation_id":"406105545859284992","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"It's World #AIDS Day on 1 December. Read about our activities in the area of medicines for #HIV: http://t.co/zUUzoLZvRr","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":43,"end":65,"url":"http://t.co/SrhYKPITIv","expanded_url":"http://bit.ly/1eDhFEq","display_url":"bit.ly/1eDhFEq"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":{}},"id":"406104619433988096","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T16:57:40.000Z","conversation_id":"406104619433988096","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: TOPRA Annual Report 2012/13 http://t.co/SrhYKPITIv","referenced_tweets":[{"type":"retweeted","id":"406087866968580096"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"annotations":{}},"id":"406104450713923586","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T16:57:00.000Z","conversation_id":"406104450713923586","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAgovuk: MHRA starts work on SCOPE, a €4.7M pharmacovigilance Joint Action to improve EU pharmacovigilance capabilities http://t.co/P…","referenced_tweets":[{"type":"retweeted","id":"406097446645682176"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":69,"end":73,"tag":"HIV"},{"start":95,"end":100,"tag":"AIDS"},{"start":118,"end":130,"tag":"infographic"},{"start":131,"end":139,"tag":"WAD2013"}],"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":[{"start":18,"end":20,"probability":0.5588,"type":"Other","normalized_text":"HIV"},{"start":107,"end":108,"probability":0.488,"type":"Place","normalized_text":"EU"}]},"id":"406104387363172352","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T16:56:45.000Z","conversation_id":"406104387363172352","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_HIVAIDS: HIV&amp;AIDS: since start of reporting,over 455000 #HIV diagnoses and 183000 #AIDS deaths in EU.See #infographic #WAD2013 htt…","referenced_tweets":[{"type":"retweeted","id":"406097641651466241"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/6ukhndmNhR","expanded_url":"http://bit.ly/1b1rElp","display_url":"bit.ly/1b1rElp"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":37,"end":48,"username":"WHO_Europe","id":"125403342"},{"start":51,"end":59,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"406104275043880960","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T16:56:18.000Z","conversation_id":"406104275043880960","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Report on annual joint @WHO_Europe / @ECDC_EU influenza surveillance meeting now available http://t.co/6ukhndmNhR","referenced_tweets":[{"type":"retweeted","id":"406102751513288704"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/qnrGLZRJ8B","expanded_url":"http://bit.ly/1eD9CqZ","display_url":"bit.ly/1eD9CqZ"}],"hashtags":[{"start":56,"end":60,"tag":"HTA"}],"mentions":{},"annotations":{}},"id":"406076433740869633","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T15:05:40.000Z","conversation_id":"406076433740869633","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA-HTA workshop: Early dialogue between regulators and #HTA bodies key to medicines development: http://t.co/qnrGLZRJ8B","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/NjCGopiGGZ","expanded_url":"http://bit.ly/1b0TBtu","display_url":"bit.ly/1b0TBtu"}],"hashtags":[{"start":80,"end":94,"tag":"schizophrenia"}],"mentions":{},"annotations":[{"start":42,"end":57,"probability":0.2725,"type":"Other","normalized_text":"Abilify Maintena"}]},"id":"406036529090662400","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T12:27:06.000Z","conversation_id":"406036529090662400","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the assessment report for Abilify Maintena, for use in treating #schizophrenia: http://t.co/NjCGopiGGZ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":117,"end":126,"tag":"Eurostat"}],"mentions":[{"start":3,"end":15,"username":"EU_Eurostat","id":"300868924"}],"annotations":{}},"id":"406030208756482048","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T12:02:00.000Z","conversation_id":"406030208756482048","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Eurostat: Causes of death in the EU in 2010: Circulatory diseases main cause of death for older men and women #Eurostat http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"406000097818726401"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":18,"end":24,"tag":"grant"},{"start":39,"end":42,"tag":"TB"},{"start":43,"end":54,"tag":"laboratory"},{"start":71,"end":74,"tag":"EU"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"annotations":{}},"id":"406030082340163586","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T12:01:30.000Z","conversation_id":"406030082340163586","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_TB: ECDC #grant to strengthen #TB #laboratory services in the #EU: call for proposals closes tomorrow. Find out more: http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"406003697882513408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/nT82ZpxBbH","expanded_url":"http://bit.ly/1hkqw1n","display_url":"bit.ly/1hkqw1n"}],"hashtags":[{"start":39,"end":48,"tag":"Diabetes"},{"start":118,"end":122,"tag":"WDD"}],"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"annotations":{}},"id":"406029519225503744","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T11:59:15.000Z","conversation_id":"406029519225503744","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WDD: The December Special Issue of #Diabetes Voice is now available online! Happy reading! http://t.co/nT82ZpxBbH #WDD","referenced_tweets":[{"type":"retweeted","id":"406011700328947712"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"annotations":{}},"id":"406029270637502464","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T11:58:16.000Z","conversation_id":"406029270637502464","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eupatientsforum: EPF November Issue is just released! To subscribe: mailing@eu-patient.eu or find the PDF version here: http://t.co/Nla…","referenced_tweets":[{"type":"retweeted","id":"406016626820001792"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/r2ubxwKAUH","expanded_url":"http://bit.ly/1iWdAhb","display_url":"bit.ly/1iWdAhb"}],"hashtags":[{"start":23,"end":28,"tag":"AIDS"}],"mentions":{},"annotations":{}},"id":"406022018405244928","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-28T11:29:27.000Z","conversation_id":"406022018405244928","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're supporting World #AIDS Day on 1 December. Read more about our work in this area: http://t.co/r2ubxwKAUH","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"AndyBiotech","id":"632341632"}],"annotations":{}},"id":"405749746976825345","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T17:27:32.000Z","conversation_id":"405713960478855168","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@AndyBiotech @sailinsomnia We will try to do so, but sometimes it isn't possible to publish until the meeting starts.","referenced_tweets":[{"type":"replied_to","id":"405749138366558208"}],"in_reply_to_user_id":"632341632","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/3cgPiiXObW","expanded_url":"http://bit.ly/1cuYXwJ","display_url":"bit.ly/1cuYXwJ"}],"hashtags":[{"start":59,"end":69,"tag":"Parkinson"}],"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"annotations":{}},"id":"405748628657958912","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T17:23:06.000Z","conversation_id":"405748628657958912","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @euparkinsons: Gene-silencing study finds new targets 4 #Parkinson’s disease: http://t.co/3cgPiiXObW","referenced_tweets":[{"type":"retweeted","id":"405747908768583680"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/5qqekRVAWL","expanded_url":"http://bit.ly/1afAtpV","display_url":"bit.ly/1afAtpV"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"AndyBiotech","id":"632341632"}],"annotations":{}},"id":"405748427486547968","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T17:22:18.000Z","conversation_id":"405713960478855168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@AndyBiotech @sailinsomnia We will be publishing all of our committees' agendas and minutes by the end of the year: http://t.co/5qqekRVAWL","referenced_tweets":[{"type":"replied_to","id":"405747875302236160"}],"in_reply_to_user_id":"632341632","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":14,"username":"FDArecalls","id":"18058609"}],"annotations":[{"start":16,"end":21,"probability":0.528,"type":"Person","normalized_text":"Baxter"}]},"id":"405744111589670913","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T17:05:09.000Z","conversation_id":"405744111589670913","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDArecalls: Baxter Initiates Nationwide Voluntary Recall of One Lot of Nitroglycerin in 5% Dextrose Injection: Baxter Inte... http://t.…","referenced_tweets":[{"type":"retweeted","id":"405742849607467008"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/sK9t5kvOMl","expanded_url":"http://reut.rs/Ig1a5Z","display_url":"reut.rs/Ig1a5Z"}],"hashtags":{},"mentions":[{"start":109,"end":117,"username":"Reuters","id":"1652541"}],"annotations":{}},"id":"405739000217862144","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T16:44:50.000Z","conversation_id":"405739000217862144","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: Study links high sodium \"fizzy\" medicines to raised heart risks http://t.co/sK9t5kvOMl via @reuters","referenced_tweets":[{"type":"retweeted","id":"405720381115203586"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/l3r4piqnqV","expanded_url":"http://www.thestreet.com/story/12126871/1/2014-fda-drug-approval-decision-calendar.html","display_url":"thestreet.com/story/12126871…"}],"hashtags":[{"start":23,"end":27,"tag":"FDA"}],"mentions":{},"annotations":{}},"id":"405714341854314496","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T15:06:51.000Z","conversation_id":"405714341854314496","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: 2014 #FDA Drug Approval Decision Calendar http://t.co/l3r4piqnqV","referenced_tweets":[{"type":"retweeted","id":"405713960478855168"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/rnGjAsz0Q9","expanded_url":"http://bit.ly/1bnOc2v","display_url":"bit.ly/1bnOc2v"}],"hashtags":[{"start":128,"end":135,"tag":"pharma"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"annotations":[{"start":85,"end":102,"probability":0.7027,"type":"Place","normalized_text":"Cardiff University"}]},"id":"405710239439147008","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T14:50:33.000Z","conversation_id":"405710239439147008","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: TOPRA is offering a new PhD in Regulatory Affairs in conjunction with Cardiff University. http://t.co/rnGjAsz0Q9 #pharma #re…","referenced_tweets":[{"type":"retweeted","id":"405708814797635585"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/uA5XKXIKL3","expanded_url":"http://bit.ly/Ih0qNQ","display_url":"bit.ly/Ih0qNQ"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"id":"405710108807540737","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T14:50:02.000Z","conversation_id":"405710108807540737","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"RT @Legemiddelinfo: Emergency contraceptive Norlevo has low effect on women over 75kg and no effect  over 80kg: http://t.co/uA5XKXIKL3","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":58,"end":67,"tag":"diabetes"},{"start":111,"end":124,"tag":"HorizonMagEU"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"annotations":{}},"id":"405702942960783360","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T14:21:33.000Z","conversation_id":"405702942960783360","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @innovationunion: An astounding 90% of cases of type-2 #diabetes could have been prevented, find out how in #HorizonMagEU: http://t.co/v…","referenced_tweets":[{"type":"retweeted","id":"405694036431745025"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/PG2CwtKWBO","expanded_url":"http://bit.ly/IiNTJB","display_url":"bit.ly/IiNTJB"}],"hashtags":[{"start":111,"end":124,"tag":"HeartFailure"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"405702722596257792","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T14:20:41.000Z","conversation_id":"405702722596257792","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: Heart failure: key stakeholder collaboration for unmet health needs http://t.co/PG2CwtKWBO #HeartFailure","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":19,"end":27,"tag":"Podcast"},{"start":29,"end":33,"tag":"FDA"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"id":"405677082794946560","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T12:38:48.000Z","conversation_id":"405677082794946560","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @FDA_Drug_Info: #Podcast: #FDA removes some prescribing and dispensing restrictions for rosiglitazone-containing medicines. http://t.co/…","referenced_tweets":[{"type":"retweeted","id":"405676730696101888"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/MYC04DWSCj","expanded_url":"http://bit.ly/1a3ExrA","display_url":"bit.ly/1a3ExrA"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"405667602321526784","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T12:01:07.000Z","conversation_id":"405667602321526784","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Apply now to attend a webinar on requesting terms for our electronic application forms on 15 January 2014: http://t.co/MYC04DWSCj","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":18,"end":28,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"id":"405665688603222017","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T11:53:31.000Z","conversation_id":"405665688603222017","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: #hepatitis C treatment significantly reduces the risks of liver disease, so why are so few people getting treated? http:/…","referenced_tweets":[{"type":"retweeted","id":"405665470071599104"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/36vmby2XVD","expanded_url":"http://bit.ly/1a3ExrA","display_url":"bit.ly/1a3ExrA"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"405656805172576256","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T11:18:13.000Z","conversation_id":"405656805172576256","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're hosting interactive webinars on requesting terms for electronic application forms on 15 January 2014: http://t.co/36vmby2XVD","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":27,"end":31,"tag":"SME"}],"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":62,"end":71,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"405649790353948673","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T10:50:21.000Z","conversation_id":"405649790353948673","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Martinharvey100: Small #SME drug developers who talk with @EMA_News early in R&amp;D have 90% approval rate. More info here: http://t.co/tE…","referenced_tweets":[{"type":"retweeted","id":"405649549018284032"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":48,"end":57,"tag":"hospital"},{"start":58,"end":67,"tag":"pharmacy"}],"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"annotations":[{"start":71,"end":76,"probability":0.9875,"type":"Place","normalized_text":"Europe"}]},"id":"405639922150674433","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T10:11:08.000Z","conversation_id":"405639922150674433","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAHPtweet: 2014 will be an important year 4 #hospital #pharmacy in Europe! Learn more about our Summit in this new video http://t.co/Tl…","referenced_tweets":[{"type":"retweeted","id":"405637437935738880"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":43,"end":65,"url":"http://t.co/99gwa4J4bS","expanded_url":"http://bit.ly/17TmaZJ","display_url":"bit.ly/17TmaZJ"}],"hashtags":[{"start":66,"end":78,"tag":"sideeffects"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"id":"405636890876846080","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:59:05.000Z","conversation_id":"405636890876846080","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"RT @GCessak: How to report side effects:  \nhttp://t.co/99gwa4J4bS #sideeffects","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"405636203682099200","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:56:21.000Z","conversation_id":"405636203682099200","public_metrics":{"retweet_count":140,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: Widespread use of antibiotics among children who do not need them would increase risk of infections becoming resistant to antibiot…","referenced_tweets":[{"type":"retweeted","id":"405635886420729856"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/P6v9X3Tmmd","expanded_url":"http://bit.ly/1etmJer","display_url":"bit.ly/1etmJer"}],"hashtags":[{"start":40,"end":45,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"id":"405636137168826368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:56:06.000Z","conversation_id":"405636137168826368","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Distribution of confirmed #MERS-CoV cases by reporting country as of 21Nov2013, in epi update: http://t.co/P6v9X3Tmmd http://…","referenced_tweets":[{"type":"retweeted","id":"405634660824129536"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/7kY9OcdCiP","expanded_url":"http://bit.ly/1bSC2cU","display_url":"bit.ly/1bSC2cU"}],"hashtags":[{"start":54,"end":59,"tag":"SMEs"}],"mentions":{},"annotations":{}},"id":"405633897087524864","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:47:12.000Z","conversation_id":"405633897087524864","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"For SME Week, find out about the support we can offer #SMEs and other medicines developers: http://t.co/7kY9OcdCiP","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":45,"end":55,"tag":"hepatitis"}],"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"annotations":{}},"id":"405630691745869824","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:34:27.000Z","conversation_id":"405630691745869824","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Hep_Alliance: Work in the field of viral #hepatitis? Become a Friend of the Alliance, we want to recognise you for your amzing work!htt…","referenced_tweets":[{"type":"retweeted","id":"405628962090393601"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":48,"end":52,"tag":"HIV"},{"start":76,"end":79,"tag":"EU"}],"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"annotations":{}},"id":"405630552201392128","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:33:54.000Z","conversation_id":"405630552201392128","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_HIVAIDS: In 2012, more than 29 000 new #HIV cases diagnosed in the #EU, a rate of 5.8 cases per 100 000 people. Full report: http:…","referenced_tweets":[{"type":"retweeted","id":"405628899759247360"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/L7qkUzN0RO","expanded_url":"http://bit.ly/17TisiL","display_url":"bit.ly/17TisiL"}],"hashtags":[{"start":42,"end":54,"tag":"sideeffects"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"id":"405630274286780416","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-27T09:32:48.000Z","conversation_id":"405630274286780416","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"RT @URPLWMiPB: How to report side effects #sideeffects http://t.co/L7qkUzN0RO","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/2W1Lg5yNUM","expanded_url":"http://www.usforacle.com/study-shows-stem-cells-may-repair-brain-injury-1.2847875#.UpTLSVYo4dV","display_url":"usforacle.com/study-shows-st…"}],"hashtags":[{"start":30,"end":40,"tag":"StemCells"},{"start":88,"end":98,"tag":"neurology"},{"start":99,"end":103,"tag":"TBI"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"annotations":{}},"id":"405414951335899136","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:17:11.000Z","conversation_id":"405414951335899136","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DrugInfoAssn: Study Shows #StemCells May Repair Brain Injury http://t.co/2W1Lg5yNUM #neurology #TBI","referenced_tweets":[{"type":"retweeted","id":"405386771287912450"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/visx2pNJpw","expanded_url":"http://bit.ly/194zmrJ","display_url":"bit.ly/194zmrJ"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"id":"405414639921426432","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:15:57.000Z","conversation_id":"405414639921426432","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Combined hormonal contraceptives - confirmation of PRAC recommendations http://t.co/visx2pNJpw","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/XV9qtjdoQ6","expanded_url":"http://bit.ly/18m6wJ5","display_url":"bit.ly/18m6wJ5"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"id":"405412426922729472","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:07:09.000Z","conversation_id":"405412426922729472","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @INFARMED_IP: Iclusig - recommendations to minimise the risk of blood clots http://t.co/XV9qtjdoQ6","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/P6v9X3Tmmd","expanded_url":"http://bit.ly/1etmJer","display_url":"bit.ly/1etmJer"}],"hashtags":[{"start":30,"end":35,"tag":"MERS"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"id":"405412223536738304","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:06:21.000Z","conversation_id":"405412223536738304","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: Distribution of #MERS-CoV cases by mo of onset &amp; prob place of infection, Mar2012-Nov2013: http://t.co/P6v9X3Tmmd http://t.co…","referenced_tweets":[{"type":"retweeted","id":"405383879172714496"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/EwV5og4tIo","expanded_url":"http://fightthefakes.org/join-the-fight/","display_url":"fightthefakes.org/join-the-fight/"}],"hashtags":[{"start":20,"end":29,"tag":"fakemeds"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"annotations":{}},"id":"405412174253654016","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:06:09.000Z","conversation_id":"405412174253654016","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Fighting #fakemeds is everybody's business. Here is why: http://t.co/EwV5og4tIo","referenced_tweets":[{"type":"retweeted","id":"405379197528719361"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/tzLmex58nF","expanded_url":"http://bit.ly/1gf3m9r","display_url":"bit.ly/1gf3m9r"}],"hashtags":[{"start":41,"end":44,"tag":"TB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"annotations":{}},"id":"405410674957746176","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T19:00:11.000Z","conversation_id":"405410674957746176","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_TB: ExplainTB is a new app with #TB patient information in 26 languages. Find out more: http://t.co/tzLmex58nF","referenced_tweets":[{"type":"retweeted","id":"405369241349943296"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":89,"end":98,"tag":"fakemeds"}],"mentions":[{"start":3,"end":17,"username":"worldheartfed","id":"83809282"},{"start":114,"end":128,"username":"FightTheFakes","id":"1860605736"}],"annotations":{}},"id":"405410532296908800","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T18:59:37.000Z","conversation_id":"405410532296908800","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @worldheartfed: We've joined 9 other organizations to protect patients worldwide from #fakemeds. Join us &amp; @FightTheFakes! http://t.co/o…","referenced_tweets":[{"type":"retweeted","id":"405366990426349568"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/Mg78pimw5O","expanded_url":"http://www.pinterest.com/efpia/","display_url":"pinterest.com/efpia/"}],"hashtags":[{"start":25,"end":35,"tag":"Pinterest"},{"start":60,"end":67,"tag":"cancer"},{"start":69,"end":81,"tag":"socialmedia"},{"start":83,"end":90,"tag":"health"},{"start":92,"end":96,"tag":"hiv"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":127,"end":138,"username":"Boehringer","id":"17437735"}],"annotations":{}},"id":"405410462734761984","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T18:59:21.000Z","conversation_id":"405410462734761984","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFPIA: Here is EFPIA #Pinterest board - infographics on #cancer, #socialmedia, #health, #hiv, etc. http://t.co/Mg78pimw5O (@Boehringer)","referenced_tweets":[{"type":"retweeted","id":"405366937678393345"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/mo5tNfw4CY","expanded_url":"http://bit.ly/1bSC2cU","display_url":"bit.ly/1bSC2cU"}],"hashtags":[{"start":59,"end":64,"tag":"SMEs"}],"mentions":{},"annotations":{}},"id":"405392919244587008","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T17:49:38.000Z","conversation_id":"405392919244587008","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've just published an update on the support we can offer #SMEs and other medicines developers: http://t.co/mo5tNfw4CY","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/KsGT8kWRba","expanded_url":"http://www.pharmexec.com/pharmexec/Noteworthy/Clinical-Trial-Sponsors-Struggle-with-Data-Disclos/ArticleStandard/Article/detail/829352?ref=25#.UpSz0Kn37sI.twitter","display_url":"pharmexec.com/pharmexec/Note…"}],"hashtags":[{"start":18,"end":32,"tag":"ClinicalTrial"},{"start":56,"end":61,"tag":"Data"},{"start":88,"end":103,"tag":"Pharmaceutical"}],"mentions":{},"annotations":{}},"id":"405365917103570945","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T16:02:20.000Z","conversation_id":"405365917103570945","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #ClinicalTrial Sponsors Struggle with #Data Disclosure Requirements - #Pharmaceutical Executive http://t.co/KsGT8kWRba","referenced_tweets":[{"type":"retweeted","id":"405346409169162241"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/R79dorsGZz","expanded_url":"http://www.biocentury.com/dailynews/politics/2013-11-25/fda-wants-more-transparency-for-meta-analyses","display_url":"biocentury.com/dailynews/poli…"}],"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":34,"end":47,"tag":"transparency"}],"mentions":{},"annotations":{}},"id":"405365638744379392","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T16:01:14.000Z","conversation_id":"405365638744379392","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #FDA wants more #transparency for meta-analyses http://t.co/R79dorsGZz","referenced_tweets":[{"type":"retweeted","id":"405343877130772480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/KbFdNTCEEW","expanded_url":"http://bit.ly/1jG16YF","display_url":"bit.ly/1jG16YF"}],"hashtags":[{"start":100,"end":112,"tag":"vaccination"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"405362830943088640","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T15:50:04.000Z","conversation_id":"405362830943088640","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: ADVANCE is born, European project for monitoring benefits and risks of vaccines #vaccination... http://t.co/KbFdNTCEEW","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/9G5z8eeQn0","expanded_url":"http://bit.ly/1bl0dFN","display_url":"bit.ly/1bl0dFN"},{"start":122,"end":144,"url":"http://t.co/DHntCHQqer","expanded_url":"http://bit.ly/1jG00w6","display_url":"bit.ly/1jG00w6"}],"hashtags":[{"start":37,"end":45,"tag":"ADVANCE"},{"start":89,"end":98,"tag":"vaccines"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"id":"405361600351059968","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T15:45:11.000Z","conversation_id":"405361600351059968","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @Aifa_ufficiale: European project #ADVANCE is born monitoring benefits &amp; risks of #vaccines http://t.co/9G5z8eeQn0 http://t.co/DHntCHQqer","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/jx5xSGbqZc","expanded_url":"http://www.outsourcing-pharma.com/Clinical-Development/Pfizer-Active-role-for-patients-as-smartphones-lead-way-in-virtual-trials?utm_source=AddThis&utm_medium=Twitter&utm_campaign=SocialMedia/#.UpSvy4_jYBw.twitter","display_url":"outsourcing-pharma.com/Clinical-Devel…"}],"hashtags":[{"start":18,"end":25,"tag":"Pfizer"},{"start":43,"end":52,"tag":"patients"},{"start":56,"end":68,"tag":"smartphones"},{"start":89,"end":96,"tag":"trials"}],"mentions":[{"start":125,"end":140,"username":"OutsourcPharma","id":"106451186"}],"annotations":{}},"id":"405361270817177600","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T15:43:52.000Z","conversation_id":"405361270817177600","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #Pfizer: Active role for #patients as #smartphones lead way in virtual #trials  http://t.co/jx5xSGbqZc via @OutsourcPharma","referenced_tweets":[{"type":"retweeted","id":"405342156107165696"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/BLcEo5MMpB","expanded_url":"http://reut.rs/18jS7go","display_url":"reut.rs/18jS7go"}],"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":29,"end":39,"tag":"Marketing"},{"start":55,"end":61,"tag":"Glaxo"},{"start":62,"end":71,"tag":"diabetes"},{"start":77,"end":85,"tag":"Avandia"}],"mentions":[{"start":113,"end":121,"username":"Reuters","id":"1652541"}],"annotations":{}},"id":"405361008538943488","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T15:42:50.000Z","conversation_id":"405361008538943488","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #FDA lifts #Marketing constraints on #Glaxo #diabetes drug #Avandia http://t.co/BLcEo5MMpB via @reuters","referenced_tweets":[{"type":"retweeted","id":"405341016107921408"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/3pwOuscKsz","expanded_url":"http://bit.ly/1jFZiz1","display_url":"bit.ly/1jFZiz1"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":[{"start":45,"end":51,"probability":0.3192,"type":"Organization","normalized_text":"Norlevo"}]},"id":"405360728158134272","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T15:41:43.000Z","conversation_id":"405360728158134272","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @LV_MPA: Emergency contraceptive product, Norlevo has low effect in women who weigh more than 75 kg http://t.co/3pwOuscKsz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/E4zpp5kFzI","expanded_url":"http://cordis.europa.eu/result/brief/rcn/11466_en.html","display_url":"cordis.europa.eu/result/brief/r…"}],"hashtags":[{"start":14,"end":25,"tag":"Scientific"},{"start":30,"end":38,"tag":"ethical"},{"start":51,"end":68,"tag":"neuropsychiatric"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":101,"end":116,"username":"maxplanckpress","id":"205195655"}],"annotations":{}},"id":"405349429193879552","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T14:56:49.000Z","conversation_id":"405349429193879552","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: #Scientific and #ethical advances in #neuropsychiatric research http://t.co/E4zpp5kFzI @maxplanckpress","referenced_tweets":[{"type":"retweeted","id":"405307838995914752"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/4SXP4UA8sC","expanded_url":"http://bit.ly/17PYyF6","display_url":"bit.ly/17PYyF6"}],"hashtags":[{"start":13,"end":21,"tag":"Vitekta"},{"start":23,"end":36,"tag":"elvitegravir"},{"start":42,"end":46,"tag":"HIV"}],"mentions":{},"annotations":{}},"id":"405306649994207233","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T12:06:50.000Z","conversation_id":"405306649994207233","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for #Vitekta (#elvitegravir) for #HIV is available on our website: http://t.co/4SXP4UA8sC","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/a5dQiZPM6v","expanded_url":"http://bit.ly/17PTMrn","display_url":"bit.ly/17PTMrn"}],"hashtags":[{"start":0,"end":8,"tag":"ADVANCE"},{"start":65,"end":74,"tag":"vaccines"}],"mentions":[{"start":99,"end":106,"username":"imi_ju","id":"1473203261469790214"},{"start":111,"end":119,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"405306509497606145","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T12:06:16.000Z","conversation_id":"405306509497606145","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#ADVANCE project will help monitoring of benefits &amp; risks of #vaccines; launched together with @IMI_JU and @ECDC_EU: http://t.co/a5dQiZPM6v","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/pNezff022q","expanded_url":"http://bit.ly/IqfzMv","display_url":"bit.ly/IqfzMv"}],"hashtags":[{"start":84,"end":88,"tag":"HTA"}],"mentions":{},"annotations":{}},"id":"405305873561423872","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T12:03:45.000Z","conversation_id":"405305873561423872","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Watch our workshop on parallel scientific advice with health-technology-assessment (#HTA) bodies today: http://t.co/pNezff022q","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":21,"tag":"ADVANCE"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":127,"end":134,"username":"imi_ju","id":"1473203261469790214"}],"annotations":{}},"id":"405305432064815104","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T12:01:59.000Z","conversation_id":"405305432064815104","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #ADVANCE project launched to improve benefit &amp; risk assessment of vaccines, ECDC to focus on implementability @IMI_JU http://t…","referenced_tweets":[{"type":"retweeted","id":"405303137130405888"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"annotations":{}},"id":"405299635951894528","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T11:38:57.000Z","conversation_id":"405299635951894528","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @MHRAmedicines: Company-led drug recalls: Company-led drug recall: Boots Pharmaceuticals liquid medicines - The Boots Company ... http:/…","referenced_tweets":[{"type":"retweeted","id":"405299404745506816"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/nArDyQkR9x","expanded_url":"http://www.ustream.tv/channel/european-medicines-agency","display_url":"ustream.tv/channel/europe…"}],"hashtags":[{"start":88,"end":100,"tag":"coiworkshop"},{"start":101,"end":110,"tag":"European"},{"start":111,"end":121,"tag":"Medicines"},{"start":122,"end":129,"tag":"Agency"}],"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"annotations":{}},"id":"405299523376779264","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T11:38:31.000Z","conversation_id":"405299523376779264","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eumsplatform: Live streaming on health-technology-assessment http://t.co/nArDyQkR9x #coiworkshop #European #Medicines #Agency","referenced_tweets":[{"type":"retweeted","id":"405299160812761088"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/rao7gGqGZH","expanded_url":"http://bit.ly/17PYyF6","display_url":"bit.ly/17PYyF6"}],"hashtags":[{"start":42,"end":50,"tag":"Vitekta"},{"start":52,"end":65,"tag":"elvitegravir"},{"start":71,"end":75,"tag":"HIV"}],"mentions":{},"annotations":{}},"id":"405297191050571776","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T11:29:15.000Z","conversation_id":"405297191050571776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Vitekta (#elvitegravir) for #HIV: http://t.co/rao7gGqGZH","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"}],"annotations":[{"start":65,"end":70,"probability":0.9935,"type":"Place","normalized_text":"Europe"}]},"id":"405294991188062208","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T11:20:30.000Z","conversation_id":"405290862344536064","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@xOneStepBehind We do not deal with patents, pricing or trade in Europe (or the Pacific region): http://t.co/Z7GrvbXFM6","referenced_tweets":[{"type":"replied_to","id":"405290862344536064"}],"in_reply_to_user_id":"40722651","attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"id":"405291092817354753","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T11:05:01.000Z","conversation_id":"405291092817354753","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: EMA: Workshop on parallel scientific advice with health-technology-assessment bodies is taking place now: http://t.co/JwU0oRlV…","referenced_tweets":[{"type":"retweeted","id":"405290495682699264"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/yl7A7C5T2V","expanded_url":"http://bit.ly/17PTMrn","display_url":"bit.ly/17PTMrn"}],"hashtags":[{"start":0,"end":8,"tag":"ADVANCE"},{"start":64,"end":73,"tag":"vaccines"}],"mentions":{},"annotations":{}},"id":"405288630471909376","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T10:55:14.000Z","conversation_id":"405288630471909376","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#ADVANCE, European project for monitoring benefits and risks of #vaccines throughout their lifecycle launched: http://t.co/yl7A7C5T2V","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/Hj7x8wF10Z","expanded_url":"http://bit.ly/17POj3P","display_url":"bit.ly/17POj3P"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":106,"end":114,"username":"ECDC_EU","id":"204752573"},{"start":115,"end":124,"username":"EMA_News","id":"116716199"},{"start":125,"end":129,"username":"GSK","id":"5383942"}],"annotations":{}},"id":"405282575704285184","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T10:31:10.000Z","conversation_id":"405282575704285184","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: IMI project ADVANCE will improve vaccine benefit &amp; risk assessment http://t.co/Hj7x8wF10Z @ECDC_EU @EMA_News @GSK @erasmusmcnie…","referenced_tweets":[{"type":"retweeted","id":"405282205397565441"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/rW4yuxNtU6","expanded_url":"http://www.usatoday.com/story/news/nation/2013/11/25/fda-overturns-safety-limits-on-diabetes-drug/3708245/","display_url":"usatoday.com/story/news/nat…"}],"hashtags":[{"start":18,"end":22,"tag":"FDA"},{"start":33,"end":40,"tag":"safety"},{"start":51,"end":60,"tag":"diabetes"}],"mentions":[{"start":93,"end":102,"username":"USATODAY","id":"15754281"}],"annotations":{}},"id":"405282449174716416","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T10:30:40.000Z","conversation_id":"405282449174716416","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @sailinsomnia: #FDA overturns #safety limits on #diabetes drug http://t.co/rW4yuxNtU6 via @USATODAY","referenced_tweets":[{"type":"retweeted","id":"405281548791857152"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/9DvBxt11DG","expanded_url":"http://ow.ly/rbHei","display_url":"ow.ly/rbHei"}],"hashtags":[{"start":109,"end":114,"tag":"GIST"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"405282244681424896","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T10:29:51.000Z","conversation_id":"405282244681424896","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myESMO: @EMA_News recommends refusal of Marketing Authorisation for Masitinib, intended for treatment of #GIST http://t.co/9DvBxt11DG","referenced_tweets":[{"type":"retweeted","id":"405275601562787840"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/GzIeNAYdgw","expanded_url":"http://bit.ly/IqfzMv","display_url":"bit.ly/IqfzMv"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"405272404001570816","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T09:50:45.000Z","conversation_id":"405272404001570816","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Workshop on parallel scientific advice with health-technology-assessment bodies is taking place now. Watch online: http://t.co/GzIeNAYdgw","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/4Bgu766hEm","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36277","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":64,"end":69,"probability":0.9969,"type":"Place","normalized_text":"London"}]},"id":"405271602452905984","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T09:47:34.000Z","conversation_id":"405271602452905984","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @GCessak: New research centre on dementia opens its doors in London http://t.co/4Bgu766hEm …","referenced_tweets":[{"type":"retweeted","id":"405267144604020736"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/x1tULk8aZE","expanded_url":"http://shar.es/Dbggx","display_url":"shar.es/Dbggx"}],"hashtags":{},"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"},{"start":108,"end":118,"username":"ShareThis","id":"14116807"}],"annotations":[{"start":21,"end":26,"probability":0.4501,"type":"Person","normalized_text":"AbbVie"},{"start":29,"end":37,"probability":0.6719,"type":"Person","normalized_text":"Intermune"}]},"id":"405267720737804288","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-26T09:32:08.000Z","conversation_id":"405267720737804288","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IlariaPassarani: AbbVie, Intermune and the EMA – Court cases and motivations http://t.co/x1tULk8aZE via @sharethis","referenced_tweets":[{"type":"retweeted","id":"405266236260372480"}],"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/WPB6ktms4K","expanded_url":"http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=36277","display_url":"cordis.europa.eu/fetch?CALLER=E…"}],"hashtags":[{"start":37,"end":46,"tag":"dementia"},{"start":66,"end":73,"tag":"London"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"id":"405026547687374848","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T17:33:48.000Z","conversation_id":"405026547687374848","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: New research centre on #dementia opens its doors in #London http://t.co/WPB6ktms4K","referenced_tweets":[{"type":"retweeted","id":"405024559348600832"}],"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/OKBRv0Xj73","expanded_url":"http://bit.ly/1jALzcK","display_url":"bit.ly/1jALzcK"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"404997035511672833","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T15:36:32.000Z","conversation_id":"404997035511672833","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The EPAR for Lidocaine/Prilocaine Plethora is now available: http://t.co/OKBRv0Xj73","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/Ujzs3nnSYz","expanded_url":"http://bit.ly/1dviDFz","display_url":"bit.ly/1dviDFz"}],"hashtags":[{"start":14,"end":18,"tag":"SME"}],"mentions":{},"annotations":{}},"id":"404996727028985856","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T15:35:18.000Z","conversation_id":"404996727028985856","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"It's European #SME Week. Check our website for details on our work with pharmaceutical SMEs: http://t.co/Ujzs3nnSYz","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/s3DPyXwGBN","expanded_url":"http://bit.ly/1bu7MaC","display_url":"bit.ly/1bu7MaC"}],"hashtags":[{"start":110,"end":121,"tag":"regaffairs"},{"start":122,"end":129,"tag":"pharma"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"},{"start":130,"end":139,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"404995954161381377","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T15:32:14.000Z","conversation_id":"404995954161381377","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @TOPRANEWS: Last chance to book for the EMA Review of the Year and Outlook for 2014 http://t.co/s3DPyXwGBN #regaffairs #pharma @EMA_News","referenced_tweets":[{"type":"retweeted","id":"404944243958902785"}],"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/xZ3b8gMGfi","expanded_url":"http://bit.ly/1cLc7FH","display_url":"bit.ly/1cLc7FH"}],"hashtags":[{"start":66,"end":70,"tag":"HTA"}],"mentions":{},"annotations":{}},"id":"404976331206959104","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T14:14:16.000Z","conversation_id":"404976331206959104","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're holding a joint workshop on parallel scientific advice with #HTA bodies tomorrow. Watch it live on our website: http://t.co/xZ3b8gMGfi","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/haCTYYWrOJ","expanded_url":"http://bit.ly/1jALzcK","display_url":"bit.ly/1jALzcK"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"404931710854631424","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:16:57.000Z","conversation_id":"404931710854631424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for a newly approved medicine, Lidocaine/Prilocaine Plethora: http://t.co/haCTYYWrOJ","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/8GsFvgJEu9","expanded_url":"http://bit.ly/1dviDFz","display_url":"bit.ly/1dviDFz"}],"hashtags":[{"start":26,"end":30,"tag":"SME"}],"mentions":{},"annotations":{}},"id":"404931130123902976","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:14:39.000Z","conversation_id":"404931130123902976","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're supporting European #SME Week. Check our website for details on our work with SMEs: http://t.co/8GsFvgJEu9","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/ouON7w6FJn","expanded_url":"http://bit.ly/1i1AYfp","display_url":"bit.ly/1i1AYfp"}],"hashtags":[{"start":32,"end":41,"tag":"Abraxane"},{"start":66,"end":77,"tag":"pancreatic"},{"start":78,"end":85,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"404928483668668416","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:04:08.000Z","conversation_id":"404928483668668416","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"We recommended extending use of #Abraxane to include treatment of #pancreatic #cancer: http://t.co/ouON7w6FJn","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/SdNvISL7B7","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"hashtags":[{"start":31,"end":35,"tag":"HIV"}],"mentions":{},"annotations":{}},"id":"404928286175674368","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:03:21.000Z","conversation_id":"404928286175674368","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"We recommended approval of new #HIV medicine: http://t.co/SdNvISL7B7","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/6GdMNc4PWF","expanded_url":"http://bit.ly/1i1ALJf","display_url":"bit.ly/1i1ALJf"}],"hashtags":[{"start":45,"end":58,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"id":"404927978422800384","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:02:07.000Z","conversation_id":"404927978422800384","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We recommended two new treatment options for #tuberculosis: http://t.co/6GdMNc4PWF","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/1Lqp35yNgG","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":[{"start":35,"end":47,"tag":"daclatasvir"}],"mentions":{},"annotations":{}},"id":"404927660783988736","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:00:52.000Z","conversation_id":"404927660783988736","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We advised on compassionate use of #daclatasvir: http://t.co/1Lqp35yNgG","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/D8cMLabt1c","expanded_url":"http://bit.ly/1bIip72","display_url":"bit.ly/1bIip72"}],"hashtags":[{"start":27,"end":38,"tag":"sofosbuvir"},{"start":68,"end":78,"tag":"hepatitis"}],"mentions":{},"annotations":{}},"id":"404927514843152384","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T11:00:17.000Z","conversation_id":"404927514843152384","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"We recommended approval of #sofosbuvir for the treatment of chronic #hepatitis C: http://t.co/D8cMLabt1c","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/GhPrJLaXjy","expanded_url":"http://bit.ly/1fqSKGT","display_url":"bit.ly/1fqSKGT"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"404927369703456769","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T10:59:42.000Z","conversation_id":"404927369703456769","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Last Friday we published the CHMP meeting highlights: http://t.co/GhPrJLaXjy","referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/laohjOblaV","expanded_url":"http://bit.ly/19NKmJm","display_url":"bit.ly/19NKmJm"}],"hashtags":[{"start":34,"end":51,"tag":"thiocolchicoside"}],"mentions":{},"annotations":{}},"id":"404927169702289408","author_id":"116716199","possibly_sensitive":false,"created_at":"2013-11-25T10:58:55.000Z","conversation_id":"404927169702289408","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We recommended restricting use of #thiocolchicoside by mouth or injection: http://t.co/laohjOblaV","referenced_tweets":{},"attachments":{"media_keys":{}}}]
